WO2016121923A1 - Muscle synthesis promoter - Google Patents
Muscle synthesis promoter Download PDFInfo
- Publication number
- WO2016121923A1 WO2016121923A1 PCT/JP2016/052638 JP2016052638W WO2016121923A1 WO 2016121923 A1 WO2016121923 A1 WO 2016121923A1 JP 2016052638 W JP2016052638 W JP 2016052638W WO 2016121923 A1 WO2016121923 A1 WO 2016121923A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- protein
- weight
- muscle synthesis
- liquid composition
- milk
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Definitions
- the present invention relates to a muscle synthesis promoter.
- whey protein whey protein
- casein protein made from milk
- Whey protein has a high rate (absorption time) from ingestion to digestion and absorption (short time) and contains a lot of BCAA (branched chain amino acids: valine, leucine, isoleucine), thus preventing muscle fatigue, It is said that muscles can be strengthened efficiently.
- BCAA branched chain amino acids: valine, leucine, isoleucine
- casein protein is metabolized slowly and continuously compared to whey protein, so the rate from absorption to digestion and absorption (slow absorption rate) is slow (long time), and immediate muscle synthesis promotion is required. It is said that it is unsuitable for the target (see Japanese Patent Application Publication No. 2009-507044). Therefore, whey protein is mainly used as protein powder.
- Non-patent Document 1 Proceedings of the 64th Annual Meeting of the Japanese Society of Physical Education
- milk protein-enriched milk drinks are associated with exercise load compared to normal milk as food to be taken immediately after exercise It has been shown to be more effective in making the body.
- Non-patent Document 1 Proceedings of the 64th Annual Meeting of the Japanese Society of Physical Education, 2013, page 166, for the purpose of intake of a large amount of milk protein is used as an active ingredient.
- a muscle synthesis promoter that does not necessarily require the intake of a large amount of milk protein and has a muscle synthesis promotion effect equivalent to or higher than the muscle synthesis promotion effect is known. Therefore, it has been a problem to provide a new muscle synthesis promoter that exhibits such effects.
- milk protein contributes to the muscle synthesis promoting effect in a dose-dependent manner in the prior art, but 0.2 to 1.2% by weight.
- the acidic liquid composition containing a protein mixture is a non-fat dry milk solution, that is, a muscle synthesis promoter containing a neutral liquid composition consisting only of a large amount of milk protein mixture as an active ingredient (for example, Non-patent Document 1: The Japanese Society of Physical Education) Compared to the 64th Annual Meeting Proceedings, 2013, p.
- the present invention is as follows. [1] 0.2-1.2% by weight of soybean polysaccharide, 0.1-0.5% by weight of HM pectin, 0.01-0.1% by weight of fibrous insoluble cellulose, and casein protein
- a muscle synthesis promoter comprising an acidic liquid composition containing a milk protein mixture containing whey protein as an active ingredient, wherein the protein amount ratio of casein protein to whey protein (casein protein / whey protein) is 2 to 20 A muscle synthesis promoter, [2] The muscle synthesis promoter according to [1], wherein the acidic liquid composition further comprises 0.5 to 5% by weight of trehalose, [3] The muscle synthesis promoter according to [1] or [2], wherein the acidic liquid composition has a pH of 3 to 6, [4] The muscle synthesis promoter according to any one of [1] to [3], wherein the fibrous insoluble cellulose is fermented cellulose, [5] In any one of [1] to [4], the milk protein mixture contained in the
- the muscle synthesis promoter according to the description, [6]
- the unit packaging form according to any one of [1] to [5], comprising a unit packaging form per serving, wherein the unit packaging form contains a milk protein mixture in a total protein amount of 3 to 40 g as a meal intake.
- muscle synthesis promoter according to any one of [1] to [6] for a subject to exercise, [8] The muscle synthesis promoter according to [7], wherein the exercise is muscle training, [9] 0.2-1.2% by weight soybean polysaccharide, 0.1-0.5% by weight HM pectin, 0.01-0.1% by weight fibrous insoluble cellulose, and casein protein
- a method for promoting muscle synthesis comprising ingesting an acidic liquid composition containing a milk protein mixture containing whey protein to a subject in need of muscle synthesis promotion, wherein the protein amount ratio of casein protein to whey protein (Casein protein / whey protein) is 2 to 20, a method for promoting muscle synthesis, [10] 0.2-1.2% by weight soybean polysaccharide, 0.1-0.5% by weight HM pectin, 0.01-0.1% by weight fibrous insoluble cellulose, and casein protein A method for promoting muscle synthesis (excluding medical practices for humans), comprising
- the effect of promoting muscle synthesis can be enhanced, and a neutral liquid containing milk protein at the same concentration
- the muscle synthesis promoting effect equivalent to or higher than the muscle synthesis promoting effect comprising the composition as an active ingredient can be exhibited. Therefore, according to the present invention, an effect of promoting muscle synthesis can be achieved without necessarily ingesting a large amount of milk protein.
- the rate of skeletal muscle synthesis (FSR (% / day)) when the muscle synthesis promoter of the present invention (milk protein 3.4 wt%) and skim milk powder solution (milk protein 3.4 wt%) were orally administered. It shows the transition. Skeletal muscle synthesis rate (FSR (% / day) when orally administered with the muscle synthesis promoter of the present invention (milk protein 3.4 wt%) and a high-dose skim milk solution (milk protein 6.8 wt%). ).
- the muscle synthesis promoter of the present invention comprises an acidic liquid composition as an active ingredient, and is preferably a muscle synthesis promoter containing an acidic liquid composition as an active ingredient.
- the muscle synthesis promoter of the present invention is an acidic liquid composition comprising a soy polysaccharide, HM pectin, fibrous insoluble cellulose, and a milk protein mixture containing casein protein and whey protein in a specific protein ratio. It is a muscle synthesis promoter comprising a product as an active ingredient. More specifically, the muscle synthesis promoter of the present invention comprises 0.2 to 1.2% by weight soybean polysaccharide, 0.1 to 0.5% by weight HM pectin, 0.01 to 0.1% by weight.
- % Muscle insoluble cellulose and a muscle synthesis promoter comprising an acidic liquid composition containing a milk protein mixture containing casein protein and whey protein as an active ingredient, the protein amount ratio of casein protein to whey protein It is a muscle synthesis promoter having (casein protein / whey protein) of 2 to 20.
- the muscle synthesis promoter of the present invention is used for a subject in need of immediate acceleration of muscle synthesis.
- Active ingredient means an ingredient required for exerting a muscle synthesis promoting effect.
- the “active ingredient” means an ingredient required for exerting a muscle synthesis promoting effect for a subject requiring immediate muscle synthesis promotion.
- “Promoting muscle synthesis” means promoting the synthesis of muscle by taking milk protein and absorbing it in the body as a nutrient. Therefore, the muscle synthesis promoter of the present invention is used for that and the state resulting therefrom.
- the purpose of muscle synthesis promotion includes muscle gain, muscle growth promotion, muscle tissue repair, muscle strengthening, muscle strength improvement, health promotion effect and muscle performance improvement accompanying muscle synthesis promotion, preferably muscle tissue repair, It is the improvement of muscular strength, the health promotion effect accompanying the promotion of muscle synthesis and the improvement of exercise ability. Promoting muscle synthesis also includes assimilation of muscle proteins from amino acids.
- “Immediately effective muscle synthesis promotion” means promoting muscle synthesis accompanying immediate absorption of milk protein.
- Subjects needing muscle synthesis promotion means subjects who need to promote muscle protein synthesis in order to repair muscle tissue and promote muscle growth. For the purpose of this, it means a subject who exercises to promote muscle synthesis, prevent muscle loss, and promote recovery of muscle mass.
- the exercise is preferably strength training (resistance exercise), and more preferably long-term strength training, for example, in that muscle synthesis is promoted by applying a certain load to muscle strength. It is strength training that is continued for 30 minutes to 5 hours at a frequency of 1 to 7 days in a week. Examples of strength training include dumbbell exercise, squat exercise, and machine training.
- the target may be an animal other than a human (domestic animals such as horses and cows, pets such as dogs and cats, appreciation animals kept in zoos, and the like).
- the time when the muscle synthesis promoter of the present invention is ingested (administered) to a subject in need of muscle synthesis may be before exercise, after exercise, or during exercise.
- the time of intake is preferably after exercise, more preferably immediately after exercise.
- the intake period is preferably within 3 hours after the end of exercise, immediately after exercise. More preferably, within 2 hours after the end of exercise, more preferably within 1 hour after the end of exercise, and particularly preferably within 30 minutes after the end of exercise (Levenhagenhaet al. Am J physiol Endocrinol Metab (2001), 280, E982-E993).
- the neutral muscle composition promoting effect equivalent to a neutral liquid composition containing milk protein at the same concentration is a neutral liquid composition containing milk protein at the same concentration (for example, milk, skim milk, It means the same level of the rate of protein absorption and the same effect as the muscle synthesis promoting effect associated with the absorption observed when orally ingested (administered) (concentrated milk, skim concentrated milk, etc.).
- an immediate effect of promoting muscle synthesis equivalent to a neutral liquid composition containing milk protein at the same concentration is a neutral liquid composition containing milk protein at the same concentration (for example, , Milk, skim milk, concentrated milk, concentrated skim milk, etc.), the same level of protein absorption rate and the same level of muscle synthesis promoting effect associated with the absorption Means effect.
- the effect of promoting muscle synthesis can be confirmed by, for example, measuring the upper limb triceps muscle synthesis rate (FSR) within 1 hour after administration of the test substance after the swimming test of rats. it can.
- FSR upper limb triceps muscle synthesis rate
- the FSR of the test group is comparable or comparable to the FSR of the control group that orally ingested a neutral liquid composition containing milk protein that is said to have an immediate effect of promoting muscle synthesis at the same concentration.
- the immediate effect of promoting muscle synthesis is preferably a rate of synthesizing muscle in a short time after ingesting the muscle synthesis promoter of the present invention, more preferably within 30 minutes to 3 hours after ingestion, more preferably Can be confirmed by measuring the rate of muscle synthesis within 30 minutes to 2 hours after ingestion, more preferably within 30 minutes to 1 hour after ingestion, and particularly preferably 30 minutes after ingestion.
- Protein amount means the amount of protein as a polymer of amino acids contained in various proteins such as milk protein, whey protein or casein protein.
- Protein amount ratio means the ratio of the amount of protein as a polymer of amino acids contained in various proteins such as milk protein, whey protein, or casein protein.
- the amount of protein may be calculated based on known information such as a food composition table, or may be calculated by measuring by a conventional method such as Kjeldahl method or Raleigh method. Actually, in the case of the Kjeldahl method, it can be calculated by measuring nitrogen contained in various proteins and multiplying the value by a nitrogen-protein conversion factor (usually 6.25).
- the acidic liquid composition used in the present invention includes 0.2 to 1.2% by weight of soybean polysaccharide, 0.1 to 0.5% by weight of HM pectin, and 0.01 to 0.1% by weight of fiber. And a milk protein mixture containing casein protein and whey protein in a specific protein amount ratio, and an acidified liquid composition.
- the acidic liquid composition used in the present invention may not be completely liquid, and may be partly solid and / or gel.
- the milk protein mixture contained in the acidic liquid composition used in the present invention is not particularly limited as long as it contains whey protein and casein protein in a specific protein amount ratio, and is separated and purified separately from whey protein.
- Casein protein may be prepared by mixing to a specific protein amount ratio, or it may already contain whey protein and casein protein that have not been separated or purified separately at a specific protein amount ratio. You may mix and prepare a raw material (raw material), a foodstuff, etc. At this time, the milk protein mixture used in the present invention does not require a separation step or purification step of whey protein or casein protein, and the production cost thereof is low, so that whey protein and casein protein are already specified. It can be prepared by mixing the raw materials and foods contained in the protein amount ratio as the main components, and mixing the whey protein and casein protein, which are separately purified, if necessary, so that the specific protein amount ratio is obtained. preferable.
- whey protein separated and purified separately from casein protein examples include whey stock solutions (sweet whey, acid whey, etc.), concentrates, dried products (whey powder, etc.), frozen products, hydrolyzed products, etc. And reducing solutions thereof. Further, desalted whey, whey protein concentrate (WPC), purified whey protein (WPI), ⁇ -lactalbumin ( ⁇ -La), ⁇ -lactoglobulin ( ⁇ -Lg), immunoglobulin, lactoferrin, and the like, and These reducing solutions can be used.
- Casein protein separated and purified separately from whey protein includes, for example, casein isolate (natural cheese such as fresh cheese, sodium caseinate, calcium caseinate), its concentrate, its dried product, its A frozen material, a hydrolyzate thereof, a reducing solution thereof, and the like can be used. Furthermore, purified products such as ⁇ -casein, ⁇ -casein, k-casein, and reducing solutions thereof can be used.
- raw materials and foods that already contain whey protein and casein protein in a specific protein amount ratio include, for example, raw milk, pasteurized milk (such as milk), skim milk, component-adjusted milk, processed milk, and dairy products (concentrated) Milk, powdered milk, condensed milk, fermented milk (such as yogurt), lactic acid bacteria beverages, processed cheeses, ice creams, creams), milk protein concentrate (MPC), its concentrate, its dried product, its frozen product, its water Decomposed products and the like, and reducing solutions thereof can be used.
- raw milk pasteurized milk (such as milk), skim milk, component-adjusted milk, processed milk, and dairy products (concentrated) Milk, powdered milk, condensed milk, fermented milk (such as yogurt), lactic acid bacteria beverages, processed cheeses, ice creams, creams), milk protein concentrate (MPC), its concentrate, its dried product, its frozen product, its water Decomposed products and the like, and reducing solutions thereof can be used.
- the milk protein mixture is a milk protein concentrate that is a milk raw material rich in casein protein in that it is easy to prepare an acidic liquid composition containing a milk protein mixture containing a high concentration of casein protein.
- MPC casein protein / whey protein
- the protein amount ratio of casein protein to whey protein is 4. At this time, you may obtain and use a commercial item for these, and may prepare and use it for themselves.
- the milk protein mixture contained in the acidic liquid composition used in the present invention is composed of whey protein and casein protein in a specific protein amount ratio.
- the protein amount ratio between casein protein and whey protein ( Casein protein / whey protein) is 2 to 20, preferably 2 to 10, more preferably 2 to 6, and further preferably 2 to 4.
- the protein amount ratio between casein protein and whey protein means the protein amount ratio in the milk protein mixture contained in the acidic liquid composition contained in the muscle synthesis promoter.
- the amount ratio of casein protein to whey protein (casein protein / whey protein) is intentionally adjusted (designed), and further prepared into an acidic liquid composition. In this respect, it is very different from the prior art.
- the acidic liquid composition used in the present invention generally has a milk protein mixture containing a high concentration of casein protein, where the casein protein in the milk protein is likely to coagulate with acid and separation and precipitation resulting from the acid coagulation occur. Even the contained acidic liquid composition is in a form that suppresses separation and precipitation, has good redispersibility, is low in viscosity, and is easy to ingest (administer). If it is the range applicable to this form, the detailed property (pH, viscosity, etc.) can be designed arbitrarily.
- the pH of the acidic liquid composition used in the present invention is, for example, 3 to 6, 3.1 to 5.8, 3.2 to 5.6, 3.3 to 5.4, 3.4 to 5.2. 3.5-5, 3.6-4.8, 3.7-4.6, 3.8-4.4. It is preferable that the pH of the acidic liquid composition of the present invention exceeds 3 in order to prevent the acidity from being felt strongly and difficult to take. Moreover, it is preferable that the pH of the acidic liquid composition of the present invention is less than 6 in order to prevent the acidity from being felt weakly refreshing and difficult to take as an acidic liquid composition.
- the viscosity (10 ° C.) of the acidic liquid composition used in the present invention is the viscosity of the acidic liquid composition measured with a B-type rotational viscometer.
- the viscosity (10 ° C.) of the acidic liquid composition used in the present invention is, for example, 3 to 30 mPa ⁇ s, 3.5 to 30 mPa ⁇ s, 4 to 30 mPa ⁇ s, 4.5 to 30 mPa ⁇ s, 5 to 30 mPa.
- the viscosity (10 ° C.) of the acidic liquid composition used in the present invention is less than 30 mPa ⁇ s in order to prevent refreshing from being impaired and difficult to take.
- the viscosity (10 ° C.) of the acidic liquid composition used in the present invention is the viscosity of the acidic liquid composition measured with a general-purpose B-type rotational viscometer such as a Brookfield viscometer.
- the acidic liquid composition used in the present invention comprises a milk protein mixture containing casein protein and whey protein in a specific protein amount ratio.
- the casein protein contained in the milk protein mixture is generally stable in a neutral region, but in an environment in a pH region lower than around the isoelectric point of pH 4.6, casein protein is caused by acid coagulation. Aggregates with each other, leading to separation of the acidic liquid composition and occurrence of precipitation.
- the acidic liquid composition comprising a specific composition used in the present invention is an acidic liquid composition containing a milk protein mixture containing a high concentration of casein protein, separation and precipitation of the acidic liquid composition is suppressed.
- the redispersibility is good, and the form is low in viscosity and easy to ingest.
- concentration of the milk protein mixture containing casein protein contained in the acidic liquid composition used in the present invention is high, for example, 3% by weight or more and 3.2% by weight 3.4% or more, 3.6% or more, 3.8% or more, 4% or more, 4.2% or more, 4.4% or more, 3 to 10%, 3 to 9.5 wt%, 3-9 wt%, 3-8.5 wt%, 3-8 wt%, 3-7.5 wt%, 3-7 wt%, 3.2-10 wt%, 2 to 9.5 wt%, 3.2 to 9 wt%, 3.2 to 8.5 wt%, 3.2 to 8 wt%, 3.2 to 7.5 wt%, 3.2 to 7 wt% %, 3.4-10 wt%, 3.4-9.5 wt%, 3.4-9 wt%, 3.4-8.5 wt%, 3.4-8 wt%
- the concentration of the milk protein mixture containing casein protein contained in the acidic liquid composition used in the present invention is not high, it is, for example, 3% by weight or less, 2.8% by weight or less, 2 .6% by weight or less, 2.4% by weight or less, 2.2% by weight or less, 2% by weight or less, 0.5 to 3% by weight, 1 to 3% by weight, 1.2 to 3% by weight, 1.4 ⁇ 3 wt%, 1.6-3 wt%, 1.8-3 wt%, 0.5-2.8 wt%, 1-2.8 wt%, 1.2-2.8 wt%, 1 4.4 to 2.8 wt%, 1.6 to 2.8 wt%, 1.8 to 2.8 wt%, 0.5 to 2.6 wt%, 1 to 2.6 wt%, 1.2 ⁇ 2.6 wt%, 1.4-2.6 wt%, 1.6-2.6 wt%, 1.8-2.6 wt%, 0.5-2.4 wt%, 1-2 .
- each concentration of the casein protein and the whey protein contained in the milk protein mixture can be easily calculated from the protein amount ratio of the casein protein and the whey protein described above.
- the acidic liquid composition used in the present invention is an acidic liquid composition containing a milk protein mixture containing a high concentration of casein protein, separation and precipitation of the acidic liquid composition are suppressed, and redispersibility is also good.
- it may contain 2 to 1.2% by weight soybean polysaccharide, 0.1 to 0.5% by weight HM pectin, 0.01 to 0.1% by weight fibrous insoluble cellulose.
- the soybean polysaccharide of the present invention may be one containing one or more of rhamnose, galactose, arabinose, xylose, glucose and uronic acid derived from soybean, and among soybeans, those derived from cotyledons are preferable.
- the molecular weight of the soybean polysaccharide of the present invention is not particularly limited and is preferably a high molecular weight, and preferably has an average molecular weight of several thousand to several million, specifically 5,000 to 1,000,000. .
- the average molecular weight of the soybean polysaccharide is a value determined by an intrinsic viscosity method using a standard pullulan (Showa Denko KK) as a standard substance and measuring the viscosity in a 0.1M NaNO 3 solution.
- Such soybean polysaccharides are commercially available, for example, SM-700 (manufactured by San-Ei Gen FFI Co., Ltd.) and SM-900 (manufactured by San-Ei Gen FFI Co., Ltd.). Soy polysaccharides are said to suppress the separation and precipitation of acidic liquid compositions caused by acid coagulation between casein proteins in acidic liquid compositions due to the structure of their side chains.
- the addition amount of the soybean polysaccharide of the present invention is 0.1 to 0.5% by weight of HM pectin and 0.01 to 0.1% by weight of fibrous material with respect to the acidic liquid composition used in the present invention.
- insoluble cellulose is contained, for example, 0.2 to 1.2% by weight, 0.25 to 1.15% by weight, 0.3 to 1.1% by weight, 0.35 to 1.05% by weight 0.4 to 1 wt%, 0.4 to 0.9 wt%.
- the added amount of the soybean polysaccharide of the present invention is less than 1.2% by weight, the acidic liquid composition can feel a unique flavor of soybean, and it is difficult to prevent the acidic liquid composition from being ingested. Is preferable.
- the addition amount of the soybean polysaccharide of the present invention exceeds 0.2% by weight, even if it is an acidic liquid composition containing a milk protein mixture containing a high concentration of casein protein. Separation of liquid composition and occurrence of precipitation can be suppressed, and redispersibility is also improved. Finally, when taken as a muscle synthesis promoter of the present invention, milk protein curdization in the stomach is achieved. It is preferable in terms of preventing, promoting absorption of milk protein, and enhancing the effect of promoting muscle synthesis.
- the HM pectin of the present invention is an acidic polysaccharide having ⁇ -D-galacturonic acid as a main chain component, which exists as a cell wall component in vegetables and fruits.
- Galacturonic acid constituting pectin is partially methyl esterified and is divided into LM pectin and HM pectin depending on the degree of esterification.
- HM pectin generally has a degree of esterification of 50% or more.
- Such HM pectin is commercially available, for example, SM-478 (manufactured by Saneigen FFI, Inc.), SM-666 (manufactured by Saneigen FFI, Inc.), AYD5110SB (manufactured by Unitech Foods, Inc.). )and so on.
- HM pectin is characterized by being negatively charged, and is said to prevent aggregation of casein proteins by binding to the casein protein, and the bound casein proteins repel each other due to the charge
- HM pectin of the present invention is 0.2 to 1.2% by weight of soybean polysaccharide and 0.01 to 0.1% by weight of fibrous form with respect to the acidic liquid composition used in the present invention.
- insoluble cellulose is contained, for example, 0.1 to 0.5% by weight, 0.1 to 0.45% by weight, 0.1 to 0.4% by weight, 0.1 to 0.35% by weight 0.1-0.3 wt%, 0.12-0.29 wt%, 0.14-0.28 wt%, 0.16-0.27 wt%, 0.18-0.26 wt% 0.2 to 0.25% by weight.
- HM pectin of the present invention When the added amount of HM pectin of the present invention is less than 0.5% by weight, even an acidic liquid composition containing a milk protein mixture containing a high concentration of casein protein has a low viscosity and is easily ingested. Preferred above. Moreover, even if it is an acidic liquid composition containing the milk protein mixture containing a high concentration casein protein that the addition amount of HM pectin of this invention exceeds 0.1 weight%, the acidic liquid used by this invention Separation of the composition and occurrence of precipitation can be suppressed, and redispersibility is also improved. Finally, when taken as a muscle synthesis promoter of the present invention, prevention of curding milk protein in the stomach is prevented. It is preferable in terms of promoting absorption of milk protein and enhancing muscle synthesis promoting effect.
- the acidic liquid composition used in the present invention is an acidic liquid composition containing a milk protein mixture containing a high concentration of casein protein, separation and precipitation of the acidic liquid composition is suppressed, and redispersibility is also achieved. It is a good, low-viscosity, easy-to-ingest form, and when ingested as a muscle synthesis promoter of the present invention, it prevents the formation of curd of milk protein in the stomach and promotes absorption of milk protein and then muscles.
- stabilizers such as sodium carboxymethylcellulose and / or alginate propylene glycol ester may be used in combination with soybean polysaccharide and / or HM pectin or in place of soybean polysaccharide and / or HM pectin. Can be added.
- other stabilizers such as sodium carboxymethylcellulose and / or propylene glycol alginate, have a lower viscosity and inhibit the separation and precipitation of acidic liquid compositions at lower viscosity compared to soy polysaccharides and / or HM pectin.
- the dispersibility is also good. It is preferably used in combination with polysaccharides and / or HM pectin, or instead of soybean polysaccharides and / or HM pectin.
- sodium carboxymethyl cellulose can be added.
- Sodium carboxymethyl cellulose is obtained by substituting a carboxymethyl group for the hydroxyl group of glucose of cellulose, and usually has a degree of etherification of about 0.6 to 1.5.
- Such sodium carboxymethylcellulose is commercially available, for example, Serogen F-SL (Daiichi Kogyo Seiyaku), Serogen F-810A (Daiichi Kogyo Seiyaku), Serogen F-SB (Daiichi Kogyo). Pharmaceutical Co., Ltd.), Serogen F-820B (Daiichi Kogyo Seiyaku Co., Ltd.), Serogen F-1220B (Daiichi Kogyo Seiyaku Co., Ltd.), and the like.
- Alginic acid propylene glycol ester can be added to the acidic liquid composition used in the present invention.
- Alginate propylene glycol ester is a substance obtained by chemically modifying polysaccharide alginic acid purified from algal algae such as kombu and wakame.
- propylene glycol alginate is commercially available.
- Tac Lloyd LF-M manufactured by Kikkoman Biochemifa
- Tacroid EF manufactured by Kikkoman Biochemifa
- Tacroid PF manufactured by Kikkoman Biochemifa
- Tuck Lloyd PF-H manufactured by Kikkoman Biochemifa
- the addition amount of sodium carboxymethylcellulose or propylene glycol alginate of the present invention is an acidic liquid composition containing a milk protein mixture containing a high concentration of casein protein, which is a feature of the acidic liquid composition used in the present invention.
- it suppresses separation and precipitation of acidic liquid composition has good redispersibility, is in a form that is low in viscosity and easy to ingest, and when ingested as a muscle synthesis promoter, it is a milk protein card in the stomach.
- the amount added is not limited.
- the amount of sodium carboxymethylcellulose or propylene glycol alginate added to the acidic liquid composition used in the present invention is, for example, 0.01 to 2% by weight, 0.01 to 1.5% by weight, 0.01 to 1.2% by weight, 0.01 to 1.0% by weight. If the addition amount of sodium carboxymethylcellulose or propylene glycol alginate of the present invention is 2% by weight, even an acidic liquid composition containing a milk protein mixture containing a high concentration of casein protein can be easily ingested with low viscosity. It is preferable in terms of form.
- the fibrous insoluble cellulose of the present invention is contained in the acidic liquid composition used in the present invention, and by constructing a three-dimensional network structure in the acidic liquid composition, dispersion of insoluble components such as precipitates is achieved. It is a stabilizer that can improve the properties.
- the fibrous insoluble cellulose of the present invention may be an acidic liquid composition containing a milk protein mixture containing a high concentration of casein protein, which is a characteristic of the acidic liquid composition used in the present invention. Inhibits separation and precipitation, has good redispersibility, has a low viscosity and is easily ingested, and when ingested as a muscle synthesis promoter, prevents milk protein curding in the stomach and absorbs milk protein.
- the fibrous insoluble cellulose derived from a microorganism is, for example, one obtained by separating a fermented cellulose produced by a microorganism from a culture medium, washing it, and appropriately purifying it into a fibrous form.
- the fibrous insoluble cellulose is, for example, fibrous insoluble cellulose (see JP 2005-245217 A) that has been microfibrillated to an average diameter of 0.01 to 0.1 ⁇ m, or fermented cellulose.
- the fibrous insoluble cellulose of the present invention is commercially available, for example, Sun Artist PG (manufactured by Saneigen FFI), Sun Artist PN (manufactured by Saneigen FFI). .
- the addition amount of the fibrous insoluble cellulose of the present invention is such that 0.2 to 1.2% by weight of soybean polysaccharide and 0.1 to 0.5% by weight of HM pectin are added to the acidic liquid composition used in the present invention.
- HM pectin a substance that is added to the acidic liquid composition used in the present invention.
- They are 03-0.07 wt%, 0.03-0.065 wt%, 0.03-0.06 wt%, 0.03-0.055 wt%, 0.03-0.05 wt%.
- the addition amount of the fibrous insoluble cellulose of the present invention is 0.1% by weight, even an acidic liquid composition containing a milk protein mixture containing a high concentration of casein protein has a low viscosity and is easily ingested. Is preferable. Further, the addition amount of the fibrous insoluble cellulose of the present invention exceeds 0.01% by weight, even in the case of an acidic liquid composition containing a milk protein mixture containing a high concentration of casein protein. Separation of the composition and occurrence of precipitation can be suppressed, and redispersibility is also improved. Finally, when taken as a muscle synthesis promoter, curding of milk protein in the stomach is prevented, and milk protein It is preferable in that the absorption of glycine is promoted and the muscle synthesis promoting effect of the present invention is enhanced.
- Trehalose can be further added to the acidic liquid composition used in the present invention, and by adding trehalose, even an acidic liquid composition containing a milk protein mixture containing a high concentration of casein protein, Suppresses separation and precipitation of the acidic liquid composition, has good redispersibility, and can be further imparted with a low-viscosity and easy-to-ingest form. Finally, it is ingested as a muscle synthesis promoter of the present invention. In this case, curding of milk protein in the stomach can be prevented, absorption of milk protein can be promoted, and the effect of promoting muscle synthesis can be further enhanced.
- the pH of the acidic liquid composition of the present invention exceeds 4, and is close to the isoelectric point of casein. Even in an acidic liquid composition containing a milk protein mixture containing a high concentration of casein protein, the separation and precipitation of the acidic liquid composition is suppressed, the redispersibility is good, and the form is easy to drink with low viscosity.
- the trehalose of the present invention is also commercially available, for example, Treha (produced by Hayashibara).
- the trehalose of the present invention is added in an amount of 0.2 to 1.2% by weight of soybean polysaccharide, 0.1 to 0.5% by weight of HM pectin, 0.01% to the acidic liquid composition used in the present invention.
- 0.1 to 0.1% by weight of fibrous insoluble cellulose for example, 0.1 to 5% by weight, 0.2 to 4.5% by weight, 0.3 to 4% by weight, 0.4 ⁇ 3.5 wt%, 0.5 to 3 wt%, 0.6 to 2.5 wt%, 0.7 to 2 wt%, 0.8 to 1.5 wt%, 0.9 to 1.3 %
- 0.9 to 1.1% by weight for example, 0.1 to 5% by weight, 0.2 to 4.5% by weight, 0.3 to 4% by weight, 0.4 ⁇ 3.5 wt%, 0.5 to 3 wt%, 0.6 to 2.5 wt%, 0.7 to 2 wt%, 0.8 to 1.5 wt%, 0.9 to 1.3 % By weight, 0.9 to 1.
- the acidic liquid composition of the present invention is not imparted with the flavor and texture derived from trehalose, and it is preferable for achieving a low viscosity and easy to take form. Moreover, even if it is an acidic liquid composition containing the milk protein mixture containing a high concentration casein protein that the addition amount of the trehalose of this invention exceeds 0.01 weight%, the acidic liquid composition used by this invention Separation of substances and occurrence of precipitation can be suppressed, and redispersibility is also improved. Finally, as a muscle synthesis promoter of the present invention, milk protein is not carded in the stomach, and absorption of milk protein is achieved. Is preferable in that the effect of promoting muscle synthesis of the present invention is enhanced.
- the method for producing the acidic liquid composition used in the present invention comprises 0.2 to 1.2% by weight of soybean polysaccharide, 0.1 to 0.5% by weight of HM pectin 0.01 to 0.1% by weight.
- a milk-containing solution containing fibrous insoluble cellulose and a milk protein mixture containing casein protein and whey protein is characterized in that it comprises a step of adjusting pH to acidity and a step of homogenizing.
- adjusting the pH to acid is an acidic liquid composition containing a milk protein mixture containing a high concentration of casein protein, which is a feature of the present invention.
- it suppresses separation and precipitation of the acidic liquid composition, has good redispersibility, has a low viscosity and is easy to drink, and when ingested as a muscle synthesis promoter of the present invention, milk protein in the stomach
- the milk-containing solution can be lowered to a predetermined pH
- Methods for adjusting the pH of this milk-containing solution to acid include, for example, a method of fermenting a milk-containing solution with a fermenting microorganism such as lactic acid bacteria, and a method of adding an acid to a milk-containing solution.
- the milk-containing solution contains an acidic liquid composition containing a milk protein mixture containing a high concentration of casein protein, which is one of the characteristics of the acidic liquid composition of the present invention. Even if it is a product, it suppresses separation and precipitation of the acidic liquid composition, has good redispersibility, has a low viscosity and is easy to drink, and when taken as a muscle synthesis promoter, milk in the stomach 0.2 to 1.2% by weight of soy polysaccharides, 0.1 to 0.5%, in order to prevent the formation of protein curd and promote the absorption of milk protein and enhance the effect of promoting muscle synthesis It is preferable to contain 1% by weight of HM pectin and 0.01 to 0.1% by weight of fibrous insoluble cellulose.
- the soybean polysaccharide, HM pectin, and fibrous insoluble cellulose contained in the milk-containing solution are added together with some or all of other raw materials, and 50 to 100 are added. You may make it melt
- the milk-containing solution is, for example, a stabilizer obtained by dissolving a milk protein mixture in water, soybean polysaccharide, HM pectin, and fibrous insoluble cellulose in water. It is obtained by mixing the liquid.
- the milk-containing solution in addition to adjusting the pH by adding an acid to the milk-containing solution, the milk-containing solution is mechanically sheared in order to enhance the muscle synthesis promoting effect of the present invention. Homogenization can be achieved by processing.
- the casein protein of the milk-containing solution whose pH has been adjusted is atomized to previously contain 0.2 to 1.2% by weight of soybean polysaccharide, 0.1 to 0.5% by weight of HM Acid containing pectin and a milk protein mixture containing a high concentration of casein protein, combined with 0.01 to 0.1% by weight of fibrous insoluble cellulose and one of the characteristics of the acidic liquid composition of the present invention
- Even a liquid composition suppresses separation and precipitation of an acidic liquid composition, has good redispersibility, has a low viscosity and is easy to drink, and when taken as a muscle synthesis promoter,
- an acidic liquid composition capable of preventing the curding of milk protein and promoting the absorption of milk protein and enhancing the effect of promoting muscle synthesis can be obtained.
- a general-purpose homogenizer used for homogenizing fat globules such as milk and liquefying fermented milk can be used for homogenizing fat globules such as milk and liquefying ferment
- the milk-containing solution is homogenized using a homogenizer in order to enhance the effect of the present invention.
- the homogenization pressure is, for example, 1 to 100 MPa, 2 to 80 MPa, 3 to 60 MPa, 4 to 40 MPa, 5 to 20 MPa, 6 to 19 MPa, 7 to 18 MPa, 8 to 17 MPa, 9 to 16 MPa, 10 to 15 MPa.
- the homogenizing temperature is, for example, 50 to 100 ° C., 55 to 95 ° C., 60 to 90 ° C., 65 to 85 ° C., or 70 to 80 ° C.
- the step of adjusting the pH by adding an acid to the milk-containing solution and the step of homogenizing the milk-containing solution using a homogenizer are in that order. There is no limit. That is, in the method for producing an acidic liquid composition used in the present invention, it is also possible to homogenize the milk-containing solution using a homogenizer after adjusting the pH by adding an acid to the milk-containing solution. It is also possible to adjust the pH by homogenizing the milk-containing solution using a homogenizer and then adding an acid to the milk-containing solution.
- the step of homogenizing treatment is an acidic liquid composition containing a milk protein mixture containing a high concentration of casein protein, which is one of the characteristics of the acidic liquid composition. Even if it is a product, it suppresses separation and precipitation of the acidic liquid composition, has good redispersibility, has a low viscosity and is easy to ingest, and when ingested as a muscle synthesis promoter, It can be set before or after heat sterilization, which will be described later, within a range where an acidic liquid composition is obtained that prevents the formation of milk protein and promotes the absorption of milk protein and enhances the effect of promoting muscle synthesis. it can.
- heat sterilization can be performed in order to enhance the storage stability of the acidic liquid composition.
- the method for heat sterilization of the acidic liquid composition may be a known method for sterilizing milk and / or beverage and sterilization conditions.
- Sterilization methods include, for example, plate-type heat sterilization, tube-type heat sterilization, batch-type heat sterilization, energizing heat sterilization, microwave heat sterilization, indirect heat sterilization such as retort heating, direct injection such as steam injection, steam infusion, etc. Sterilization.
- the sterilization conditions are the same as for milk, for example, hold at 60 to 65 ° C for 20 to 30 minutes, hold at 80 to 100 ° C for 15 seconds to 10 minutes, hold at 110 ° C to 150 ° C for 2 to 15 seconds, and equivalent If it is sterilization conditions, it can change suitably.
- non-heat sterilization can be performed in order to improve the storage stability of the acidic liquid composition.
- the non-heat sterilization method of the acidic liquid composition of the present invention can be set with known sterilization methods and sterilization conditions.
- Non-heat sterilization methods include, for example, light irradiation sterilization, radiation irradiation sterilization, and high voltage pulse sterilization.
- the sterilization conditions for non-heat sterilization are the same as the heat sterilization of milk, for example, holding at 60 to 65 ° C. for 20 to 30 minutes, holding at 80 to 100 ° C. for 15 seconds to 10 minutes, and 110 to 150 ° C. for 2 to 2 minutes. If the sterilization effect is equivalent to this for 15 seconds, the sterilization conditions for non-heat sterilization can be appropriately changed.
- an acidic liquid composition in order to improve the storage stability of the acidic liquid composition, 0.2 to 1.2% by weight soybean polysaccharide, 0.1 to 0.5% by weight
- the temperature of the finally cooled acidic liquid composition is, for example, 0 to 30 ° C., 0 to 25 ° C., 0 to 20 ° C., 0 to 15 ° C., 0 to 12 ° C., 0 to 10 ° C.
- the acidic liquid composition used in the present invention is an acidic liquid composition containing a milk protein mixture containing a high concentration of casein protein, which is one of the characteristics of the acidic liquid composition of the present invention. Suppresses separation and precipitation of substances, has good redispersibility, has a low viscosity and is easy to drink, and prevents ingestion of milk protein in the stomach when ingested as a muscle synthesis promoter. Other food materials and / or food additive materials can be added if the effect of promoting muscle synthesis can be enhanced after promoting the absorption of the food.
- sweeteners for the purpose of imparting the palatability of the acidic liquid composition of the present invention, sweeteners (sugars, liquid sugars, fructose, maltose, trivalent sugar, etc.), sugar alcohols (erythritol, etc.), high-sensitivity sweeteners (stevia) , Aspartame, sucralose, acesulfame potassium), fragrance, fruit juice, vegetable juice, and the like.
- minerals calcium, iron, manganese, magnesium, zinc, etc.
- vitamins, functional materials, probiotic lactic acid bacteria, etc. are added, The muscle synthesis promoter of the present invention can be used.
- the muscle synthesis promoter of the present invention can be in the form of a packaged beverage or a packaged beverage for the purpose of providing in the market.
- a well-known thing such as a paper container (a gable top type container, a brick type container, etc.), a soft bag, a plastic bottle, a can, a bottle, can be used for a container.
- the capacity of the container is not particularly limited, and is, for example, 10 to 5000 g, 20 to 4000 g, 30 to 3000 g, 40 to 2000 g, 50 to 1500 g, 60 to 1400 g, 70 to 1300 g, 80 to 1200 g, 90 to 1100 g.
- a family size for example, 300 to 5000 g, 300 to 4000 g, 300 to 3000 g, 300 to 2000 g, 300 to 1500 g, 300 to 1400 g, 300 to 1300 g, 300 to 1200 g, 300 to 1100 g
- it is 10 to 500 g, 20 to 500 g, 30 to 500 g, 40 to 500 g, 50 to 500 g, 60 to 500 g, 70 to 500 g, 80 to 500 g, 90 to 500 g.
- the muscle synthesis promoter of the present invention suppresses the separation and precipitation of the acidic liquid composition, even if it is an acidic liquid composition containing milk protein containing a high concentration of casein. Good dispersibility, low viscosity and easy-to-drink form, and as a muscle synthesis promoter, prevents milk protein curd formation in the stomach and promotes absorption of milk protein, and also promotes muscle synthesis. If it can be increased, there is no limit to the form of provision to the market. For example, with the muscle synthesis promoter of the present invention, chilled distribution at 10 ° C. or lower and normal temperature distribution are possible. The muscle synthesis promoter of the present invention also has a heat resistance effect.
- the muscle synthesis promoter of the present invention has a heat-resistant effect, so that it can be preferably provided as a liquid product form. At the same time, it can be provided as a product form for warm sales using a hot vendor or the like.
- the milk protein mixture is ingested (administered) so that the total protein amount is 0.06 g / kg body weight per meal, Specifically, the weight is 0.06 to 0.7 g / kg body weight, preferably 0.06 to 0.6 g / kg body weight, more preferably 0.06 to 0.5 g / kg body weight, and still more preferably 0.0. It is ingested (administered) at a dose of 08 to 0.4 g / kg body weight, particularly preferably 0.1 to 0.4 g / kg body weight.
- the typical weight of the subject is estimated to be about 60 kg.
- one meal means one time in a state that requires immediate effective muscle synthesis promotion.
- a single meal is not taken at a time (at a time), It may be taken in several degrees.
- the muscle synthesis promoting agent of the present invention is ingested (administered) to a subject in need of immediate muscle synthesis promotion, the amino acid concentration in the blood stream can be immediately In terms of improvement, it is preferably within 2 hours after the end of exercise, more preferably within 1 hour after the end of exercise, more preferably within 30 minutes after the end of exercise, and particularly preferably, Within 5 minutes after the end of exercise.
- the method of ingesting (administering) the muscle synthesis promoting agent of the present invention to a subject in need of immediate muscle synthesis promotion is based on oral administration (oral administration), enteral administration, gastric fistula, etc. Can be appropriately selected, but is preferably taken orally.
- the muscle synthesis promoter of the present invention comprises a unit package form per serving, and the milk protein mixture is contained in the unit as the total intake of the protein. And adjusted to 3 g or more, specifically 3 to 40 g, preferably 3 to 20 g, more preferably 4 to 20 g, still more preferably 4 to 15 g, and particularly preferably 5 to 15 g. Do it.
- “consisting of a unit packaging form per meal” is a form in which the intake amount per meal is determined in advance, for example, as a food that can be taken orally in a specific amount, not only general foods but also beverages (Drinks, etc.), health supplements, health functional foods, supplements, etc.
- unit packaging form per meal for example, in the case of liquid beverages, gel-like, paste-like, paste-like jelly, powder-like, granule-like, capsule-like, block-like solid foods, etc.
- a specific amount (dose) can be defined in packaging containers such as cans, glass bottles (such as bottles), plastic containers (such as plastic bottles), packs, pouches, film containers, paper boxes, etc., or intake per serving (usage, dose) ) Is displayed on a packaging container, a homepage, etc., and the form which can prescribe
- the muscle synthesis promoter of the present invention comprises 0.4 to 0.9% by weight of soybean polysaccharide, 0.2 to 0.25% by weight of HM pectin, 0.03 to 0%.
- a muscle synthesis promoter comprising, as active ingredients, an acidic liquid composition comprising 0.05% by weight of fibrous insoluble cellulose and a milk protein mixture containing casein protein and whey protein, The protein amount ratio of casein protein to whey protein (casein protein / whey protein) is 2-6.
- the muscle synthesis promoter of the present invention comprises 0.4 to 0.9% by weight of soybean polysaccharide, 0.2 to 0.25% by weight of HM pectin, 0.03 to A muscle synthesis promoter comprising as an active ingredient an acidic liquid composition comprising 0.05% by weight of fibrous insoluble cellulose and a milk protein mixture containing casein protein and whey protein,
- the protein amount ratio of casein protein to whey protein is 2-4.
- the muscle synthesis promoter of the present invention comprises 0.4 to 0.9% by weight of soybean polysaccharide, 0.2 to 0.25% by weight of HM pectin, 0.03 to Muscle synthesis promotion comprising 0.05% by weight fibrous insoluble cellulose, trehalose 0.9 to 1.1% by weight and an acidic liquid composition containing a milk protein mixture containing casein protein and whey protein as active ingredients An agent, The protein amount ratio of casein protein to whey protein (casein protein / whey protein) is 2-4.
- the muscle synthesis promoter of the present invention can provide a composition comprising a muscle synthesis promoter. That is, the muscle synthesis promoter of the present invention can be used alone as it is, but as long as the muscle synthesis promotion function is exhibited, various compositions for oral intake (for oral administration) such as foods and pharmaceuticals. On the other hand, it can also be included as a raw material (material), an additive, etc., and can obtain the composition which has a muscle synthesis promotion effect. Therefore, according to one embodiment of the present invention, a composition comprising the muscle synthesis promoter of the present invention is provided.
- soybean polysaccharide 0.1-0.5% by weight HM pectin, 0.01-0.1% by weight fibrous.
- a composition comprising an acidic liquid composition containing a milk protein mixture containing insoluble cellulose, casein protein and whey protein as an active ingredient, wherein the protein amount ratio of casein protein to whey protein (casein protein / whey protein) is 2
- a composition for promoting muscle synthesis that is ⁇ 20 can be provided.
- the composition of the present invention may be a food composition or a pharmaceutical composition.
- the food composition is other than the pharmaceutical composition, and is not particularly limited as long as it is a form that can be taken orally, such as a solution, suspension, emulsion, powder, or solid molded product.
- instant noodles, retort food, canned food, microwave food, instant soup / miso soup, freeze-dried food, etc . soft drink, fruit juice drink, vegetable drink, soy milk drink, coffee drink, tea Beverages such as beverages, powdered beverages, concentrated beverages, alcoholic beverages; flour products such as bread, pasta, noodles, cake mixes, bread crumbs; rice cakes, caramel, chewing gum, chocolate, cookies, biscuits, cakes, pies, snacks, crackers, Confectionery such as Japanese confectionery, dessert confectionery; sauces, tomato processing seasonings, flavor seasonings, cooking mixes, sauces, dressings, soups, curry and stew ingredients; processed fats, butter, margarine, Fats and oils such as mayonnaise; milk drinks, yogurts, lactic acid bacteria drinks, ice creams, creams
- Foods are also labeled with health foods, functional foods, dietary supplements, functional labeling foods, foods for specified health use, foods for the sick, infant formulas, powdered milk for pregnant or lactating women, or a disease risk reduction label. Such foods are also included.
- soybean polysaccharide 0.1-0.5% by weight HM pectin, 0.01-0.1% by weight fibrous.
- the protein amount ratio of casein protein to whey protein is 2 to 20, comprising as an active ingredient an acidic liquid composition containing a milk protein mixture containing insoluble cellulose, casein protein and whey protein,
- a food for promoting muscle synthesis is provided.
- the food for promoting muscle synthesis of the present invention includes foods that display the effect of promoting muscle synthesis or the effects resulting therefrom.
- a muscle synthesis promoting beverage (preferably a dairy product, more preferably a dairy beverage or a lactic acid bacteria beverage) comprising an acidic liquid composition containing a milk protein mixture containing insoluble cellulose, casein protein and whey protein as an active ingredient,
- a dairy product for promoting muscle synthesis wherein the ratio of casein protein to protein (casein protein / whey protein) is 2 to 20.
- the pharmaceutical composition is prepared as an oral preparation or a parenteral preparation according to a conventional method using additives that are acceptable for formulation.
- oral preparations take the form of solid preparations such as tablets, powders, fine granules, granules, capsules, pills, sustained-release preparations, and liquid preparations such as solutions, suspensions, and emulsions. Can do.
- a parenteral preparation it can take the form of an injection or a suppository. From the viewpoint of simplicity, an oral preparation is preferable.
- Additives that are acceptable for formulation include, for example, excipients, stabilizers, preservatives, wetting agents, emulsifiers, lubricants, sweeteners, colorants, fragrances, buffers, antioxidants, pH Examples thereof include regulators.
- the pharmaceutical composition of the present invention comprises a composition for the treatment of diseases requiring the promotion of muscle synthesis, specifically a muscular damage disease such as sarcopenia, more specifically a preventive composition and a therapeutic composition. Is included.
- soybean polysaccharide 0.1-0.5% by weight HM pectin, 0.01-0.1% by weight fiber.
- a method for promoting muscle synthesis comprising: ingesting an acidic liquid composition comprising a milk protein mixture comprising insoluble cellulose, casein protein and whey protein simultaneously or sequentially to a subject in need of muscle synthesis promotion
- a method for promoting muscle synthesis in which the ratio of the amount of casein protein to whey protein (casein protein / whey protein) is 2 to 20, is provided.
- the method for accelerating muscle synthesis of the present invention is preferably a method that excludes medical practice for humans.
- the “medical action for humans” means an action that requires a doctor or the like to ingest (administer) a medicine to a human.
- the muscle synthesis promoting method of the present invention can be carried out according to the contents described in the present specification for the muscle synthesis promoting agent of the present invention.
- the acidic liquid composition may contain 0.5 to 5% by weight of trehalose.
- the pH of the acidic liquid composition can be adjusted to 3 to 6 in the muscle synthesis promoting method of the present invention.
- the acidic liquid composition may contain fermented cellulose as fibrous unnecessary cellulose.
- the milk protein mixture is ingested (administered) so that the total protein amount is 0.06 g / kg body weight or more per meal. Specifically, it is 0.06 to 0.7 g / kg body weight, preferably 0.06 to 0.6 g / kg body weight, more preferably 0.06 to 0.5 g / kg body weight, still more preferably It can be ingested so as to give 0.08 to 0.4 g / kg body weight, particularly preferably 0.1 to 0.4 g / kg body weight.
- the milk protein mixture in the muscle synthesis promotion method of the present invention, can be ingested so that the total protein amount is 3 g or more per meal, specifically 3 It can be ingested to a dose of ⁇ 40 g, preferably 3 to 20 g, more preferably 4 to 20 g, even more preferably 4 to 15 g, particularly preferably 5 to 15 g.
- the subject in need of muscle synthesis promotion is preferably a subject in need of immediate muscle synthesis promotion, more preferably It can be ingested by a subject that exercises, more preferably by a subject performing muscle training.
- the acidic liquid composition in the muscle synthesis promotion method of the present invention, can be ingested in a heated liquid form to a subject in need of muscle synthesis promotion.
- soybean polysaccharide 0.1-0.5% by weight HM pectin, 0.01-0.1% by weight fibrous.
- An insoluble cellulose, an acidic liquid composition comprising a milk protein mixture comprising casein protein and whey protein, ingested by a disease subject in need of muscle synthesis promotion, for a disease in need of muscle synthesis promotion
- a treatment method is provided, wherein the protein amount ratio of casein protein to whey protein (casein protein / whey protein) is 2-20.
- the method for treating a disease requiring the promotion of muscle synthesis of the present invention includes a method for treating a muscle damage disease, for example, a method for treating sarcopenia. Treatment methods include prophylactic and therapeutic methods.
- the treatment method of the present invention can be carried out in accordance with the contents described in the present specification for the muscle synthesis promotion method of the present invention.
- a muscle synthesis promoter comprising as an active ingredient an acidic liquid composition comprising 0.1% by weight of fibrous insoluble cellulose and a milk protein mixture comprising casein protein and whey protein, or a composition comprising the same
- an acidic liquid composition comprising 0.1% by weight of fibrous insoluble cellulose and a milk protein mixture comprising casein protein and whey protein, or a composition comprising the same
- the use of the invention is a non-therapeutic use.
- the use of the muscle synthesis promoter of the present invention or the composition comprising the same can be carried out according to the contents described herein for the muscle synthesis promoter of the present invention and the muscle synthesis promotion method.
- a muscle synthesis promoter comprising as an active ingredient an acidic liquid composition comprising HM pectin, 0.01 to 0.1% by weight of fibrous insoluble cellulose, and a milk protein mixture containing casein protein and whey protein, or There is provided a composition comprising the same, a muscle synthesis promoter having a protein content ratio of casein protein to whey protein (casein protein / whey protein) of 2 to 20, or a composition comprising the same.
- the use of the muscle synthesis promoter or composition of the present invention can be carried out in accordance with the contents described herein for the muscle synthesis promoter and the muscle synthesis promotion method of the present invention.
- the acidic liquid composition in the use of the present invention, can contain 0.5 to 5% by weight of trehalose. According to one preferred embodiment of the present invention, the pH of the acidic liquid composition can be adjusted to 3-6 in the use of the present invention. Furthermore, according to one preferable aspect of the present invention, in the use of the present invention, the acidic liquid composition can contain fermented cellulose as fibrous unnecessary cellulose.
- the milk protein mixture in the use of the present invention, can be ingested (administered) so that the total protein amount is 0.06 g / kg body weight or more per meal, Specifically, it is 0.06 to 0.7 g / kg body weight, preferably 0.06 to 0.6 g / kg body weight, more preferably 0.06 to 0.5 g / kg body weight, and still more preferably 0.08. It can be ingested at a dose of ⁇ 0.4 g / kg body weight, particularly preferably 0.1-0.4 g / kg body weight.
- the milk protein mixture in the use of the present invention, can be ingested so that the total protein amount is 3 g or more per meal, specifically, 3 to 40 g,
- the ingestion amount is preferably 3 to 20 g, more preferably 4 to 20 g, still more preferably 4 to 15 g, and particularly preferably 5 to 15 g.
- the subject in the use of the present invention, is an exercise subject, preferably a muscle training subject.
- an insoluble cellulose and an acidic liquid composition comprising a milk protein mixture containing casein protein and whey protein, wherein the protein amount ratio of casein protein to whey protein (casein protein / whey protein) is 2 to 20
- An acidic liquid composition is provided to facilitate synthesis.
- the acidic liquid composition for promoting muscle synthesis of the present invention can be designed according to the contents described herein for the muscle synthesis promoter of the present invention.
- the muscle synthesis promoter of the present invention is, for example, 0.2 to 1.2% by weight soybean polysaccharide, 0.1 to 0.5% by weight HM pectin, 0.01 to 0.1% by weight.
- a muscle synthesis promoter comprising a milk protein mixture containing casein protein and whey protein, which is free of fibrous insoluble cellulose and is not acidified, as an active ingredient, and a casein protein for whey protein
- the protein synthesis ratio (casein protein / whey protein) is 4, a muscle synthesis promoter based on the knowledge of Non-Patent Document 1 (hereinafter referred to as “muscle synthesis containing a neutral liquid composition consisting only of a milk protein mixture as an active ingredient” Compared with the “accelerating agent”), the muscle synthesis promoting effect is further enhanced.
- the muscle synthesis promoter of the present invention is a neutral liquid composition consisting only of a milk protein mixture. Compared with the muscle synthesis promoter containing as an active ingredient, it was shown to have a high effect.
- the muscle synthesis promoter of the present invention was ingested (administered) at a low dose of 0.85 g milk protein / kg body weight, and consisted only of milk protein mixture
- a muscle synthesis promoter containing a neutral liquid composition as an active ingredient is ingested (administered) at a high dose of 1.8 g milk protein / kg body weight, the effect as a muscle synthesis promoter is comparable. It was.
- the muscle synthesis promoter of the present invention is stronger when a certain amount of milk protein is ingested (administered) compared to a muscle synthesis promoter comprising a neutral liquid composition consisting only of a milk protein mixture as an active ingredient. Expected to promote muscle synthesis.
- the muscle synthesis promoter of the present invention reduces the amount of milk protein mixture to be consumed in order to obtain the same effect as the muscle synthesis promoter comprising a neutral liquid composition consisting only of a milk protein mixture as an active ingredient. Can be more easily taken (administered).
- the muscle synthesis promoter of the present invention has a refreshing property with a moderate acidity, and has the same concentration of milk protein as compared to a muscle synthesis promoter comprising a neutral liquid composition consisting only of a milk protein mixture as an active ingredient. Even when it contains a mixture, it becomes easier to ingest (administer).
- Example 1 4.25 kg of milk protein concentrate (milk protein 80 wt%, lactose 6.5 wt%) was dissolved by heating in 40.75 kg of water to obtain a solution A. Soy polysaccharides (SM-900, Saneigen FFI) 0.45 kg, HM pectin (AYD5110SB, Unitech Foods) 0.2 kg, fermented cellulose (Sun artist PG, Saneigen FFI) 0.05 kg 1 kg of trehalose and 3.3 kg of sugar 0.0063 kg of sucralose were dissolved by heating in 39.99 kg of water to obtain a solution B. A solution C was prepared by dissolving 0.64 kg of citric acid in 9.36 kg of water.
- the solution C was added in 10 portions over 5 minutes while stirring the mixed solution to obtain a base mix before sterilization.
- the base mix was homogenized at 15 MPa (70 to 80 ° C.) with a plate sterilizer, sterilized at 130 ° C. for 2 seconds, and then cooled to 10 ° C. or lower to obtain the muscle synthesis promoter of Example 1. (3.4% by weight of milk protein, 0.45% by weight of soybean polysaccharide, 0.2% by weight of HM pectin, 0.05% by weight of fermented cellulose, 1% by weight of trehalose).
- the muscle synthesis promoter of Example 1 had a pH of 4.1 and a viscosity of 10 mPa ⁇ s (10 ° C.). “Drinking mouth”, “precipitation” and “redispersibility” were all good.
- Example 1 is referred to as “muscle synthesis promoter”.
- Example 1 The muscle synthesis promoting effect of the muscle synthesis promoter of Example 1 was verified as follows.
- Rat swimming test SD male rats obtained from CLEA Japan, Inc. having an initial weight of 130 to 170 g were used as experimental animals. All rats were individually housed in stainless steel cages at room temperature of 22 ⁇ 2 ° C. with a light period of 7 to 19 o'clock and a dark period of 19 to 7 o'clock.
- the rats were preliminarily raised for 3 to 5 days using a solid feed (Oriental Yeast Co., Ltd.), and then subjected to a 30-minute swimming exercise (water temperature 34 ° C.) in order to acclimate to the swimming exercise. After fasting for 16 hours from the next day to the day after the acclimated swimming exercise, the rats were divided into 9 groups (6 to 8 animals in each test group) so that there was no difference in body weight between the test groups. Thereafter, the rats were subjected to a 2-hour swimming exercise. Immediately after the end of swimming exercise, rats were orally ingested with a muscle synthesis promoter or a skim milk solution of 3.4% by weight of milk protein at 24.24 mL / kg body weight.
- a deuterium labeled phenylalanine solution (prepared by dissolving 225 mg of deuterium labeled phenylalanine in 10 mL of physiological saline) was added at 2.0 mL / Rats were administered tail vein with kg body weight. Rats were dissected under isoflurane anesthesia 15 minutes after tail vein administration (ie 30 minutes, 60 minutes, 90 minutes, or 120 minutes after oral ingestion). After whole blood was collected from the abdominal vena cava, the triceps muscle of the upper limb was removed, washed with physiological saline, and immediately frozen with liquid nitrogen. The time of tail vein administration and the time of cryopreservation of the upper limb triceps were accurately recorded. The upper limb triceps were stored at ⁇ 80 ° C. until analysis.
- apparatus LC / MS / MS (manufactured by Waters), column: ACQUITY UPLC BEH C18 (manufactured by Waters), mobile phase: acetonitrile containing 0.05% TFA water / 0.05% TFA, injection amount 3 ⁇ L, flow rate 0.3 mL / min, UV 215 nm.
- FSR skeletal muscle synthesis rate
- the average value ⁇ standard error of each test group was determined from the obtained numerical values.
- Student's t-test was performed between the muscle synthesis promoter group and the skim milk solution group at each time point (30 minutes, 60 minutes, 90 minutes, or 120 minutes after oral intake). The significance level was less than 5% (p ⁇ 0.05). The result is shown in FIG.
- the skeletal muscle synthesis rate of the rat 30 minutes after ingestion was significantly higher than that of the skim milk solution (p ⁇ 0.05, FIG. 1).
- the intake of the muscle synthesis promoter tended to increase the value of the skeletal muscle synthesis rate even after 60 minutes, 90 minutes, and 120 minutes of intake compared to the skim milk solution (p ⁇ 0.10, FIG. 1). From these results, it was shown that the muscle synthesis promoter has a higher skeletal muscle synthesis promoting effect than the skim milk powder solution.
- Example 2 The muscle synthesis promoting effect of the muscle synthesis promoter of Example 1 was verified as follows.
- Rat swimming test SD male rats obtained from CLEA Japan, Inc. having an initial weight of 130 to 170 g were used as experimental animals. All rats were individually housed in stainless steel cages at room temperature of 22 ⁇ 2 ° C. with a light period of 7 to 19 o'clock and a dark period of 19 to 7 o'clock.
- the rats were preliminarily raised for 3 to 5 days using a solid feed (Oriental Yeast Co., Ltd.), and then subjected to a 30-minute swimming exercise (water temperature 34 ° C.) in order to acclimate to the swimming exercise. After fasting for 16 hours from the next day to the day after the acclimated swimming exercise, the rats were divided into 9 groups (6 to 8 animals in each test group) so that there was no difference in body weight between the test groups. Thereafter, the rats were subjected to a 2-hour swimming exercise.
- a solid feed Oriental Yeast Co., Ltd.
- rats were orally ingested with a muscle synthesis promoter or 6.8 wt% skim milk solution (high-dose skim milk solution) of milk protein at 24.24 mL / kg body weight.
- a deuterium labeled phenylalanine solution prepared by dissolving 225 mg of deuterium labeled phenylalanine in 10 mL of physiological saline was added at 2.0 mL / Rats were administered tail vein with kg body weight. Rats were dissected under isoflurane anesthesia 15 minutes after tail vein administration (ie 30 minutes, 60 minutes, 90 minutes, or 120 minutes after oral ingestion).
- the triceps muscle of the upper limb was removed, washed with physiological saline, and immediately frozen with liquid nitrogen. The time of tail vein administration and the time of cryopreservation of the upper limb triceps were accurately recorded. The upper limb triceps were stored at ⁇ 80 ° C. until analysis.
- apparatus LC / MS / MS (manufactured by Waters), column: ACQUITY UPLC BEH C18 (manufactured by Waters), mobile phase: acetonitrile containing 0.05% TFA water / 0.05% TFA, injection amount 3 ⁇ L, flow rate 0.3 mL / min, UV 215 nm.
- FSR skeletal muscle synthesis rate
- the average value ⁇ standard error of each test group was determined from the obtained numerical values.
- Student's t-test was performed between the muscle synthesis promoter group and the skim milk solution group at each time point (30 minutes, 60 minutes, 90 minutes, or 120 minutes after oral intake). The significance level was less than 5% (p ⁇ 0.05). The result is shown in FIG.
- the muscle synthesis promoter showed an effect of promoting skeletal muscle synthesis equivalent to that of a high-dose skim milk solution.
- the intake of milk protein as the active body is 0.85 g / kg body weight in the muscle synthesis promoter group, and 1.8 g / kg body weight in the high-dose skim milk solution group. It was also shown that skeletal muscle synthesis was promoted with low milk protein intake.
- the muscle synthesis promoter of the present invention is not aggregated (carded) in the stomach after ingestion (administration) as compared with the skim milk solution, and the subsequent intestinal tract It was inferred that the milk protein absorbability increased in, and the effect of promoting muscle synthesis was enhanced.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
本特許出願は、先に出願された日本国特許出願である特願2015-016093号(出願日:2015年1月29日)に基づく優先権の主張を伴うものであり、かかる先の特許出願における全開示内容は、引用することにより本願発明の開示の一部とされる。 This patent application is accompanied by a priority claim based on Japanese Patent Application No. 2015-016093 (filing date: January 29, 2015) which is a previously filed Japanese patent application. The entire disclosure in is hereby incorporated by reference into the present disclosure.
本発明は、筋肉合成促進剤に関する。 The present invention relates to a muscle synthesis promoter.
近年、健康増進や運動能力向上を目的として、筋肉合成の促進、筋肉喪失の予防、および筋肉量の回復促進のために、タンパク質を主成分とする栄養補助剤(サプリメント)を経口摂取して、運動する者(対象)は多い。このような栄養補助剤として、プロテイン粉末があり、その主成分として、牛乳を原料とするホエイタンパク質(乳清タンパク質)およびカゼインタンパク質が知られている。 In recent years, for the purpose of promoting health and improving exercise capacity, in order to promote muscle synthesis, prevent muscle loss, and promote recovery of muscle mass, orally ingested a protein-based nutritional supplement (supplement), There are many people (subjects) who exercise. As such a nutritional supplement, there is protein powder, and as its main component, whey protein (whey protein) and casein protein made from milk are known.
ホエイタンパク質では、経口摂取から消化吸収までの速度(吸収速度)が速く(時間が短く)、また、BCAA(分岐鎖アミノ酸:バリン、ロイシン、イソロイシン)が多く含まれるため、筋肉疲労を防ぎながら、筋肉を効率良く増強できるといわれている。一方、カゼインタンパク質では、ホエイタンパク質と比べて、ゆっくりと持続的に代謝されるため、経口摂取から消化吸収までの速度(吸収速度)が遅く(時間が長く)、即効的な筋肉合成促進を必要とする対象には不向きであるといわれている(特許文献1:特表2009-507044号公報参照)。そのため、プロテイン粉末には、ホエイタンパク質が主に用いられている。 Whey protein has a high rate (absorption time) from ingestion to digestion and absorption (short time) and contains a lot of BCAA (branched chain amino acids: valine, leucine, isoleucine), thus preventing muscle fatigue, It is said that muscles can be strengthened efficiently. On the other hand, casein protein is metabolized slowly and continuously compared to whey protein, so the rate from absorption to digestion and absorption (slow absorption rate) is slow (long time), and immediate muscle synthesis promotion is required. It is said that it is unsuitable for the target (see Japanese Patent Application Publication No. 2009-507044). Therefore, whey protein is mainly used as protein powder.
一方、カゼインタンパク質とホエイタンパク質が所定量で含有されている乳タンパク質に対しても、筋肉合成促進効果が知られている。具体的には、運動後の乳タンパク質の摂取は用量依存的に骨格筋合成を促進し、骨格筋分解を抑制することが知られている(非特許文献1:日本体育学会第64回大会予稿集、2013年、166頁参照)。さらに、非特許文献1:日本体育学会第64回大会予稿集、2013年、166頁によれば、運動直後に摂取する食品として、通常の牛乳に比べて乳タンパク質強化乳飲料が運動負荷に伴うカラダ作りにさらに効果的であることが示されている。 On the other hand, a muscle synthesis promoting effect is also known for milk protein containing casein protein and whey protein in predetermined amounts. Specifically, it is known that intake of milk protein after exercise promotes skeletal muscle synthesis in a dose-dependent manner and suppresses skeletal muscle degradation (Non-patent Document 1: Proceedings of the 64th Annual Meeting of the Japanese Society of Physical Education) Shu, 2013, page 166). Furthermore, according to the Non-patent Document 1: Proceedings of the 64th Annual Meeting of the Japanese Society of Physical Education, 2013, page 166, milk protein-enriched milk drinks are associated with exercise load compared to normal milk as food to be taken immediately after exercise It has been shown to be more effective in making the body.
すなわち、乳タンパク質を摂取して、筋肉合成を促進させるためには、高濃度の乳タンパク質強化乳飲料を摂取する、あるいは通常の牛乳を多量に摂取することなど、総合的な乳タンパク質の摂取量を高めることが有効である。 That is, in order to ingest milk protein and promote muscle synthesis, the intake of total milk protein, such as ingesting high-concentration milk protein-enriched milk drinks or large amounts of normal milk Is effective.
高濃度の乳タンパク質強化乳飲料を摂取する、あるいは通常の牛乳を多量に摂取することなど、総合的な乳タンパク質の摂取量を高めるためには、多量の乳タンパク質の摂取をしなければならないという問題が発生する。このような多量の乳タンパク質の摂取は、時に、エネルギーとして乳タンパク質を多量に摂取できない乳幼児や高齢者には、その摂取自体が困難となり、さらに、摂取エネルギーの過多に伴う、肥満を始めとする生活習慣病の発症の懸念もある。また、年齢を問わず、多量の乳タンパク質を摂取すること自体が負担となることも考えられる。特に運動直後は、筋肉合成を速やかに促進させる必要があるのにも関わらず、運動によるホルモン分泌作用によって食欲が減退するため、多量の乳タンパク質の摂取が負担となることが考えられる。 In order to increase the overall intake of milk protein, such as taking a high-concentration milk protein-enriched milk drink or taking a large amount of normal milk, it is said that a large amount of milk protein must be consumed A problem occurs. Ingestion of such a large amount of milk protein sometimes makes it difficult for infants and the elderly who cannot take a large amount of milk protein as energy, and further, such as obesity accompanying excessive intake of energy There are also concerns about the development of lifestyle-related diseases. In addition, taking a large amount of milk protein may be a burden regardless of age. In particular, immediately after exercise, although it is necessary to promptly promote muscle synthesis, the appetite is reduced due to hormone secretion by exercise, so that it is considered that a large amount of milk protein intake becomes a burden.
このように、多量の乳タンパク質摂取を目的とした、非特許文献1:日本体育学会第64回大会予稿集、2013年、166頁のような乳タンパク質を含む中性液状組成物を有効成分とする筋肉合成促進効果と同等、またはそれ以上の筋肉合成促進効果を奏する、必ずしも多量の乳タンパク質の摂取を必要としない筋肉合成促進剤は、これまで知れられていない。そこで、このような効果を奏する、新たな筋肉合成促進剤を提供することが課題であった。 As described above, a neutral liquid composition containing milk protein, such as Non-patent Document 1: Proceedings of the 64th Annual Meeting of the Japanese Society of Physical Education, 2013, page 166, for the purpose of intake of a large amount of milk protein is used as an active ingredient. A muscle synthesis promoter that does not necessarily require the intake of a large amount of milk protein and has a muscle synthesis promotion effect equivalent to or higher than the muscle synthesis promotion effect is known. Therefore, it has been a problem to provide a new muscle synthesis promoter that exhibits such effects.
本発明者らは、前記課題を解決すべく鋭意研究を重ねた結果、0.2~1.2重量%の大豆多糖類、0.1~0.5重量%のHMペクチン、0.01~0.1重量%の繊維状の不溶性セルロース、および特定のタンパク質量比のカゼインタンパク質とホエイタンパク質とを含む乳タンパク質混合物を含む酸性液状組成物が、摂取しやすく、また多量の乳タンパク質を摂取しなくとも、筋肉合成促進効果を奏するという現象を見出した。 As a result of intensive studies to solve the above problems, the present inventors have found that 0.2 to 1.2% by weight of soybean polysaccharide, 0.1 to 0.5% by weight of HM pectin, 0.01 to An acidic liquid composition containing 0.1% by weight of fibrous insoluble cellulose and a milk protein mixture containing casein protein and whey protein at a specific protein ratio is easy to ingest and consumes a large amount of milk protein. Even without this, I found a phenomenon that it has an effect of promoting muscle synthesis.
具体的には、本発明者らは今般、従来技術では、筋肉合成促進効果には、乳タンパク質が用量依存的に寄与していると知られていながらも、0.2~1.2重量%の大豆多糖類、0.1~0.5重量%のHMペクチン、0.01~0.1重量%の繊維状の不溶性セルロース、および特定のタンパク質量比のカゼインタンパク質とホエイタンパク質とを含む乳タンパク質混合物を含む酸性液状組成物が、脱脂粉乳溶液、すなわち、多量の乳タンパク質混合物のみからなる中性液状組成物を有効成分とする筋肉合成促進剤(例えば、非特許文献1:日本体育学会第64回大会予稿集、2013年、166頁参照)と比較して、即効的な筋肉合成促進作用があるという現象を予想外にも見出した。また、0.2~1.2重量%の大豆多糖類、0.1~0.5重量%のHMペクチン、0.01~0.1重量%の繊維状の不溶性セルロース、および特定のタンパク質量比のカゼインタンパク質とホエイタンパク質とを含む乳タンパク質混合物を含む酸性液状組成物は、乳タンパク質濃度が低い酸性液状組成物であっても、多量の乳タンパク質混合物のみからなる中性液状組成物を有効成分とする筋肉合成促進剤と比較して、同等の筋肉合成促進作用があるという現象を予想外にも見出した。上記の現象は驚くべきものであった。本発明はかかる知見に基づくものである。 Specifically, the present inventors now know that milk protein contributes to the muscle synthesis promoting effect in a dose-dependent manner in the prior art, but 0.2 to 1.2% by weight. Milk containing 0.1 to 0.5 wt.% HM pectin, 0.01 to 0.1 wt.% Fibrous insoluble cellulose, and a specific protein amount ratio of casein protein and whey protein The acidic liquid composition containing a protein mixture is a non-fat dry milk solution, that is, a muscle synthesis promoter containing a neutral liquid composition consisting only of a large amount of milk protein mixture as an active ingredient (for example, Non-patent Document 1: The Japanese Society of Physical Education) Compared to the 64th Annual Meeting Proceedings, 2013, p. 166), we have unexpectedly found a phenomenon that there is an immediate effect of promoting muscle synthesis. 0.2-1.2% by weight soybean polysaccharide, 0.1-0.5% by weight HM pectin, 0.01-0.1% by weight fibrous insoluble cellulose, and a specific amount of protein An acidic liquid composition containing a milk protein mixture containing a ratio of casein protein and whey protein is effective as a neutral liquid composition consisting only of a large amount of milk protein mixture, even if the acidic liquid composition has a low milk protein concentration. We have unexpectedly found a phenomenon that it has the same muscle synthesis promoting action as compared with the muscle synthesis promoter used as a component. The above phenomenon was surprising. The present invention is based on such knowledge.
すなわち、本発明は、次の通りとなる。
[1]0.2~1.2重量%の大豆多糖類、0.1~0.5重量%のHMペクチン、0.01~0.1重量%の繊維状の不溶性セルロース、およびカゼインタンパク質とホエイタンパク質とを含む乳タンパク質混合物を含む酸性液状組成物を有効成分として含んでなる筋肉合成促進剤であって、ホエイタンパク質に対するカゼインタンパク質のタンパク質量比(カゼインタンパク質/ホエイタンパク質)が2~20である、筋肉合成促進剤、
[2]酸性液状組成物が、0.5~5重量%のトレハロースをさらに含んでなる、[1]に記載の筋肉合成促進剤、
[3]酸性液状組成物のpHが3~6である、[1]または[2]に記載の筋肉合成促進剤、
[4]繊維状の不溶性セルロースが発酵セルロースである、[1]~[3]のいずれか1に記載の筋肉合成促進剤、
[5]酸性液状組成物に含まれる乳タンパク質混合物が総タンパク質量で一食あたり0.06~0.7g/kg体重となるように摂取される、[1]~[4]のいずれか1に記載の筋肉合成促進剤、
[6]一食あたりの単位包装形態からなり、該単位包装形態中に、乳タンパク質混合物を一食摂取量として総タンパク質量で3~40g含む、[1]~[5]のいずれか1に記載の筋肉合成促進剤、
[7]運動する対象のための、[1]~[6]のいずれか1に記載の筋肉合成促進剤、
[8]運動が筋肉トレーニングである、[7]に記載の筋肉合成促進剤、
[9]0.2~1.2重量%の大豆多糖類、0.1~0.5重量%のHMペクチン、0.01~0.1重量%の繊維状の不溶性セルロース、およびカゼインタンパク質とホエイタンパク質とを含む乳タンパク質混合物を含む酸性液状組成物を、筋肉合成促進を必要とする対象に摂取させることを含んでなる、筋肉合成促進方法であって、ホエイタンパク質に対するカゼインタンパク質のタンパク質量比(カゼインタンパク質/ホエイタンパク質)が2~20である、筋肉合成促進方法、
[10]0.2~1.2重量%の大豆多糖類、0.1~0.5重量%のHMペクチン、0.01~0.1重量%の繊維状の不溶性セルロース、およびカゼインタンパク質とホエイタンパク質とを含む乳タンパク質混合物を含む酸性液状組成物を、筋肉合成促進を必要とする対象に摂取させることを含んでなる、筋肉合成促進方法(ヒトに対する医療行為を除く)であって、ホエイタンパク質に対するカゼインタンパク質のタンパク質量比(カゼインタンパク質/ホエイタンパク質)が2~20である、筋肉合成促進方法、
[11]筋肉合成を促進するための、0.2~1.2重量%の大豆多糖類、0.1~0.5重量%のHMペクチン、0.01~0.1重量%の繊維状の不溶性セルロース、およびカゼインタンパク質とホエイタンパク質とを含む乳タンパク質混合物を含む酸性液状組成物を有効成分として含んでなる筋肉合成促進剤の使用であって、ホエイタンパク質に対するカゼインタンパク質のタンパク質量比(カゼインタンパク質/ホエイタンパク質)が2~20である、使用、
[12]筋肉合成を促進するための食品または医薬品の製造のための、0.2~1.2重量%の大豆多糖類、0.1~0.5重量%のHMペクチン、0.01~0.1重量%の繊維状の不溶性セルロース、およびカゼインタンパク質とホエイタンパク質とを含む乳タンパク質混合物を含む酸性液状組成物を有効成分として含んでなる筋肉合成促進剤の使用であって、ホエイタンパク質に対するカゼインタンパク質のタンパク質量比(カゼインタンパク質/ホエイタンパク質)が2~20である、使用、
[13]0.2~1.2重量%の大豆多糖類、0.1~0.5重量%のHMペクチン、0.01~0.1重量%の繊維状の不溶性セルロース、およびカゼインタンパク質とホエイタンパク質とを含む乳タンパク質混合物を含む酸性液状組成物であって、ホエイタンパク質に対するカゼインタンパク質のタンパク質量比(カゼインタンパク質/ホエイタンパク質)が2~20である、筋肉合成を促進するための、酸性液状組成物。
That is, the present invention is as follows.
[1] 0.2-1.2% by weight of soybean polysaccharide, 0.1-0.5% by weight of HM pectin, 0.01-0.1% by weight of fibrous insoluble cellulose, and casein protein A muscle synthesis promoter comprising an acidic liquid composition containing a milk protein mixture containing whey protein as an active ingredient, wherein the protein amount ratio of casein protein to whey protein (casein protein / whey protein) is 2 to 20 A muscle synthesis promoter,
[2] The muscle synthesis promoter according to [1], wherein the acidic liquid composition further comprises 0.5 to 5% by weight of trehalose,
[3] The muscle synthesis promoter according to [1] or [2], wherein the acidic liquid composition has a pH of 3 to 6,
[4] The muscle synthesis promoter according to any one of [1] to [3], wherein the fibrous insoluble cellulose is fermented cellulose,
[5] In any one of [1] to [4], the milk protein mixture contained in the acidic liquid composition is ingested so that the total protein amount is 0.06 to 0.7 g / kg body weight per serving. The muscle synthesis promoter according to the description,
[6] The unit packaging form according to any one of [1] to [5], comprising a unit packaging form per serving, wherein the unit packaging form contains a milk protein mixture in a total protein amount of 3 to 40 g as a meal intake. Of muscle synthesis promoter,
[7] The muscle synthesis promoter according to any one of [1] to [6] for a subject to exercise,
[8] The muscle synthesis promoter according to [7], wherein the exercise is muscle training,
[9] 0.2-1.2% by weight soybean polysaccharide, 0.1-0.5% by weight HM pectin, 0.01-0.1% by weight fibrous insoluble cellulose, and casein protein A method for promoting muscle synthesis, comprising ingesting an acidic liquid composition containing a milk protein mixture containing whey protein to a subject in need of muscle synthesis promotion, wherein the protein amount ratio of casein protein to whey protein (Casein protein / whey protein) is 2 to 20, a method for promoting muscle synthesis,
[10] 0.2-1.2% by weight soybean polysaccharide, 0.1-0.5% by weight HM pectin, 0.01-0.1% by weight fibrous insoluble cellulose, and casein protein A method for promoting muscle synthesis (excluding medical practices for humans), comprising ingesting an acidic liquid composition comprising a milk protein mixture containing whey protein to a subject in need of muscle synthesis promotion, wherein whey A method for promoting muscle synthesis, wherein the protein amount ratio of casein protein to protein (casein protein / whey protein) is 2 to 20,
[11] 0.2-1.2% by weight soybean polysaccharide, 0.1-0.5% by weight HM pectin, 0.01-0.1% by weight fibrous to promote muscle synthesis Use of an insoluble cellulose, and an acidic liquid composition comprising a milk protein mixture containing casein protein and whey protein as an active ingredient, wherein the ratio of casein protein to whey protein (casein) Protein / whey protein) is 2-20, use,
[12] 0.2 to 1.2% by weight of soybean polysaccharide, 0.1 to 0.5% by weight of HM pectin, 0.01 to 0.5% for the production of foods or pharmaceuticals for promoting muscle synthesis Use of a muscle synthesis promoter comprising as an active ingredient an acidic liquid composition comprising 0.1% by weight of fibrous insoluble cellulose and a milk protein mixture containing casein protein and whey protein, Use, wherein the protein amount ratio of casein protein (casein protein / whey protein) is 2-20
[13] 0.2-1.2 wt% soy polysaccharide, 0.1-0.5 wt% HM pectin, 0.01-0.1 wt% fibrous insoluble cellulose, and casein protein An acidic liquid composition comprising a milk protein mixture containing whey protein, wherein the protein content ratio of casein protein to whey protein (casein protein / whey protein) is 2 to 20, acidic to promote muscle synthesis Liquid composition.
本発明によれば、胃内での乳タンパク質のカード化を防ぎ、乳タンパク質の吸収を促進させた上で、筋肉合成促進効果を高めることができ、乳タンパク質が同一濃度で含まれる中性液状組成物を有効成分とする筋肉合成促進効果と同等、またはそれ以上の筋肉合成促進効果を奏することができる。よって、本発明によれば、必ずしも多量の乳タンパク質の摂取をしなくても、筋肉合成促進効果を奏することができる。 ADVANTAGE OF THE INVENTION According to this invention, after making the milk protein curd in the stomach and promoting absorption of milk protein, the effect of promoting muscle synthesis can be enhanced, and a neutral liquid containing milk protein at the same concentration The muscle synthesis promoting effect equivalent to or higher than the muscle synthesis promoting effect comprising the composition as an active ingredient can be exhibited. Therefore, according to the present invention, an effect of promoting muscle synthesis can be achieved without necessarily ingesting a large amount of milk protein.
以下では、本発明を詳細に説明するが、本発明は、個々の形態には限定されない。 Hereinafter, the present invention will be described in detail, but the present invention is not limited to individual forms.
本発明の筋肉合成促進剤は、酸性液状組成物を有効成分として含んでなり、好ましくは、酸性液状組成物を有効成分とする筋肉合成促進剤である。具体的には、本発明の筋肉合成促進剤は、大豆多糖類、HMペクチン、繊維状の不溶性セルロース、および特定のタンパク質量比のカゼインタンパク質とホエイタンパク質とを含む乳タンパク質混合物を含む酸性液状組成物を有効成分として含んでなる筋肉合成促進剤である。より具体的には、本発明の筋肉合成促進剤は、0.2~1.2重量%の大豆多糖類、0.1~0.5重量%のHMペクチン、0.01~0.1重量%の繊維状の不溶性セルロース、およびカゼインタンパク質とホエイタンパク質とを含む乳タンパク質混合物を含む酸性液状組成物を有効成分として含んでなる筋肉合成促進剤であって、ホエイタンパク質に対するカゼインタンパク質のタンパク質量比(カゼインタンパク質/ホエイタンパク質)が2~20である筋肉合成促進剤である。本発明の好ましい態様によれば、本発明の筋肉合成促進剤は、即効的な筋肉合成促進を必要とする対象に使用されるものである。 The muscle synthesis promoter of the present invention comprises an acidic liquid composition as an active ingredient, and is preferably a muscle synthesis promoter containing an acidic liquid composition as an active ingredient. Specifically, the muscle synthesis promoter of the present invention is an acidic liquid composition comprising a soy polysaccharide, HM pectin, fibrous insoluble cellulose, and a milk protein mixture containing casein protein and whey protein in a specific protein ratio. It is a muscle synthesis promoter comprising a product as an active ingredient. More specifically, the muscle synthesis promoter of the present invention comprises 0.2 to 1.2% by weight soybean polysaccharide, 0.1 to 0.5% by weight HM pectin, 0.01 to 0.1% by weight. % Muscle insoluble cellulose, and a muscle synthesis promoter comprising an acidic liquid composition containing a milk protein mixture containing casein protein and whey protein as an active ingredient, the protein amount ratio of casein protein to whey protein It is a muscle synthesis promoter having (casein protein / whey protein) of 2 to 20. According to a preferred embodiment of the present invention, the muscle synthesis promoter of the present invention is used for a subject in need of immediate acceleration of muscle synthesis.
「有効成分」とは筋肉合成促進効果を奏する上で必要とされる成分のことを意味する。一つの好ましい形態として、「有効成分」とは、即効的な筋肉合成促進を必要とする対象のための筋肉合成促進効果を奏する上での必要とされる成分のことを意味する。 “Active ingredient” means an ingredient required for exerting a muscle synthesis promoting effect. As one preferred form, the “active ingredient” means an ingredient required for exerting a muscle synthesis promoting effect for a subject requiring immediate muscle synthesis promotion.
「筋肉合成促進」とは、乳タンパク質を摂取し、栄養素として体内で吸収することにより、筋肉の合成を促進することを意味する。従って、本発明の筋肉合成促進剤は、そのことにおよびそのことに起因する状態に用いられる。例えば、筋肉合成促進の目的には、筋肉増量、筋肉成長助長、筋肉組織修復、筋肉増強、筋力向上、筋肉合成促進に伴う健康増進効果および運動能力向上が挙げられ、好ましくは、筋肉組織修復、筋力向上、筋肉合成促進に伴う健康増進効果および運動能力向上である。筋肉合成促進には、アミノ酸からの筋肉タンパク質の同化も包含される。「即効的な筋肉合成促進」とは、乳タンパク質の即時吸収に伴う筋肉の合成を促進することを意味する。 “Promoting muscle synthesis” means promoting the synthesis of muscle by taking milk protein and absorbing it in the body as a nutrient. Therefore, the muscle synthesis promoter of the present invention is used for that and the state resulting therefrom. For example, the purpose of muscle synthesis promotion includes muscle gain, muscle growth promotion, muscle tissue repair, muscle strengthening, muscle strength improvement, health promotion effect and muscle performance improvement accompanying muscle synthesis promotion, preferably muscle tissue repair, It is the improvement of muscular strength, the health promotion effect accompanying the promotion of muscle synthesis and the improvement of exercise ability. Promoting muscle synthesis also includes assimilation of muscle proteins from amino acids. “Immediately effective muscle synthesis promotion” means promoting muscle synthesis accompanying immediate absorption of milk protein.
「筋肉合成促進を必要とする対象」とは、筋肉組織を修復し、筋肉成長を助長するために、筋肉タンパク質の合成を促進する必要がある対象を意味し、例えば、健康増進や運動能力向上を目的として、筋肉合成の促進、筋肉喪失の予防、および筋肉量の回復促進のために、運動する対象を意味する。ここで、筋力に一定の負荷をかけることにより、筋肉の合成が促進される点で、運動は、好ましくは、筋力トレーニング(レジスタンス運動)であり、より好ましくは、長期的な筋力トレーニング、例えば、連続して30分間~5時間を、1週間のうち1日~7日の頻度で継続される筋力トレーニングである。筋力トレーニングには、例えば、ダンベル運動、スクワット運動、マシントレーニングが挙げられる。 “Subjects needing muscle synthesis promotion” means subjects who need to promote muscle protein synthesis in order to repair muscle tissue and promote muscle growth. For the purpose of this, it means a subject who exercises to promote muscle synthesis, prevent muscle loss, and promote recovery of muscle mass. Here, the exercise is preferably strength training (resistance exercise), and more preferably long-term strength training, for example, in that muscle synthesis is promoted by applying a certain load to muscle strength. It is strength training that is continued for 30 minutes to 5 hours at a frequency of 1 to 7 days in a week. Examples of strength training include dumbbell exercise, squat exercise, and machine training.
本発明の筋肉合成促進を必要とする対象には、例えば、スポーツ選手、スポーツ愛好者(アスリート)、生活習慣病の改善のために運動を必要とする者、高齢者などの健康増進のために運動を必要とする者、または筋肉合成促進を必要とする疾患、例えば筋肉損傷疾患(例えば、サルコペニア)を患い、運動により筋肉合成の促進を必要とする患者が挙げられる。また、この対象は、ヒト以外の動物(馬、牛などの家畜、犬、猫などの愛玩動物、動物園などで飼育されている鑑賞動物など)であってもよい。 For the purpose of promoting muscle synthesis of the present invention, for example, athletes, sports enthusiasts (athletes), those who need exercise to improve lifestyle-related diseases, elderly people, etc. Examples include those who require exercise, or patients who suffer from a disease requiring muscle synthesis promotion, such as a muscle injury disease (eg, sarcopenia), and need to promote muscle synthesis through exercise. In addition, the target may be an animal other than a human (domestic animals such as horses and cows, pets such as dogs and cats, appreciation animals kept in zoos, and the like).
本発明の筋肉合成促進剤を筋肉合成促進を必要とする対象に摂取させる(投与する)時期は、運動前であっても運動後であっても運動中であってもよい。ここで、この摂取させる時期は、好ましくは、運動後であり、より好ましくは、運動直後である。そして、運動により生じる骨格筋分解(異化)を抑制し、かつ、アミノ酸からタンパク質への同化を促進できる点で、この摂取させる時期は、好ましくは、運動直後のうち、運動終了後から3時間以内であり、より好ましくは、運動終了後から2時間以内であり、さらに好ましくは、運動終了後から1時間以内であり、特に好ましくは、運動終了後から30分以内である(Levenhagen et al. Am J physiol Endocrinol Metab (2001), 280, E982-E993参照)。 The time when the muscle synthesis promoter of the present invention is ingested (administered) to a subject in need of muscle synthesis may be before exercise, after exercise, or during exercise. Here, the time of intake is preferably after exercise, more preferably immediately after exercise. In terms of suppressing skeletal muscle degradation (catabolism) caused by exercise and promoting assimilation from amino acids to proteins, the intake period is preferably within 3 hours after the end of exercise, immediately after exercise. More preferably, within 2 hours after the end of exercise, more preferably within 1 hour after the end of exercise, and particularly preferably within 30 minutes after the end of exercise (Levenhagenhaet al. Am J physiol Endocrinol Metab (2001), 280, E982-E993).
筋肉合成促進効果において、乳タンパク質が同一濃度で含まれる中性液状組成物と同等の筋肉合成促進効果とは、乳タンパク質が同一濃度で含まれる中性液状組成物(例えば、牛乳、脱脂乳、濃縮乳、脱脂濃縮乳など)を経口摂取(投与)した場合にみられる、タンパク質の吸収の速度と同レベルの速度、およびその吸収に伴う筋肉合成促進作用と同レベルの効果を意味する。また、筋肉合成促進効果において、乳タンパク質が同一濃度で含まれる中性液状組成物と同等の即効的な筋肉合成促進効果作用とは、乳タンパク質が同一濃度で含まれる中性液状組成物(例えば、牛乳、脱脂乳、濃縮乳、脱脂濃縮乳など)を経口摂取(投与)した場合にみられる、タンパク質の吸収の速度と同レベルの速度、およびその吸収に伴う筋肉合成促進作用と同レベルの効果を意味する。ここで、筋肉合成促進効果は、例えば、ラットの水泳試験後に、試験物質を投与してから1時間以内において、試験群の上肢三頭筋合成速度(FSR)を測定することによって確認することができる。すなわち、即効的な筋肉合成促進作用があるといわれている乳タンパク質が同じ濃度で含まれる中性液状組成物を経口摂取した対照群のFSRに比べて、試験群のFSRが同程度や同程度以上の場合には、筋肉合成促進作用として有意であると判断できる。この場合、即効的な筋肉合成促進効果は、好ましくは本発明の筋肉合成促進剤を摂取してから短時間での筋肉を合成する速度、より好ましくは、摂取後30分から3時間以内、さらに好ましくは摂取後30分から2時間以内、さらに好ましくは摂取後30分から1時間以内、特に好ましくは摂取後から30分での筋肉を合成する速度を測定することによって確認することができる。 In the muscle synthesis promoting effect, the neutral muscle composition promoting effect equivalent to a neutral liquid composition containing milk protein at the same concentration is a neutral liquid composition containing milk protein at the same concentration (for example, milk, skim milk, It means the same level of the rate of protein absorption and the same effect as the muscle synthesis promoting effect associated with the absorption observed when orally ingested (administered) (concentrated milk, skim concentrated milk, etc.). Further, in the effect of promoting muscle synthesis, an immediate effect of promoting muscle synthesis equivalent to a neutral liquid composition containing milk protein at the same concentration is a neutral liquid composition containing milk protein at the same concentration (for example, , Milk, skim milk, concentrated milk, concentrated skim milk, etc.), the same level of protein absorption rate and the same level of muscle synthesis promoting effect associated with the absorption Means effect. Here, the effect of promoting muscle synthesis can be confirmed by, for example, measuring the upper limb triceps muscle synthesis rate (FSR) within 1 hour after administration of the test substance after the swimming test of rats. it can. That is, the FSR of the test group is comparable or comparable to the FSR of the control group that orally ingested a neutral liquid composition containing milk protein that is said to have an immediate effect of promoting muscle synthesis at the same concentration. In the above case, it can be determined that the muscle synthesis promoting action is significant. In this case, the immediate effect of promoting muscle synthesis is preferably a rate of synthesizing muscle in a short time after ingesting the muscle synthesis promoter of the present invention, more preferably within 30 minutes to 3 hours after ingestion, more preferably Can be confirmed by measuring the rate of muscle synthesis within 30 minutes to 2 hours after ingestion, more preferably within 30 minutes to 1 hour after ingestion, and particularly preferably 30 minutes after ingestion.
「タンパク質量」とは、乳タンパク質、ホエイタンパク質またはカゼインタンパク質の各種のタンパク質に含まれるアミノ酸の高分子としてのタンパク質の量を意味する。「タンパク質量比」とは、乳タンパク質、ホエイタンパク質またはカゼインタンパク質の各種のタンパク質に含まれるアミノ酸の高分子としてのタンパク質の量の比率を意味する。ここで、タンパク質量は、例えば、食品成分表などの公知の情報に基づいて算出してもよく、また、ケルダール法やローリー法などの慣用の方法によって測定して算出してもよい。実際に、ケルダール法の場合には、各種のタンパク質に含まれる窒素を測定し、その値に、窒素-タンパク質換算係数(通常 6.25)を乗じて算出することができる。 "Protein amount" means the amount of protein as a polymer of amino acids contained in various proteins such as milk protein, whey protein or casein protein. “Protein amount ratio” means the ratio of the amount of protein as a polymer of amino acids contained in various proteins such as milk protein, whey protein, or casein protein. Here, the amount of protein may be calculated based on known information such as a food composition table, or may be calculated by measuring by a conventional method such as Kjeldahl method or Raleigh method. Actually, in the case of the Kjeldahl method, it can be calculated by measuring nitrogen contained in various proteins and multiplying the value by a nitrogen-protein conversion factor (usually 6.25).
本発明で用いられる酸性液状組成物とは、0.2~1.2重量%の大豆多糖類、0.1~0.5重量%のHMペクチン、0.01~0.1重量%の繊維状の不溶性セルロース、および特定のタンパク質量比のカゼインタンパク質とホエイタンパク質とを含む乳タンパク質混合物を含み、酸性化した液状組成物をいう。本発明で用いられる酸性液状組成物は、完全な液状でなくともよく、一部に固形状および/またはゲル状のものが含まれているものであってもよい。 The acidic liquid composition used in the present invention includes 0.2 to 1.2% by weight of soybean polysaccharide, 0.1 to 0.5% by weight of HM pectin, and 0.01 to 0.1% by weight of fiber. And a milk protein mixture containing casein protein and whey protein in a specific protein amount ratio, and an acidified liquid composition. The acidic liquid composition used in the present invention may not be completely liquid, and may be partly solid and / or gel.
本発明で用いられる酸性液状組成物に含有される乳タンパク質混合物は、ホエイタンパク質とカゼインタンパク質とを特定のタンパク質量比で含んでいれば特に限定されず、別々に分離や精製されたホエイタンパク質とカゼインタンパク質とを特定のタンパク質量比になるように混合して調製してもよいし、あるいは、別々に分離や精製されていないホエイタンパク質とカゼインタンパク質とを既に特定のタンパク質量比で含んでいる原料(素材)や食品などを混合して調製してもよい。このとき、本発明で用いられる乳タンパク質混合物では、ホエイタンパク質やカゼインタンパク質の分離工程や精製工程を必要とせず、それらの製造費が安価である点で、ホエイタンパク質とカゼインタンパク質とを既に特定のタンパク質量比で含んでいる原料や食品などを主要な成分とし、必要に応じて、別々に精製されたホエイタンパク質やカゼインタンパク質とを特定のタンパク質量比になるように混合して調製することが好ましい。 The milk protein mixture contained in the acidic liquid composition used in the present invention is not particularly limited as long as it contains whey protein and casein protein in a specific protein amount ratio, and is separated and purified separately from whey protein. Casein protein may be prepared by mixing to a specific protein amount ratio, or it may already contain whey protein and casein protein that have not been separated or purified separately at a specific protein amount ratio. You may mix and prepare a raw material (raw material), a foodstuff, etc. At this time, the milk protein mixture used in the present invention does not require a separation step or purification step of whey protein or casein protein, and the production cost thereof is low, so that whey protein and casein protein are already specified. It can be prepared by mixing the raw materials and foods contained in the protein amount ratio as the main components, and mixing the whey protein and casein protein, which are separately purified, if necessary, so that the specific protein amount ratio is obtained. preferable.
カゼインタンパク質と別々に分離や精製されたホエイタンパク質には、例えば、ホエイの原液(甘性ホエイ、酸ホエイなど)、その濃縮物、その乾燥物(ホエイ粉など)、その凍結物、その加水分解物など、および、これらの還元溶液などを用いることができる。さらに、脱塩ホエイ、ホエイタンパク質濃縮物(WPC)、ホエイタンパク質精製物(WPI)、α-ラクトアルブミン(α-La)、β-ラクトグロブリン(β-Lg)、免疫グロブリン、ラクトフェリンなど、および、これらの還元溶液を用いることができる。そして、ホエイタンパク質と別々に分離や精製されたカゼインタンパク質には、例えば、カゼインの分離物(フレッシュチーズなどのナチュラルチーズ、ナトリウムカゼイネート、カルシウムカゼイネートなど)、その濃縮物、その乾燥物、その凍結物、その加水分解物など、および、これらの還元溶液などを用いることができる。さらに、α-カゼイン、β-カゼイン、k-カゼインなどの精製物、および、これらの還元溶液を用いることができる。また、ホエイタンパク質とカゼインタンパク質とを既に特定のタンパク質量比で含んでいる原料や食品には、例えば、生乳、殺菌乳(牛乳など)、脱脂乳、成分調整牛乳、加工乳、乳製品(濃縮乳、粉乳、練乳、発酵乳(ヨーグルトなど)、乳酸菌飲料、プロセスチーズ類、アイスクリーム類、クリーム類)、乳タンパク質濃縮物(MPC)、その濃縮物、その乾燥物、その凍結物、その加水分解物など、および、これらの還元溶液などを用いることができる。これらの中でも、高濃度のカゼインタンパク質を含む乳タンパク質混合物を含有する酸性液状組成物の調製が容易な点で、乳タンパク質混合物は、カゼインタンパク質を豊富に含有する乳原料である、乳タンパク質濃縮物(MPC)を用いることが好ましい。この乳タンパク質濃縮物には、カゼインタンパク質とホエイタンパク質とのタンパク質量比(カゼインタンパク質/ホエイタンパク質)は、4である。このとき、これらには、市販品を入手して用いてもよいし、自ら調製して用いてもよい。 Examples of whey protein separated and purified separately from casein protein include whey stock solutions (sweet whey, acid whey, etc.), concentrates, dried products (whey powder, etc.), frozen products, hydrolyzed products, etc. And reducing solutions thereof. Further, desalted whey, whey protein concentrate (WPC), purified whey protein (WPI), α-lactalbumin (α-La), β-lactoglobulin (β-Lg), immunoglobulin, lactoferrin, and the like, and These reducing solutions can be used. Casein protein separated and purified separately from whey protein includes, for example, casein isolate (natural cheese such as fresh cheese, sodium caseinate, calcium caseinate), its concentrate, its dried product, its A frozen material, a hydrolyzate thereof, a reducing solution thereof, and the like can be used. Furthermore, purified products such as α-casein, β-casein, k-casein, and reducing solutions thereof can be used. In addition, raw materials and foods that already contain whey protein and casein protein in a specific protein amount ratio include, for example, raw milk, pasteurized milk (such as milk), skim milk, component-adjusted milk, processed milk, and dairy products (concentrated) Milk, powdered milk, condensed milk, fermented milk (such as yogurt), lactic acid bacteria beverages, processed cheeses, ice creams, creams), milk protein concentrate (MPC), its concentrate, its dried product, its frozen product, its water Decomposed products and the like, and reducing solutions thereof can be used. Among these, the milk protein mixture is a milk protein concentrate that is a milk raw material rich in casein protein in that it is easy to prepare an acidic liquid composition containing a milk protein mixture containing a high concentration of casein protein. (MPC) is preferably used. In this milk protein concentrate, the protein amount ratio of casein protein to whey protein (casein protein / whey protein) is 4. At this time, you may obtain and use a commercial item for these, and may prepare and use it for themselves.
本発明で用いられる酸性液状組成物に含有される乳タンパク質混合物は、特定のタンパク質量比のホエイタンパク質とカゼインタンパク質とから構成され、具体的には、カゼインタンパク質とホエイタンパク質とのタンパク質量比(カゼインタンパク質/ホエイタンパク質)が2~20であり、好ましくは2~10であり、より好ましくは2~6であり、さらに好ましくは2~4である。本発明では、カゼインタンパク質とホエイタンパク質とのタンパク質量比は、筋肉合成促進剤に含まれる酸性液状組成物に含まれる乳タンパク質混合物でのタンパク質量比を意味する。なお、本発明で用いられる乳タンパク質混合物では、カゼインタンパク質とホエイタンパク質とのタンパク質量比(カゼインタンパク質/ホエイタンパク質)が意図的に調整(設計)されて、さらに酸性液状組成物に調製されている点で、従来技術とは大きく異なっている。 The milk protein mixture contained in the acidic liquid composition used in the present invention is composed of whey protein and casein protein in a specific protein amount ratio. Specifically, the protein amount ratio between casein protein and whey protein ( Casein protein / whey protein) is 2 to 20, preferably 2 to 10, more preferably 2 to 6, and further preferably 2 to 4. In the present invention, the protein amount ratio between casein protein and whey protein means the protein amount ratio in the milk protein mixture contained in the acidic liquid composition contained in the muscle synthesis promoter. In the milk protein mixture used in the present invention, the amount ratio of casein protein to whey protein (casein protein / whey protein) is intentionally adjusted (designed), and further prepared into an acidic liquid composition. In this respect, it is very different from the prior art.
本発明で用いられる酸性液状組成物は、一般的に、乳タンパク質中のカゼインタンパク質が酸凝固しやすく、酸凝固に由来する分離および沈殿が生じるところ、高濃度のカゼインタンパク質を含む乳タンパク質混合物を含有する酸性液状組成物であっても、分離および沈殿を抑制し、再分散性も良好で、低粘度で摂取(投与)しやすい形態である。この形態に該当する範囲であれば、その詳細な性質(pH、粘度など)は、任意に設計することができる。 The acidic liquid composition used in the present invention generally has a milk protein mixture containing a high concentration of casein protein, where the casein protein in the milk protein is likely to coagulate with acid and separation and precipitation resulting from the acid coagulation occur. Even the contained acidic liquid composition is in a form that suppresses separation and precipitation, has good redispersibility, is low in viscosity, and is easy to ingest (administer). If it is the range applicable to this form, the detailed property (pH, viscosity, etc.) can be designed arbitrarily.
本発明で用いられる酸性液状組成物のpHは、例えば、3~6、3.1~5.8、3.2~5.6、3.3~5.4、3.4~5.2、3.5~5、3.6~4.8、3.7~4.6、3.8~4.4である。本発明の酸性液状組成物のpHが3を上回ることは、酸味が強く感じられて摂取しづらくなるのを防止する上で好ましい。また、本発明の酸性液状組成物のpHが6を下回ることは、酸味が弱く感じられ、爽やかさが損なわれ、酸性液状組成物として、摂取しづらくなるのを防止する上で好ましい。 The pH of the acidic liquid composition used in the present invention is, for example, 3 to 6, 3.1 to 5.8, 3.2 to 5.6, 3.3 to 5.4, 3.4 to 5.2. 3.5-5, 3.6-4.8, 3.7-4.6, 3.8-4.4. It is preferable that the pH of the acidic liquid composition of the present invention exceeds 3 in order to prevent the acidity from being felt strongly and difficult to take. Moreover, it is preferable that the pH of the acidic liquid composition of the present invention is less than 6 in order to prevent the acidity from being felt weakly refreshing and difficult to take as an acidic liquid composition.
本発明で用いられる酸性液状組成物の粘度(10℃)は、B型回転粘度計により測定された酸性液状組成物の粘度である。本発明で用いられる酸性液状組成物の粘度(10℃)は、例えば、3~30mPa・s、3.5~30mPa・s、4~30mPa・s、4.5~30mPa・s、5~30mPa・s、5.5~29mPa・s、6~28mPa・s、6.5~27mPa・s、7~26mPa・s、7.5~25mPa・s、8~24mPa・s、8.5~23mPa・s、9~22mPa・s、9.5~21mPa・s、10~20mPa・sである。本発明で用いられる酸性液状組成物の粘度(10℃)が3mPa・sを上回ることは、酸性液状組成物のカゼインタンパク質が安定しづらくなり、酸性液状組成物の分離および沈殿が発生しやすくなるのを防止する上で好ましい。また、本発明で用いられる酸性液状組成物の粘度(10℃)が30mPa・sを下回ることは、爽やかさが損なわれて摂取しづらくなるのを防止する上で好ましい。なお、本発明で用いられる酸性液状組成物の粘度(10℃)は、ブルックフィールド粘度計などの汎用のB型回転粘度計などで測定された酸性液状組成物の粘度である。 The viscosity (10 ° C.) of the acidic liquid composition used in the present invention is the viscosity of the acidic liquid composition measured with a B-type rotational viscometer. The viscosity (10 ° C.) of the acidic liquid composition used in the present invention is, for example, 3 to 30 mPa · s, 3.5 to 30 mPa · s, 4 to 30 mPa · s, 4.5 to 30 mPa · s, 5 to 30 mPa. · S, 5.5 to 29 mPa · s, 6 to 28 mPa · s, 6.5 to 27 mPa · s, 7 to 26 mPa · s, 7.5 to 25 mPa · s, 8 to 24 mPa · s, 8.5 to 23 mPa S, 9 to 22 mPa · s, 9.5 to 21 mPa · s, and 10 to 20 mPa · s. When the viscosity (10 ° C.) of the acidic liquid composition used in the present invention exceeds 3 mPa · s, the casein protein of the acidic liquid composition becomes difficult to stabilize, and the acidic liquid composition is likely to be separated and precipitated. It is preferable for preventing the above. Moreover, it is preferable that the viscosity (10 ° C.) of the acidic liquid composition used in the present invention is less than 30 mPa · s in order to prevent refreshing from being impaired and difficult to take. The viscosity (10 ° C.) of the acidic liquid composition used in the present invention is the viscosity of the acidic liquid composition measured with a general-purpose B-type rotational viscometer such as a Brookfield viscometer.
本発明で用いられる酸性液状組成物は、特定のタンパク質量比のカゼインタンパク質とホエイタンパク質とを含む乳タンパク質混合物を含んでなる。ここで、乳タンパク質混合物に含まれるカゼインタンパク質は、一般的に、中性領域では安定であるが、等電点であるpH4.6周辺よりも低いpH領域の環境では、酸凝固により、カゼインタンパク質同士が凝集し、これが酸性液状組成物の分離や沈殿の発生につながる。一方、本発明で用いられる特定の組成からなる酸性液状組成物は、高濃度のカゼインタンパク質を含む乳タンパク質混合物を含有する酸性液状組成物であっても、酸性液状組成物の分離および沈殿を抑制し、再分散性も良好で、低粘度で摂取しやすい形態である。ここでいう、本発明に用いられる酸性液状組成物に含有されている、カゼインタンパク質を含む乳タンパク質混合物の濃度は、高濃度である場合には、例えば、3重量%以上、3.2重量%以上、3.4重量%以上、3.6重量%以上、3.8重量%以上、4重量%以上、4.2重量%以上、4.4重量%以上、3~10重量%、3~9.5重量%、3~9重量%、3~8.5重量%、3~8重量%、3~7.5重量%、3~7重量%、3.2~10重量%、3.2~9.5重量%、3.2~9重量%、3.2~8.5重量%、3.2~8重量%、3.2~7.5重量%、3.2~7重量%、3.4~10重量%、3.4~9.5重量%、3.4~9重量%、3.4~8.5重量%、3.4~8重量%、3.4~7.5重量%、3.4~7重量%、3.6~10重量%、3.6~9.5重量%、3.6~9重量%、3.6~8.5重量%、3.6~8重量%、3.6~7.5重量%、3.6~7重量%、3.8~10重量%、3.8~9.5重量%、3.8~9重量%、3.8~8.5重量%、3.8~8重量%、3.8~7.5重量%、3.8~7重量%、4~10重量%、4~9.5重量%、4~9重量%、4~8.5重量%、4~8重量%、4~7.5重量%、4~7重量%、4.2~10重量%、4.2~9.5重量%、4.2~9重量%、4.2~8.5重量%、4.2~8重量%、4.2~7.5重量%、4.2~7重量%、4.4~10重量%、4.4~9.5重量%、4.4~9重量%、4.4~8.5重量%、4.4~8重量%、4.4~7.5重量%、4.4~7重量%である。また、本発明で用いられる酸性液状組成物に含有されている、カゼインタンパク質を含む乳タンパク質混合物の濃度は、高濃度でない場合には、例えば、3重量%以下、2.8重量%以下、2.6重量%以下、2.4重量%以下、2.2重量%以下、2重量%以下、0.5~3重量%、1~3重量%、1.2~3重量%、1.4~3重量%、1.6~3重量%、1.8~3重量%、0.5~2.8重量%、1~2.8重量%、1.2~2.8重量%、1.4~2.8重量%、1.6~2.8重量%、1.8~2.8重量%、0.5~2.6重量%、1~2.6重量%、1.2~2.6重量%、1.4~2.6重量%、1.6~2.6重量%、1.8~2.6重量%、0.5~2.4重量%、1~2.4重量%、1.2~2.4重量%、1.4~2.4重量%、1.6~2.4重量%、1.8~2.4重量%、0.5~2.2重量%、1~2.2重量%、1.2~2.2重量%、1.4~2.2重量%、1.6~2.2重量%、1.8~2.2重量%、0.5~2重量%、1~2重量%、1.2~2重量%、1.4~2重量%、1.6~2重量%、1.8~2重量%である。ここで、乳タンパク質混合物に含まれる、カゼインタンパク質およびホエイタンパク質の各濃度は、前述したカゼインタンパク質とホエイタンパク質とのタンパク質量比から、容易に算出できる。 The acidic liquid composition used in the present invention comprises a milk protein mixture containing casein protein and whey protein in a specific protein amount ratio. Here, the casein protein contained in the milk protein mixture is generally stable in a neutral region, but in an environment in a pH region lower than around the isoelectric point of pH 4.6, casein protein is caused by acid coagulation. Aggregates with each other, leading to separation of the acidic liquid composition and occurrence of precipitation. On the other hand, even if the acidic liquid composition comprising a specific composition used in the present invention is an acidic liquid composition containing a milk protein mixture containing a high concentration of casein protein, separation and precipitation of the acidic liquid composition is suppressed. In addition, the redispersibility is good, and the form is low in viscosity and easy to ingest. When the concentration of the milk protein mixture containing casein protein contained in the acidic liquid composition used in the present invention is high, for example, 3% by weight or more and 3.2% by weight 3.4% or more, 3.6% or more, 3.8% or more, 4% or more, 4.2% or more, 4.4% or more, 3 to 10%, 3 to 9.5 wt%, 3-9 wt%, 3-8.5 wt%, 3-8 wt%, 3-7.5 wt%, 3-7 wt%, 3.2-10 wt%, 2 to 9.5 wt%, 3.2 to 9 wt%, 3.2 to 8.5 wt%, 3.2 to 8 wt%, 3.2 to 7.5 wt%, 3.2 to 7 wt% %, 3.4-10 wt%, 3.4-9.5 wt%, 3.4-9 wt%, 3.4-8.5 wt%, 3.4-8 wt%, 3.4- 7.5% by weight, 3.4-7 layers %, 3.6 to 10% by weight, 3.6 to 9.5% by weight, 3.6 to 9% by weight, 3.6 to 8.5% by weight, 3.6 to 8% by weight, 3.6 to 7.5 wt%, 3.6-7 wt%, 3.8-10 wt%, 3.8-9.5 wt%, 3.8-9 wt%, 3.8-8.5 wt%, 3.8-8 wt%, 3.8-7.5 wt%, 3.8-7 wt%, 4-10 wt%, 4-9.5 wt%, 4-9 wt%, 4-8. 5 wt%, 4-8 wt%, 4-7.5 wt%, 4-7 wt%, 4.2-10 wt%, 4.2-9.5 wt%, 4.2-9 wt%, 4.2-8.5 wt%, 4.2-8 wt%, 4.2-7.5 wt%, 4.2-7 wt%, 4.4-10 wt%, 4.4-9. 5 wt%, 4.4-9 wt%, 4.4-8.5 wt%, 4.4-8 wt%, 4.4-7.5 wt%, 4.4 7 percent by weight. Further, when the concentration of the milk protein mixture containing casein protein contained in the acidic liquid composition used in the present invention is not high, it is, for example, 3% by weight or less, 2.8% by weight or less, 2 .6% by weight or less, 2.4% by weight or less, 2.2% by weight or less, 2% by weight or less, 0.5 to 3% by weight, 1 to 3% by weight, 1.2 to 3% by weight, 1.4 ~ 3 wt%, 1.6-3 wt%, 1.8-3 wt%, 0.5-2.8 wt%, 1-2.8 wt%, 1.2-2.8 wt%, 1 4.4 to 2.8 wt%, 1.6 to 2.8 wt%, 1.8 to 2.8 wt%, 0.5 to 2.6 wt%, 1 to 2.6 wt%, 1.2 ~ 2.6 wt%, 1.4-2.6 wt%, 1.6-2.6 wt%, 1.8-2.6 wt%, 0.5-2.4 wt%, 1-2 .4% by weight, 1.2-2.4% by weight, 1.4 2.4 wt%, 1.6-2.4 wt%, 1.8-2.4 wt%, 0.5-2.2 wt%, 1-2.2 wt%, 1.2-2. 2% by weight, 1.4-2.2% by weight, 1.6-2.2% by weight, 1.8-2.2% by weight, 0.5-2% by weight, 1-2% by weight, 2 to 2% by weight, 1.4 to 2% by weight, 1.6 to 2% by weight, and 1.8 to 2% by weight. Here, each concentration of the casein protein and the whey protein contained in the milk protein mixture can be easily calculated from the protein amount ratio of the casein protein and the whey protein described above.
本発明で用いられる酸性液状組成物は、高濃度のカゼインタンパク質を含む乳タンパク質混合物を含有する酸性液状組成物であっても、酸性液状組成物の分離および沈殿を抑制し、再分散性も良好で、低粘度で摂取しやすい形態である特徴を出し、かつ、胃内での乳タンパク質のカード化を防ぎ、乳タンパク質の吸収を促進させた上で筋肉合成促進効果を高めるために、0.2~1.2重量%の大豆多糖類、0.1~0.5重量%のHMペクチン、0.01~0.1重量%の繊維状の不溶性セルロースを含有することができる。 Even if the acidic liquid composition used in the present invention is an acidic liquid composition containing a milk protein mixture containing a high concentration of casein protein, separation and precipitation of the acidic liquid composition are suppressed, and redispersibility is also good. In order to increase the muscle synthesis promoting effect while providing the characteristics of a low-viscosity and easily ingested form, preventing the curding of milk protein in the stomach, and promoting the absorption of milk protein. It may contain 2 to 1.2% by weight soybean polysaccharide, 0.1 to 0.5% by weight HM pectin, 0.01 to 0.1% by weight fibrous insoluble cellulose.
本発明の大豆多糖類とは、大豆由来のラムノース、ガラクトース、アラビノース、キシロース、グルコース、ウロン酸の1種もしくは2種以上を含むものであればよく、大豆のなかでも子葉由来のものが好ましい。本発明の大豆多糖類は、その分子量に特に制限はなく、高分子の分子量であることが好ましく、平均分子量が数千~数百万、具体的には5千~100万であるのが好ましい。なお、この大豆多糖類の平均分子量は標準プルラン(昭和電工株式会社)を標準物質として0.1MのNaNO3溶液中の粘度を測定する極限粘度法で求めた値である。かかる大豆多糖類は商業的に入手可能であり、例えば、SM-700(三栄源エフ・エフ・アイ社製)、SM-900(三栄源エフ・エフ・アイ社製)がある。大豆多糖類は、その側鎖の構造により、酸性液状組成物中のカゼインタンパク質同士の酸凝固が原因となる、酸性液状組成物の分離および沈殿を抑制すると言われている。 The soybean polysaccharide of the present invention may be one containing one or more of rhamnose, galactose, arabinose, xylose, glucose and uronic acid derived from soybean, and among soybeans, those derived from cotyledons are preferable. The molecular weight of the soybean polysaccharide of the present invention is not particularly limited and is preferably a high molecular weight, and preferably has an average molecular weight of several thousand to several million, specifically 5,000 to 1,000,000. . The average molecular weight of the soybean polysaccharide is a value determined by an intrinsic viscosity method using a standard pullulan (Showa Denko KK) as a standard substance and measuring the viscosity in a 0.1M NaNO 3 solution. Such soybean polysaccharides are commercially available, for example, SM-700 (manufactured by San-Ei Gen FFI Co., Ltd.) and SM-900 (manufactured by San-Ei Gen FFI Co., Ltd.). Soy polysaccharides are said to suppress the separation and precipitation of acidic liquid compositions caused by acid coagulation between casein proteins in acidic liquid compositions due to the structure of their side chains.
本発明の大豆多糖類の添加量は、本発明で用いられる酸性液状組成物に対して、0.1~0.5重量%のHMペクチン、0.01~0.1重量%の繊維状の不溶性セルロースを含有させる場合には、例えば、0.2~1.2重量%、0.25~1.15重量%、0.3~1.1重量%、0.35~1.05重量%、0.4~1重量%、0.4~0.9重量%である。本発明の大豆多糖類の添加量が1.2重量%を下回ることは、酸性液状組成物に大豆独特の風味が感じられるようになり、酸性液状組成物として摂取しづらくなることを回避する上で好ましい。また、本発明の大豆多糖類の添加量が0.2重量%を上回ることは、高濃度のカゼインタンパク質を含む乳タンパク質混合物を含有する酸性液状組成物であっても、本発明で用いられる酸性液状組成物の分離および沈殿の発生を抑制でき、さらには、再分散性も良好となり、最終的には、本発明の筋肉合成促進剤として摂取した場合、胃内での乳タンパク質のカード化を防ぎ、乳タンパク質の吸収を促進し、筋肉合成促進効果が高まる点で、好ましい。 The addition amount of the soybean polysaccharide of the present invention is 0.1 to 0.5% by weight of HM pectin and 0.01 to 0.1% by weight of fibrous material with respect to the acidic liquid composition used in the present invention. When insoluble cellulose is contained, for example, 0.2 to 1.2% by weight, 0.25 to 1.15% by weight, 0.3 to 1.1% by weight, 0.35 to 1.05% by weight 0.4 to 1 wt%, 0.4 to 0.9 wt%. When the added amount of the soybean polysaccharide of the present invention is less than 1.2% by weight, the acidic liquid composition can feel a unique flavor of soybean, and it is difficult to prevent the acidic liquid composition from being ingested. Is preferable. Further, the addition amount of the soybean polysaccharide of the present invention exceeds 0.2% by weight, even if it is an acidic liquid composition containing a milk protein mixture containing a high concentration of casein protein. Separation of liquid composition and occurrence of precipitation can be suppressed, and redispersibility is also improved. Finally, when taken as a muscle synthesis promoter of the present invention, milk protein curdization in the stomach is achieved. It is preferable in terms of preventing, promoting absorption of milk protein, and enhancing the effect of promoting muscle synthesis.
本発明のHMペクチンとは、野菜や果物に細胞壁成分として存在する、α-D-ガラクツロン酸を主鎖成分とする酸性多糖類である。ペクチンを構成するガラクツロン酸は部分的にメチルエステル化されており、エステル化度によってLMペクチンとHMペクチンに分けられる。HMペクチンは、一般的にエステル化度が50%以上であるものをいう。かかるHMペクチンは商業的に入手可能であり、例えば、SM-478(三栄源エフ・エフ・アイ社製)、SM-666(三栄源エフ・エフ・アイ社製)、AYD5110SB(ユニテックフーズ社製)などがある。HMペクチンは、マイナス荷電を帯びているのが特徴であり、カゼインタンパク質と結合することにより、結合したカゼインタンパク質同士が電荷により反発することで、カゼインタンパク質同士の凝集を防ぐと言われている。 The HM pectin of the present invention is an acidic polysaccharide having α-D-galacturonic acid as a main chain component, which exists as a cell wall component in vegetables and fruits. Galacturonic acid constituting pectin is partially methyl esterified and is divided into LM pectin and HM pectin depending on the degree of esterification. HM pectin generally has a degree of esterification of 50% or more. Such HM pectin is commercially available, for example, SM-478 (manufactured by Saneigen FFI, Inc.), SM-666 (manufactured by Saneigen FFI, Inc.), AYD5110SB (manufactured by Unitech Foods, Inc.). )and so on. HM pectin is characterized by being negatively charged, and is said to prevent aggregation of casein proteins by binding to the casein protein, and the bound casein proteins repel each other due to the charge.
本発明のHMペクチンの添加量は、本発明で用いられる酸性液状組成物に対して、0.2~1.2重量%の大豆多糖類、0.01~0.1重量%の繊維状の不溶性セルロースを含有させる場合には、例えば、0.1~0.5重量%、0.1~0.45重量%、0.1~0.4重量%、0.1~0.35重量%、0.1~0.3重量%、0.12~0.29重量%、0.14~0.28重量%、0.16~0.27重量%、0.18~0.26重量%、0.2~0.25重量%である。本発明のHMペクチンの添加量が0.5重量%を下回ることは、高濃度のカゼインタンパク質を含む乳タンパク質混合物を含有する酸性液状組成物であっても、低粘度で摂取しやすい形態となる上で好ましい。また、本発明のHMペクチンの添加量が0.1重量%を上回ることは、高濃度のカゼインタンパク質を含む乳タンパク質混合物を含有する酸性液状組成物であっても、本発明で用いられる酸性液状組成物の分離および沈殿の発生を抑制でき、さらには、再分散性も良好となり、最終的には、本発明の筋肉合成促進剤として摂取した場合、胃内での乳タンパク質のカード化を防ぎ、乳タンパク質の吸収を促進し、筋肉合成促進効果が高まるため点で、好ましい。 The added amount of HM pectin of the present invention is 0.2 to 1.2% by weight of soybean polysaccharide and 0.01 to 0.1% by weight of fibrous form with respect to the acidic liquid composition used in the present invention. When insoluble cellulose is contained, for example, 0.1 to 0.5% by weight, 0.1 to 0.45% by weight, 0.1 to 0.4% by weight, 0.1 to 0.35% by weight 0.1-0.3 wt%, 0.12-0.29 wt%, 0.14-0.28 wt%, 0.16-0.27 wt%, 0.18-0.26 wt% 0.2 to 0.25% by weight. When the added amount of HM pectin of the present invention is less than 0.5% by weight, even an acidic liquid composition containing a milk protein mixture containing a high concentration of casein protein has a low viscosity and is easily ingested. Preferred above. Moreover, even if it is an acidic liquid composition containing the milk protein mixture containing a high concentration casein protein that the addition amount of HM pectin of this invention exceeds 0.1 weight%, the acidic liquid used by this invention Separation of the composition and occurrence of precipitation can be suppressed, and redispersibility is also improved. Finally, when taken as a muscle synthesis promoter of the present invention, prevention of curding milk protein in the stomach is prevented. It is preferable in terms of promoting absorption of milk protein and enhancing muscle synthesis promoting effect.
本発明で用いられる酸性液状組成物には、高濃度のカゼインタンパク質を含む乳タンパク質混合物を含有する酸性液状組成物であっても、酸性液状組成物の分離および沈殿を抑制し、再分散性も良好で、低粘度で摂取しやすい形態であり、かつ、本発明の筋肉合成促進剤として摂取した場合、胃内での乳タンパク質のカード化を防ぎ、乳タンパク質の吸収を促進させた上で筋肉合成促進効果を高めるために、大豆多糖類および/またはHMペクチンと併用して、もしくは大豆多糖類および/またはHMペクチンの代わりにカルボキシメチルセルロースナトリウムおよび/またはアルギン酸プロピレングリコールエステルなどの他の安定剤を添加することができる。特に、カルボキシメチルセルロースナトリウムおよび/またはアルギン酸プロピレングリコールエステルなどの他の安定剤は、大豆多糖類および/またはHMペクチンと比較して、より低粘度で酸性液状組成物の分離および沈殿を抑制し、再分散性も良好で、かつ、筋肉合成促進剤として摂取した場合、胃内での乳タンパク質のカード化を防ぎ、乳タンパク質の吸収を促進させた上で筋肉合成促進効果を高めるためには、大豆多糖類および/またはHMペクチンと併用して、あるいは大豆多糖類および/またはHMペクチンの代わりに使用することが好ましい。 Even if the acidic liquid composition used in the present invention is an acidic liquid composition containing a milk protein mixture containing a high concentration of casein protein, separation and precipitation of the acidic liquid composition is suppressed, and redispersibility is also achieved. It is a good, low-viscosity, easy-to-ingest form, and when ingested as a muscle synthesis promoter of the present invention, it prevents the formation of curd of milk protein in the stomach and promotes absorption of milk protein and then muscles. In order to enhance the synthesis promoting effect, other stabilizers such as sodium carboxymethylcellulose and / or alginate propylene glycol ester may be used in combination with soybean polysaccharide and / or HM pectin or in place of soybean polysaccharide and / or HM pectin. Can be added. In particular, other stabilizers, such as sodium carboxymethylcellulose and / or propylene glycol alginate, have a lower viscosity and inhibit the separation and precipitation of acidic liquid compositions at lower viscosity compared to soy polysaccharides and / or HM pectin. In order to enhance the muscle synthesis promoting effect while preventing the curding of milk protein in the stomach and promoting the absorption of milk protein when taken as a muscle synthesis promoter, the dispersibility is also good. It is preferably used in combination with polysaccharides and / or HM pectin, or instead of soybean polysaccharides and / or HM pectin.
本発明で用いられる酸性液状組成物には、カルボキシメチルセルロースナトリウムを添加することができる。カルボキシメチルセルロースナトリウムは、セルロースのグルコースの水酸基にカルボキシメチル基を置換させたものであり、通常、エーテル化度0.6~1.5程度のものである。かかるカルボキシメチルセルロースナトリウムは、商業的に入手可能であり、例えば、セロゲンF-SL(第一工業製薬社製)、セロゲンF-810A(第一工業製薬社製)、セロゲンF-SB(第一工業製薬社製)、セロゲンF-820B(第一工業製薬社製)、セロゲンF-1220B(第一工業製薬社製)などがある。 In the acidic liquid composition used in the present invention, sodium carboxymethyl cellulose can be added. Sodium carboxymethyl cellulose is obtained by substituting a carboxymethyl group for the hydroxyl group of glucose of cellulose, and usually has a degree of etherification of about 0.6 to 1.5. Such sodium carboxymethylcellulose is commercially available, for example, Serogen F-SL (Daiichi Kogyo Seiyaku), Serogen F-810A (Daiichi Kogyo Seiyaku), Serogen F-SB (Daiichi Kogyo). Pharmaceutical Co., Ltd.), Serogen F-820B (Daiichi Kogyo Seiyaku Co., Ltd.), Serogen F-1220B (Daiichi Kogyo Seiyaku Co., Ltd.), and the like.
本発明で用いられる酸性液状組成物には、アルギン酸プロピレングリコールエステルを添加することができる。アルギン酸プロピレングリコールエステルは、コンブ、ワカメなどの藻藻類から精製された多糖類アルギン酸を化学修飾して得られる物質である。かかるアルギン酸プロピレングリコールエステルは、商業的に入手可能であり、例えば、タックロイドLF-M(キッコーマンバイオケミファ社製)、タックロイドEF(キッコーマンバイオケミファ社製)、タックロイドPF(キッコーマンバイオケミファ社製)、タックロイドPF-H(キッコーマンバイオケミファ社製)などがある。 Alginic acid propylene glycol ester can be added to the acidic liquid composition used in the present invention. Alginate propylene glycol ester is a substance obtained by chemically modifying polysaccharide alginic acid purified from algal algae such as kombu and wakame. Such propylene glycol alginate is commercially available. For example, Tac Lloyd LF-M (manufactured by Kikkoman Biochemifa), Tacroid EF (manufactured by Kikkoman Biochemifa), Tacroid PF (manufactured by Kikkoman Biochemifa) ), Tuck Lloyd PF-H (manufactured by Kikkoman Biochemifa).
本発明のカルボキシメチルセルロースナトリウムまたはアルギン酸プロピレングリコールエステルの添加量は、本発明で用いられる酸性液状組成物の特徴である、高濃度のカゼインタンパク質を含む乳タンパク質混合物を含有する酸性液状組成物であっても、酸性液状組成物の分離および沈殿を抑制し、再分散性も良好で、低粘度で摂取しやすい形態であり、かつ、筋肉合成促進剤として摂取した場合、胃内での乳タンパク質のカード化を防ぎ、乳タンパク質の吸収を促進させた上で筋肉合成促進効果を高められれば、その添加量には制限はない。本発明で用いられる酸性液状組成物に添加する、カルボキシメチルセルロースナトリウムまたはアルギン酸プロピレングリコールエステルの添加量は、例えば、0.01~2重量%、0.01~1.5重量%、0.01~1.2重量%、0.01~1.0重量%である。本発明のカルボキシメチルセルロースナトリウムまたはアルギン酸プロピレングリコールエステルの添加量が2重量%であれば、高濃度のカゼインタンパク質を含む乳タンパク質混合物を含有する酸性液状組成物であっても、低粘度で摂取しやすい形態となる上で好ましい。また、本発明のカルボキシメチルセルロースナトリウムまたはアルギン酸プロピレングリコールエステルの添加量が0.01重量%を上回ることは、高濃度のカゼインタンパク質を含む乳タンパク質混合物を含有する酸性液状組成物であっても、本発明で用いられる酸性液状組成物の分離および沈殿の発生を抑制でき、さらには、再分散性も良好となり、最終的には、筋肉合成促進剤として摂取した場合、胃内での乳タンパク質のカード化を防ぎ、乳タンパク質の吸収を促進し、本発明の筋肉合成促進効果が高まる点で、好ましい。 The addition amount of sodium carboxymethylcellulose or propylene glycol alginate of the present invention is an acidic liquid composition containing a milk protein mixture containing a high concentration of casein protein, which is a feature of the acidic liquid composition used in the present invention. In addition, it suppresses separation and precipitation of acidic liquid composition, has good redispersibility, is in a form that is low in viscosity and easy to ingest, and when ingested as a muscle synthesis promoter, it is a milk protein card in the stomach. As long as the effect of promoting muscle synthesis can be enhanced while preventing absorption and promoting absorption of milk protein, the amount added is not limited. The amount of sodium carboxymethylcellulose or propylene glycol alginate added to the acidic liquid composition used in the present invention is, for example, 0.01 to 2% by weight, 0.01 to 1.5% by weight, 0.01 to 1.2% by weight, 0.01 to 1.0% by weight. If the addition amount of sodium carboxymethylcellulose or propylene glycol alginate of the present invention is 2% by weight, even an acidic liquid composition containing a milk protein mixture containing a high concentration of casein protein can be easily ingested with low viscosity. It is preferable in terms of form. Moreover, even if it is an acidic liquid composition containing the milk protein mixture containing a high concentration casein protein that the addition amount of the sodium carboxymethylcellulose or propylene glycol alginate of the present invention exceeds 0.01% by weight, Separation of acidic liquid composition used in the invention and generation of precipitation can be suppressed, and redispersibility is also improved. Finally, when taken as a muscle synthesis promoter, a card of milk protein in the stomach This is preferable in that it prevents the formation of protein, promotes the absorption of milk protein, and enhances the muscle synthesis promoting effect of the present invention.
本発明の繊維状の不溶性セルロースとは、本発明で用いられる酸性液状組成物に含有させることで、その酸性液状組成物中に三次元網目構造を構築することで、沈殿などの不溶性成分の分散性を向上できる安定剤である。本発明の繊維状の不溶性セルロースは、本発明で用いられる酸性液状組成物の特徴である、高濃度のカゼインタンパク質を含む乳タンパク質混合物を含有する酸性液状組成物であっても、酸性液状組成物の分離および沈殿を抑制し、再分散性も良好で、低粘度で摂取しやすい形態であり、筋肉合成促進剤として摂取した場合、胃内で乳タンパク質のカード化を防ぎ、乳タンパク質の吸収を促進させた上で筋肉合成促進効果を高められれば、その由来などには制限がなく、植物由来および/または微生物由来のものを使用することができる。微生物由来の繊維状の不溶性セルロースは、例えば、微生物により産生された発酵セルロースを培地から分離処理され、洗浄されて、適宜精製され繊維状としたものである。この繊維状の不溶性セルロースは、例えば、平均直径0.01~0.1μmまでミクロフィブリル化されている繊維状不溶性セルロース(特開2005-245217号公報参照)、または発酵セルロースである。本発明の繊維状の不溶性セルロースは商業的に入手可能であり、例えば、サンアーティストPG(三栄源エフ・エフ・アイ社製)、サンアーティストPN(三栄源エフ・エフ・アイ社製)である。 The fibrous insoluble cellulose of the present invention is contained in the acidic liquid composition used in the present invention, and by constructing a three-dimensional network structure in the acidic liquid composition, dispersion of insoluble components such as precipitates is achieved. It is a stabilizer that can improve the properties. The fibrous insoluble cellulose of the present invention may be an acidic liquid composition containing a milk protein mixture containing a high concentration of casein protein, which is a characteristic of the acidic liquid composition used in the present invention. Inhibits separation and precipitation, has good redispersibility, has a low viscosity and is easily ingested, and when ingested as a muscle synthesis promoter, prevents milk protein curding in the stomach and absorbs milk protein. If the effect of promoting muscle synthesis can be enhanced after being promoted, the origin thereof is not limited, and those derived from plants and / or microorganisms can be used. The fibrous insoluble cellulose derived from a microorganism is, for example, one obtained by separating a fermented cellulose produced by a microorganism from a culture medium, washing it, and appropriately purifying it into a fibrous form. The fibrous insoluble cellulose is, for example, fibrous insoluble cellulose (see JP 2005-245217 A) that has been microfibrillated to an average diameter of 0.01 to 0.1 μm, or fermented cellulose. The fibrous insoluble cellulose of the present invention is commercially available, for example, Sun Artist PG (manufactured by Saneigen FFI), Sun Artist PN (manufactured by Saneigen FFI). .
本発明の繊維状の不溶性セルロースの添加量は、本発明で用いられる酸性液状組成物に0.2~1.2重量%の大豆多糖類、0.1~0.5重量%のHMペクチンを含有させる場合には、例えば、0.01~0.1重量%、0.015~0.09重量%、0.02~0.08重量%、0.025~0.085重量%、0.03~0.07重量%、0.03~0.065重量%、0.03~0.06重量%、0.03~0.055重量%、0.03~0.05重量%である。本発明の繊維状の不溶性セルロースの添加量が0.1重量%であれば、高濃度のカゼインタンパク質を含む乳タンパク質混合物を含有する酸性液状組成物であっても、低粘度で摂取しやすい形態となる上で好ましい。また、本発明の繊維状の不溶性セルロースの添加量が0.01重量%を上回ることは、特に、高濃度のカゼインタンパク質を含む乳タンパク質混合物を含有する酸性液状組成物であっても、酸性液状組成物の分離および沈殿の発生を抑制でき、さらには、再分散性も良好となり、最終的には、筋肉合成促進剤として摂取した場合、胃内での乳タンパク質のカード化を防ぎ、乳タンパク質の吸収を促進し、本発明の筋肉合成促進効果が高まる点で、好ましい。 The addition amount of the fibrous insoluble cellulose of the present invention is such that 0.2 to 1.2% by weight of soybean polysaccharide and 0.1 to 0.5% by weight of HM pectin are added to the acidic liquid composition used in the present invention. In the case of inclusion, for example, 0.01 to 0.1% by weight, 0.015 to 0.09% by weight, 0.02 to 0.08% by weight, 0.025 to 0.085% by weight, 0.0. They are 03-0.07 wt%, 0.03-0.065 wt%, 0.03-0.06 wt%, 0.03-0.055 wt%, 0.03-0.05 wt%. If the addition amount of the fibrous insoluble cellulose of the present invention is 0.1% by weight, even an acidic liquid composition containing a milk protein mixture containing a high concentration of casein protein has a low viscosity and is easily ingested. Is preferable. Further, the addition amount of the fibrous insoluble cellulose of the present invention exceeds 0.01% by weight, even in the case of an acidic liquid composition containing a milk protein mixture containing a high concentration of casein protein. Separation of the composition and occurrence of precipitation can be suppressed, and redispersibility is also improved. Finally, when taken as a muscle synthesis promoter, curding of milk protein in the stomach is prevented, and milk protein It is preferable in that the absorption of glycine is promoted and the muscle synthesis promoting effect of the present invention is enhanced.
本発明で用いられる酸性液状組成物には、さらにトレハロースを添加することができ、トレハロースを添加することで、高濃度のカゼインタンパク質を含む乳タンパク質混合物を含有する酸性液状組成物であっても、酸性液状組成物の分離および沈殿を抑制し、再分散性も良好で、低粘度で摂取しやすい形態の特徴をさらに付与することができ、最終的には、本発明の筋肉合成促進剤として摂取した場合、胃内での乳タンパク質のカード化を防ぎ、乳タンパク質の吸収を促進し、筋肉合成促進効果をより高めることができる。具体的には、本発明で用いられる酸性液状組成物に、さらにトレハロースを添加することで、本発明の酸性液状組成物のpHが4を上回り、カゼインの等電点のpHに近いところであっても、高濃度のカゼインタンパク質を含む乳タンパク質混合物を含有する酸性液状組成物であっても、酸性液状組成物の分離および沈殿を抑制し、再分散性も良好で、低粘度で飲みやすい形態であり、かつ、筋肉合成促進剤として摂取した場合、胃内での乳タンパク質のカード化を防ぎ、乳タンパク質の吸収を促進させた上で筋肉合成促進効果を高めることができる。本発明のトレハロースは商業的にも入手可能であり、例えば、トレハ(林原社製)がある。 Trehalose can be further added to the acidic liquid composition used in the present invention, and by adding trehalose, even an acidic liquid composition containing a milk protein mixture containing a high concentration of casein protein, Suppresses separation and precipitation of the acidic liquid composition, has good redispersibility, and can be further imparted with a low-viscosity and easy-to-ingest form. Finally, it is ingested as a muscle synthesis promoter of the present invention. In this case, curding of milk protein in the stomach can be prevented, absorption of milk protein can be promoted, and the effect of promoting muscle synthesis can be further enhanced. Specifically, by adding trehalose to the acidic liquid composition used in the present invention, the pH of the acidic liquid composition of the present invention exceeds 4, and is close to the isoelectric point of casein. Even in an acidic liquid composition containing a milk protein mixture containing a high concentration of casein protein, the separation and precipitation of the acidic liquid composition is suppressed, the redispersibility is good, and the form is easy to drink with low viscosity. In addition, when ingested as a muscle synthesis promoter, it can prevent the curding of milk protein in the stomach and promote the absorption of milk protein and enhance the effect of promoting muscle synthesis. The trehalose of the present invention is also commercially available, for example, Treha (produced by Hayashibara).
本発明のトレハロースの添加量は、本発明で用いられる酸性液状組成物に、0.2~1.2重量%の大豆多糖類、0.1~0.5重量%のHMペクチン、0.01~0.1重量%の繊維状の不溶性セルロースを含有させる場合には、例えば、0.1~5重量%、0.2~4.5重量%、0.3~4重量%、0.4~3.5重量%、0.5~3重量%、0.6~2.5重量%、0.7~2重量%、0.8~1.5重量%、0.9~1.3重量%、0.9~1.1重量%である。本発明のトレハロースの添加量が5重量%であれば、本発明の酸性液状組成物にトレハロースに由来する風味および食感が付与されず、低粘度で摂取しやすい形態となる上で好ましい。また、本発明のトレハロースの添加量が0.01重量%を上回ることは、高濃度のカゼインタンパク質を含む乳タンパク質混合物を含有する酸性液状組成物であっても、本発明で用いられる酸性液状組成物の分離および沈殿の発生を抑制でき、さらには、再分散性も良好となり、最終的には、本発明の筋肉合成促進剤として、胃内で乳タンパク質がカード化せず、乳タンパク質の吸収を促進し、本発明の筋肉合成促進効果が高まる点で好ましい。 The trehalose of the present invention is added in an amount of 0.2 to 1.2% by weight of soybean polysaccharide, 0.1 to 0.5% by weight of HM pectin, 0.01% to the acidic liquid composition used in the present invention. In the case of containing 0.1 to 0.1% by weight of fibrous insoluble cellulose, for example, 0.1 to 5% by weight, 0.2 to 4.5% by weight, 0.3 to 4% by weight, 0.4 ~ 3.5 wt%, 0.5 to 3 wt%, 0.6 to 2.5 wt%, 0.7 to 2 wt%, 0.8 to 1.5 wt%, 0.9 to 1.3 % By weight, 0.9 to 1.1% by weight. If the addition amount of the trehalose of the present invention is 5% by weight, the acidic liquid composition of the present invention is not imparted with the flavor and texture derived from trehalose, and it is preferable for achieving a low viscosity and easy to take form. Moreover, even if it is an acidic liquid composition containing the milk protein mixture containing a high concentration casein protein that the addition amount of the trehalose of this invention exceeds 0.01 weight%, the acidic liquid composition used by this invention Separation of substances and occurrence of precipitation can be suppressed, and redispersibility is also improved. Finally, as a muscle synthesis promoter of the present invention, milk protein is not carded in the stomach, and absorption of milk protein is achieved. Is preferable in that the effect of promoting muscle synthesis of the present invention is enhanced.
本発明で用いられる酸性液状組成物の製造方法は、0.2~1.2重量%の大豆多糖類、0.1~0.5重量%のHMペクチン0.01~0.1重量%の繊維状の不溶性セルロース、およびカゼインタンパク質とホエイタンパク質とを含む乳タンパク質混合物を含む、乳含有溶液を、pHを酸性に調整する工程、および均質化する工程、を含有することを特徴とする。 The method for producing the acidic liquid composition used in the present invention comprises 0.2 to 1.2% by weight of soybean polysaccharide, 0.1 to 0.5% by weight of HM pectin 0.01 to 0.1% by weight. A milk-containing solution containing fibrous insoluble cellulose and a milk protein mixture containing casein protein and whey protein is characterized in that it comprises a step of adjusting pH to acidity and a step of homogenizing.
本発明で用いられる酸性液状組成物の製造方法における、pHを酸性に調整することは、本発明の特徴である、高濃度のカゼインタンパク質を含む乳タンパク質混合物を含有する酸性液状組成物であっても、酸性液状組成物の分離および沈殿を抑制し、再分散性も良好で、低粘度で飲みやすい形態であり、かつ、本発明の筋肉合成促進剤として摂取した場合、胃内での乳タンパク質のカード化を防ぎ、乳タンパク質の吸収を促進させた上で筋肉合成促進効果を高めることができる酸性液状組成物が得られる範囲で、乳含有溶液を所定のpHにまで低下させることができれば、その手段や方法には特に制限はない。この乳含有溶液のpHを酸性に調整する方法は、例えば、乳含有溶液に乳酸菌などの発酵微生物により発酵させる方法、および乳含有溶液に酸を添加する方法がある。 In the method for producing an acidic liquid composition used in the present invention, adjusting the pH to acid is an acidic liquid composition containing a milk protein mixture containing a high concentration of casein protein, which is a feature of the present invention. In addition, it suppresses separation and precipitation of the acidic liquid composition, has good redispersibility, has a low viscosity and is easy to drink, and when ingested as a muscle synthesis promoter of the present invention, milk protein in the stomach In the range where an acidic liquid composition capable of enhancing the muscle synthesis promoting effect can be obtained after promoting the absorption of milk protein and preventing absorption of milk protein, the milk-containing solution can be lowered to a predetermined pH, There are no particular restrictions on the means and methods. Methods for adjusting the pH of this milk-containing solution to acid include, for example, a method of fermenting a milk-containing solution with a fermenting microorganism such as lactic acid bacteria, and a method of adding an acid to a milk-containing solution.
本発明に用いられる酸性液状組成物の製造方法における、乳含有溶液には、本発明の酸性液状組成物の一つの特徴である、高濃度のカゼインタンパク質を含む乳タンパク質混合物を含有する酸性液状組成物であっても、酸性液状組成物の分離および沈殿を抑制し、再分散性も良好で、低粘度で飲みやすい形態であり、かつ、筋肉合成促進剤として摂取した場合、胃内での乳タンパク質のカード化を防ぎ、乳タンパク質の吸収を促進させた上で筋肉合成促進効果を高める特徴を出すために、0.2~1.2重量%の大豆多糖類、0.1~0.5重量%のHMペクチン、0.01~0.1重量%の繊維状の不溶性セルロースを含有することが好ましい。本発明の酸性液状組成物の製造方法における、乳含有溶液に含有する、大豆多糖類、HMペクチン、および繊維状の不溶性セルロースは、その他の原料の一部または全部と共に添加しながら、50~100℃に加温した状態で溶解させてもよいし、予め温水などで溶解したものを用意してもよい。本発明の酸性液状組成物の製造方法における、乳含有溶液は、例えば、乳タンパク質混合物を水で溶解した乳液と、大豆多糖類、HMペクチン、および繊維状の不溶性セルロースを水で溶解した安定剤液とを、混合することで得られる。 In the method for producing an acidic liquid composition used in the present invention, the milk-containing solution contains an acidic liquid composition containing a milk protein mixture containing a high concentration of casein protein, which is one of the characteristics of the acidic liquid composition of the present invention. Even if it is a product, it suppresses separation and precipitation of the acidic liquid composition, has good redispersibility, has a low viscosity and is easy to drink, and when taken as a muscle synthesis promoter, milk in the stomach 0.2 to 1.2% by weight of soy polysaccharides, 0.1 to 0.5%, in order to prevent the formation of protein curd and promote the absorption of milk protein and enhance the effect of promoting muscle synthesis It is preferable to contain 1% by weight of HM pectin and 0.01 to 0.1% by weight of fibrous insoluble cellulose. In the method for producing an acidic liquid composition of the present invention, the soybean polysaccharide, HM pectin, and fibrous insoluble cellulose contained in the milk-containing solution are added together with some or all of other raw materials, and 50 to 100 are added. You may make it melt | dissolve in the state heated at degreeC, and you may prepare what was melt | dissolved previously with warm water etc. In the method for producing the acidic liquid composition of the present invention, the milk-containing solution is, for example, a stabilizer obtained by dissolving a milk protein mixture in water, soybean polysaccharide, HM pectin, and fibrous insoluble cellulose in water. It is obtained by mixing the liquid.
本発明で用いられる酸性液状組成物の製造方法において、乳含有溶液に酸を添加してpHを調整する他に、本発明の筋肉合成促進効果を高めるために、乳含有溶液を機械的なせん断処理による均質化をすることができる。均質化により、pHを調整した乳含有溶液のカゼインタンパク質を微粒化して、予め含有されている、0.2~1.2重量%の大豆多糖類、0.1~0.5重量%のHMペクチン、および0.01~0.1重量%の繊維状の不溶性セルロースと結合し、本発明の酸性液状組成物の一つの特徴である、高濃度のカゼインタンパク質を含む乳タンパク質混合物を含有する酸性液状組成物であっても、酸性液状組成物の分離および沈殿を抑制し、再分散性も良好で、低粘度で飲みやすい形態であり、かつ、筋肉合成促進剤として摂取した場合、胃内での乳タンパク質のカード化を防ぎ、乳タンパク質の吸収を促進させた上で筋肉合成促進効果を高められる酸性液状組成物が得られる。均質化は、牛乳などの脂肪球の均質化、および発酵乳の液状化に使用している汎用の均質機を使用することができる。 In the method for producing an acidic liquid composition used in the present invention, in addition to adjusting the pH by adding an acid to the milk-containing solution, the milk-containing solution is mechanically sheared in order to enhance the muscle synthesis promoting effect of the present invention. Homogenization can be achieved by processing. By homogenization, the casein protein of the milk-containing solution whose pH has been adjusted is atomized to previously contain 0.2 to 1.2% by weight of soybean polysaccharide, 0.1 to 0.5% by weight of HM Acid containing pectin and a milk protein mixture containing a high concentration of casein protein, combined with 0.01 to 0.1% by weight of fibrous insoluble cellulose and one of the characteristics of the acidic liquid composition of the present invention Even a liquid composition suppresses separation and precipitation of an acidic liquid composition, has good redispersibility, has a low viscosity and is easy to drink, and when taken as a muscle synthesis promoter, Thus, an acidic liquid composition capable of preventing the curding of milk protein and promoting the absorption of milk protein and enhancing the effect of promoting muscle synthesis can be obtained. For the homogenization, a general-purpose homogenizer used for homogenizing fat globules such as milk and liquefying fermented milk can be used.
本発明で用いられる酸性液状組成物の製造方法において、乳含有溶液に酸を添加してpHを調整する他に、本発明の効果を高めるために、乳含有溶液を均質機を使用して均質化する場合には、その均質化圧は、例えば、1~100MPa、2~80MPa、3~60MPa、4~40MPa、5~20MPa、6~19MPa、7~18MPa、8~17MPa、9~16MPa、10~15MPaである。また、均質化をする温度は、例えば、50~100℃、55~95℃、60~90℃、65~85℃、70~80℃である。また、本発明で用いられる酸性液状組成物の製造方法において、乳含有溶液に酸を添加してpHを調整する工程、および乳含有溶液を均質機を使用して均質化する工程、はその順番に制限はない。すなわち、本発明で用いられる酸性液状組成物の製造方法において、乳含有溶液に酸を添加してpHを調整した後に、その乳含有溶液を均質機を使用して均質化することも可能であり、乳含有溶液を均質機を使用して均質化した後に、その乳含有溶液に酸を添加してpHを調整することも可能である。なお、本発明で用いられる酸性液状組成物の製造方法における、均質化処理の工程は、酸性液状組成物の一つの特徴である、高濃度のカゼインタンパク質を含む乳タンパク質混合物を含有する酸性液状組成物であっても、酸性液状組成物の分離および沈殿を抑制し、再分散性も良好で、低粘度で摂取しやすい形態であり、かつ、筋肉合成促進剤として摂取した場合、胃内での乳タンパク質のカード化を防ぎ、乳タンパク質の吸収を促進させた上で筋肉合成促進効果を高める特徴の酸性液状組成物が得られる範囲において、後述する加熱殺菌の前にも後にも設定することができる。 In the method for producing an acidic liquid composition used in the present invention, in addition to adjusting the pH by adding an acid to a milk-containing solution, the milk-containing solution is homogenized using a homogenizer in order to enhance the effect of the present invention. The homogenization pressure is, for example, 1 to 100 MPa, 2 to 80 MPa, 3 to 60 MPa, 4 to 40 MPa, 5 to 20 MPa, 6 to 19 MPa, 7 to 18 MPa, 8 to 17 MPa, 9 to 16 MPa, 10 to 15 MPa. The homogenizing temperature is, for example, 50 to 100 ° C., 55 to 95 ° C., 60 to 90 ° C., 65 to 85 ° C., or 70 to 80 ° C. In the method for producing an acidic liquid composition used in the present invention, the step of adjusting the pH by adding an acid to the milk-containing solution and the step of homogenizing the milk-containing solution using a homogenizer are in that order. There is no limit. That is, in the method for producing an acidic liquid composition used in the present invention, it is also possible to homogenize the milk-containing solution using a homogenizer after adjusting the pH by adding an acid to the milk-containing solution. It is also possible to adjust the pH by homogenizing the milk-containing solution using a homogenizer and then adding an acid to the milk-containing solution. In the method for producing an acidic liquid composition used in the present invention, the step of homogenizing treatment is an acidic liquid composition containing a milk protein mixture containing a high concentration of casein protein, which is one of the characteristics of the acidic liquid composition. Even if it is a product, it suppresses separation and precipitation of the acidic liquid composition, has good redispersibility, has a low viscosity and is easy to ingest, and when ingested as a muscle synthesis promoter, It can be set before or after heat sterilization, which will be described later, within a range where an acidic liquid composition is obtained that prevents the formation of milk protein and promotes the absorption of milk protein and enhances the effect of promoting muscle synthesis. it can.
本発明で用いられる酸性液状組成物の製造方法において、酸性液状組成物の保存性を高めるために、加熱殺菌をすることができる。本発明で用いられる酸性液状組成物の製造方法における、酸性液状組成物の加熱殺菌の方法は、公知の牛乳および/または飲料の殺菌方法および殺菌条件を設定することができる。殺菌方法は、例えば、プレート式加熱殺菌、チューブ式加熱殺菌、バッチ式加熱殺菌、通電加熱殺菌、マイクロウエーブ波による加熱殺菌、レトルト加熱などの間接加熱殺菌、スチームインジェクション、スチームインフュージョンなどの直接加熱殺菌である。殺菌条件は、牛乳と同じく、例えば、60~65℃で20~30分間保持、80~100℃で15秒~10分間保持、110℃~150℃で2~15秒間保持であり、これと同等の殺菌条件であれば、適宜変更することができる。 In the method for producing an acidic liquid composition used in the present invention, heat sterilization can be performed in order to enhance the storage stability of the acidic liquid composition. In the method for producing an acidic liquid composition used in the present invention, the method for heat sterilization of the acidic liquid composition may be a known method for sterilizing milk and / or beverage and sterilization conditions. Sterilization methods include, for example, plate-type heat sterilization, tube-type heat sterilization, batch-type heat sterilization, energizing heat sterilization, microwave heat sterilization, indirect heat sterilization such as retort heating, direct injection such as steam injection, steam infusion, etc. Sterilization. The sterilization conditions are the same as for milk, for example, hold at 60 to 65 ° C for 20 to 30 minutes, hold at 80 to 100 ° C for 15 seconds to 10 minutes, hold at 110 ° C to 150 ° C for 2 to 15 seconds, and equivalent If it is sterilization conditions, it can change suitably.
本発明で用いられる酸性液状組成物の製造方法において、酸性液状組成物の保存性を高めるために、非加熱殺菌をすることができる。本発明の酸性液状組成物の製造方法における、本発明の酸性液状組成物の非加熱殺菌の方法は、公知の殺菌方法および殺菌条件を設定することができる。非加熱殺菌の殺菌方法は、例えば、光照射殺菌、放射線照射殺菌、高電圧パルス殺菌などである。非加熱殺菌の殺菌条件は、牛乳の加熱殺菌と同じ殺菌効果、例えば、60~65℃で20~30分間保持、80~100℃で15秒~10分間保持、110℃~150℃で2~15秒間保持であり、これと同等の殺菌効果があれば、非加熱殺菌の殺菌条件を適宜変更することができる。 In the method for producing an acidic liquid composition used in the present invention, non-heat sterilization can be performed in order to improve the storage stability of the acidic liquid composition. In the method for producing an acidic liquid composition of the present invention, the non-heat sterilization method of the acidic liquid composition of the present invention can be set with known sterilization methods and sterilization conditions. Non-heat sterilization methods include, for example, light irradiation sterilization, radiation irradiation sterilization, and high voltage pulse sterilization. The sterilization conditions for non-heat sterilization are the same as the heat sterilization of milk, for example, holding at 60 to 65 ° C. for 20 to 30 minutes, holding at 80 to 100 ° C. for 15 seconds to 10 minutes, and 110 to 150 ° C. for 2 to 2 minutes. If the sterilization effect is equivalent to this for 15 seconds, the sterilization conditions for non-heat sterilization can be appropriately changed.
本発明で用いられる酸性液状組成物の製造方法において、酸性液状組成物の保存性を高めるために、0.2~1.2重量%の大豆多糖類、0.1~0.5重量%のHMペクチン0.01~0.1重量%の繊維状の不溶性セルロースを含有する乳含有溶液を、pHを酸性に調整する工程と、均質化する工程を含む工程で得られた酸性液状組成物を冷却することができる。最終的に冷却された酸性液状組成物の温度は、例えば、0~30℃、0~25℃、0~20℃、0~15℃、0~12℃、0~10℃である。 In the method for producing an acidic liquid composition used in the present invention, in order to improve the storage stability of the acidic liquid composition, 0.2 to 1.2% by weight soybean polysaccharide, 0.1 to 0.5% by weight An acidic liquid composition obtained by a step including a step of adjusting pH to an acidity and a step of homogenizing a milk-containing solution containing 0.01 to 0.1% by weight of fibrous HM pectin and insoluble cellulose. Can be cooled. The temperature of the finally cooled acidic liquid composition is, for example, 0 to 30 ° C., 0 to 25 ° C., 0 to 20 ° C., 0 to 15 ° C., 0 to 12 ° C., 0 to 10 ° C.
本発明で用いられる酸性液状組成物は、本発明の酸性液状組成物の一つの特徴である、高濃度のカゼインタンパク質を含む乳タンパク質混合物を含有する酸性液状組成物であっても、酸性液状組成物の分離および沈殿を抑制し、再分散性も良好で、低粘度で飲みやすい形態であり、かつ、筋肉合成促進剤として摂取した場合、胃内での乳タンパク質のカード化を防ぎ、乳タンパク質の吸収を促進させた上で筋肉合成促進効果を高められれば、その他の食品原料および/または食品添加物原料を添加することができる。例えば、本発明の酸性液状組成物の嗜好性の付与を目的に、甘味料(砂糖類、液糖類、果糖、麦芽糖、三温糖など)、糖アルコール(エリスリトールなど)、高感度甘味料(ステビア、アスパルテーム、スクラロース、アセスルファムカリウム)、香料、果汁、野菜汁などを添加することができる。また、本発明の酸性液状組成物の機能性の付与を目的に、ミネラル類(カルシウム、鉄、マンガン、マグネシウム、亜鉛など)、ビタミン類、機能性素材、プロバイオティクス乳酸菌などを添加して、本発明の筋肉合成促進剤とすることができる。 The acidic liquid composition used in the present invention is an acidic liquid composition containing a milk protein mixture containing a high concentration of casein protein, which is one of the characteristics of the acidic liquid composition of the present invention. Suppresses separation and precipitation of substances, has good redispersibility, has a low viscosity and is easy to drink, and prevents ingestion of milk protein in the stomach when ingested as a muscle synthesis promoter. Other food materials and / or food additive materials can be added if the effect of promoting muscle synthesis can be enhanced after promoting the absorption of the food. For example, for the purpose of imparting the palatability of the acidic liquid composition of the present invention, sweeteners (sugars, liquid sugars, fructose, maltose, trivalent sugar, etc.), sugar alcohols (erythritol, etc.), high-sensitivity sweeteners (stevia) , Aspartame, sucralose, acesulfame potassium), fragrance, fruit juice, vegetable juice, and the like. In addition, for the purpose of imparting the functionality of the acidic liquid composition of the present invention, minerals (calcium, iron, manganese, magnesium, zinc, etc.), vitamins, functional materials, probiotic lactic acid bacteria, etc. are added, The muscle synthesis promoter of the present invention can be used.
本発明の筋肉合成促進剤は、市場での提供を目的として、容器詰飲料、容器入り飲料の形態にすることができる。容器は、紙容器(ゲーブルトップ型容器、ブリック型容器など)、ソフトバック、ペットボトル、缶、ビンなど、公知のものを使用することができる。容器の容量は、特に制限はなく、例えば、10~5000g、20~4000g、30~3000g、40~2000g、50~1500g、60~1400g、70~1300g、80~1200g、90~1100gである。中でも、ファミリーサイズ(複数飲用)の場合には、例えば、300~5000g、300~4000g、300~3000g、300~2000g、300~1500g、300~1400g、300~1300g、300~1200g、300~1100gであり、パーソナルサイズ(個別飲用)の場合、10~500g、20~500g、30~500g、40~500g、50~500g、60~500g、70~500g、80~500g、90~500gである。 The muscle synthesis promoter of the present invention can be in the form of a packaged beverage or a packaged beverage for the purpose of providing in the market. A well-known thing, such as a paper container (a gable top type container, a brick type container, etc.), a soft bag, a plastic bottle, a can, a bottle, can be used for a container. The capacity of the container is not particularly limited, and is, for example, 10 to 5000 g, 20 to 4000 g, 30 to 3000 g, 40 to 2000 g, 50 to 1500 g, 60 to 1400 g, 70 to 1300 g, 80 to 1200 g, 90 to 1100 g. In particular, in the case of a family size (multiple drinks), for example, 300 to 5000 g, 300 to 4000 g, 300 to 3000 g, 300 to 2000 g, 300 to 1500 g, 300 to 1400 g, 300 to 1300 g, 300 to 1200 g, 300 to 1100 g In the case of personal size (individual drinking), it is 10 to 500 g, 20 to 500 g, 30 to 500 g, 40 to 500 g, 50 to 500 g, 60 to 500 g, 70 to 500 g, 80 to 500 g, 90 to 500 g.
本発明の筋肉合成促進剤は、その特徴の一つである、高濃度のカゼインを含む乳タンパク質を含有する酸性液状組成物であっても、酸性液状組成物の分離および沈殿を抑制し、再分散性も良好で、低粘度で飲みやすい形態であり、かつ、筋肉合成促進剤として、胃内での乳タンパク質のカード化を防ぎ、乳タンパク質の吸収を促進させた上で筋肉合成促進効果を高められることができれば、市場への提供形態に制限はない。例えば、本発明の筋肉合成促進剤では、10℃以下のチルド流通、常温流通が可能である。また、本発明の筋肉合成促進剤は、耐熱効果もある。従って、本発明の筋肉合成促進剤を配合(添加、混合)した組成物では、本発明の筋肉合成促進剤が耐熱効果を奏することから、好ましくは、液状の製品形態として提供することができるととともに、ホットベンダーなどを用いた加温販売用の製品形態として提供することができる。 The muscle synthesis promoter of the present invention suppresses the separation and precipitation of the acidic liquid composition, even if it is an acidic liquid composition containing milk protein containing a high concentration of casein. Good dispersibility, low viscosity and easy-to-drink form, and as a muscle synthesis promoter, prevents milk protein curd formation in the stomach and promotes absorption of milk protein, and also promotes muscle synthesis. If it can be increased, there is no limit to the form of provision to the market. For example, with the muscle synthesis promoter of the present invention, chilled distribution at 10 ° C. or lower and normal temperature distribution are possible. The muscle synthesis promoter of the present invention also has a heat resistance effect. Therefore, in the composition in which the muscle synthesis promoter of the present invention is blended (added, mixed), the muscle synthesis promoter of the present invention has a heat-resistant effect, so that it can be preferably provided as a liquid product form. At the same time, it can be provided as a product form for warm sales using a hot vendor or the like.
本発明の一つの実施態様によれば、例えば、本発明の筋肉合成促進剤では、前記乳タンパク質混合物が総タンパク質量で一食あたり0.06g以上/kg体重となるように摂取(投与)され、具体的には、0.06~0.7g/kg体重であり、好ましくは0.06~0.6g/kg体重、より好ましくは0.06~0.5g/kg体重、さらに好ましくは0.08~0.4g/kg体重、特に好ましくは0.1~0.4g/kg体重となるように摂取(投与)される。ここで、対象の代表的な体重は、約60kgと見積もっている。 According to one embodiment of the present invention, for example, in the muscle synthesis promoter of the present invention, the milk protein mixture is ingested (administered) so that the total protein amount is 0.06 g / kg body weight per meal, Specifically, the weight is 0.06 to 0.7 g / kg body weight, preferably 0.06 to 0.6 g / kg body weight, more preferably 0.06 to 0.5 g / kg body weight, and still more preferably 0.0. It is ingested (administered) at a dose of 08 to 0.4 g / kg body weight, particularly preferably 0.1 to 0.4 g / kg body weight. Here, the typical weight of the subject is estimated to be about 60 kg.
「一食」とは、即効的な筋肉合成促進を必要とする状態の一回ごとを意味し、例えば、本発明の筋肉合成促進剤では、一食で一息に(一度に)摂取せず、数度に分けて摂取してもよい。本発明の筋肉合成促進剤を即効的な筋肉合成促進を必要とする対象に摂取させる(投与する)時期は、数度に分けて摂取する場合には、血流中のアミノ酸濃度を即効的に高められる点で、好ましくは、運動終了後から2時間以内であり、より好ましくは、運動終了後から1時間以内であり、さらに好ましくは、運動終了後から30分以内であり、特に好ましくは、運動終了後から5分以内である。 The term “one meal” means one time in a state that requires immediate effective muscle synthesis promotion. For example, in the muscle synthesis promoter of the present invention, a single meal is not taken at a time (at a time), It may be taken in several degrees. When the muscle synthesis promoting agent of the present invention is ingested (administered) to a subject in need of immediate muscle synthesis promotion, the amino acid concentration in the blood stream can be immediately In terms of improvement, it is preferably within 2 hours after the end of exercise, more preferably within 1 hour after the end of exercise, more preferably within 30 minutes after the end of exercise, and particularly preferably, Within 5 minutes after the end of exercise.
本発明の筋肉合成促進剤を即効的な筋肉合成促進を必要とする対象に摂取させる(投与する)方法は、経口摂取(経口投与)、経腸投与、胃ろうなどから、その対象および用途により、適宜選択することができるが、好ましくは経口摂取である。 The method of ingesting (administering) the muscle synthesis promoting agent of the present invention to a subject in need of immediate muscle synthesis promotion is based on oral administration (oral administration), enteral administration, gastric fistula, etc. Can be appropriately selected, but is preferably taken orally.
本発明の別の実施態様によれば、例えば、本発明の筋肉合成促進剤は、一食あたりの単位包装形態からなり、該単位中に、前記乳タンパク質混合物を、一食摂取量として総タンパク質量で3g以上に調整したものが望ましく、具体的には、3~40g、好ましくは3~20g、より好ましくは4~20g、さらに好ましくは4~15g、特に好ましくは5~15gとなるように調製してなる。ここで、「一食あたりの単位包装形態」からなるとは、一食あたりの摂取量があらかじめ定められた形態のものであり、例えば、特定量を経口摂取し得る食品として、一般食品のみならず、飲料(ドリンク剤など)、健康補助食品、保健機能食品、サプリメントなどの形態を意味する。「一食あたりの単位包装形態」では、例えば、液状の飲料、ゲル状・糊状・ペースト状のゼリー、粉末状・顆粒状・カプセル状・ブロック状の固体状の食品などの場合には、金属缶、ガラスビン(ボトルなど)、プラスチック容器(ペットボトルなど)、パック、パウチ、フィルム容器、紙箱などの包装容器で特定量(用量)を規定できる形態、あるいは、一食あたりの摂取量(用法、用量)を包装容器やホームページなどに表示することで特定量を規定できる形態が挙げられる。 According to another embodiment of the present invention, for example, the muscle synthesis promoter of the present invention comprises a unit package form per serving, and the milk protein mixture is contained in the unit as the total intake of the protein. And adjusted to 3 g or more, specifically 3 to 40 g, preferably 3 to 20 g, more preferably 4 to 20 g, still more preferably 4 to 15 g, and particularly preferably 5 to 15 g. Do it. Here, “consisting of a unit packaging form per meal” is a form in which the intake amount per meal is determined in advance, for example, as a food that can be taken orally in a specific amount, not only general foods but also beverages (Drinks, etc.), health supplements, health functional foods, supplements, etc. In "unit packaging form per meal", for example, in the case of liquid beverages, gel-like, paste-like, paste-like jelly, powder-like, granule-like, capsule-like, block-like solid foods, etc. A specific amount (dose) can be defined in packaging containers such as cans, glass bottles (such as bottles), plastic containers (such as plastic bottles), packs, pouches, film containers, paper boxes, etc., or intake per serving (usage, dose) ) Is displayed on a packaging container, a homepage, etc., and the form which can prescribe | regulate a specific quantity is mentioned.
本発明の好ましい態様によれば、本発明の筋肉合成促進剤は、0.4~0.9重量%の大豆多糖類、0.2~0.25重量%のHMペクチン、0.03~0.05重量%の繊維状の不溶性セルロース、およびカゼインタンパク質とホエイタンパク質とを含む乳タンパク質混合物を含む酸性液状組成物を有効成分として含んでなる筋肉合成促進剤であって、
ホエイタンパク質に対するカゼインタンパク質のタンパク質量比(カゼインタンパク質/ホエイタンパク質)が2~6である。
According to a preferred embodiment of the present invention, the muscle synthesis promoter of the present invention comprises 0.4 to 0.9% by weight of soybean polysaccharide, 0.2 to 0.25% by weight of HM pectin, 0.03 to 0%. A muscle synthesis promoter comprising, as active ingredients, an acidic liquid composition comprising 0.05% by weight of fibrous insoluble cellulose and a milk protein mixture containing casein protein and whey protein,
The protein amount ratio of casein protein to whey protein (casein protein / whey protein) is 2-6.
本発明のより好ましい態様によれば、本発明の筋肉合成促進剤は、0.4~0.9重量%の大豆多糖類、0.2~0.25重量%のHMペクチン、0.03~0.05重量%の繊維状の不溶性セルロース、およびカゼインタンパク質とホエイタンパク質とを含む乳タンパク質混合物を含む酸性液状組成物を有効成分として含んでなる筋肉合成促進剤であって、
ホエイタンパク質に対するカゼインタンパク質のタンパク質量比(カゼインタンパク質/ホエイタンパク質)が2~4である。
According to a more preferred embodiment of the present invention, the muscle synthesis promoter of the present invention comprises 0.4 to 0.9% by weight of soybean polysaccharide, 0.2 to 0.25% by weight of HM pectin, 0.03 to A muscle synthesis promoter comprising as an active ingredient an acidic liquid composition comprising 0.05% by weight of fibrous insoluble cellulose and a milk protein mixture containing casein protein and whey protein,
The protein amount ratio of casein protein to whey protein (casein protein / whey protein) is 2-4.
本発明のさらに好ましい態様によれば、本発明の筋肉合成促進剤は、0.4~0.9重量%の大豆多糖類、0.2~0.25重量%のHMペクチン、0.03~0.05重量%の繊維状の不溶性セルロース、トレハロース0.9~1.1重量%およびカゼインタンパク質とホエイタンパク質とを含む乳タンパク質混合物を含む酸性液状組成物を有効成分として含んでなる筋肉合成促進剤であって、
ホエイタンパク質に対するカゼインタンパク質のタンパク質量比(カゼインタンパク質/ホエイタンパク質)が2~4である。
According to a further preferred embodiment of the present invention, the muscle synthesis promoter of the present invention comprises 0.4 to 0.9% by weight of soybean polysaccharide, 0.2 to 0.25% by weight of HM pectin, 0.03 to Muscle synthesis promotion comprising 0.05% by weight fibrous insoluble cellulose, trehalose 0.9 to 1.1% by weight and an acidic liquid composition containing a milk protein mixture containing casein protein and whey protein as active ingredients An agent,
The protein amount ratio of casein protein to whey protein (casein protein / whey protein) is 2-4.
本発明の一つの実施態様によれば、例えば、本発明の筋肉合成促進剤では、筋肉合成促進剤を含んでなる組成物を提供することができる。すなわち、本発明の筋肉合成促進剤では、そのまま単独で使用することもできるが、筋肉合成促進機能が発揮される限りにおいて、食品や医薬品などの種々の経口摂取用(経口投与用)の組成物に対して、原料(素材)や添加剤などとして含ませることもでき、筋肉合成促進効果を有する組成物を得ることができる。よって、本発明の一つの実施態様によれば、本発明の筋肉合成促進剤を含んでなる組成物が提供される。 According to one embodiment of the present invention, for example, the muscle synthesis promoter of the present invention can provide a composition comprising a muscle synthesis promoter. That is, the muscle synthesis promoter of the present invention can be used alone as it is, but as long as the muscle synthesis promotion function is exhibited, various compositions for oral intake (for oral administration) such as foods and pharmaceuticals. On the other hand, it can also be included as a raw material (material), an additive, etc., and can obtain the composition which has a muscle synthesis promotion effect. Therefore, according to one embodiment of the present invention, a composition comprising the muscle synthesis promoter of the present invention is provided.
本発明の一つの実施態様によれば、0.2~1.2重量%の大豆多糖類、0.1~0.5重量%のHMペクチン、0.01~0.1重量%の繊維状の不溶性セルロース、カゼインタンパク質とホエイタンパク質とを含む乳タンパク質混合物を含む酸性液状組成物を有効成分とする組成物であって、ホエイタンパク質に対するカゼインタンパク質のタンパク質量比(カゼインタンパク質/ホエイタンパク質)が2~20である筋肉合成促進用組成物を提供することができる。本発明の組成物は、食品組成物または医薬組成物であってよい。 According to one embodiment of the invention, 0.2-1.2% by weight soybean polysaccharide, 0.1-0.5% by weight HM pectin, 0.01-0.1% by weight fibrous. A composition comprising an acidic liquid composition containing a milk protein mixture containing insoluble cellulose, casein protein and whey protein as an active ingredient, wherein the protein amount ratio of casein protein to whey protein (casein protein / whey protein) is 2 A composition for promoting muscle synthesis that is ˜20 can be provided. The composition of the present invention may be a food composition or a pharmaceutical composition.
食品組成物とは、医薬組成物以外のものであって、溶液、懸濁液、乳濁液、粉末、固体成形物など、経口摂取可能な形態であればよく特に限定されない。具体的には、例えば、即席麺、レトルト食品、缶詰、電子レンジ食品、即席スープ・みそ汁類、フリーズドライ食品などの即席食品類;清涼飲料、果汁飲料、野菜飲料、豆乳飲料、コーヒー飲料、茶飲料、粉末飲料、濃縮飲料、アルコール飲料などの飲料類;パン、パスタ、麺、ケーキミックス、パン粉などの小麦粉製品;飴、キャラメル、チューイングガム、チョコレート、クッキー、ビスケット、ケーキ、パイ、スナック、クラッカー、和菓子、デザート菓子などの菓子類;ソース、トマト加工調味料、風味調味料、調理ミックス、たれ類、ドレッシング類、つゆ類、カレー・シチューの素類などの調味料;加工油脂、バター、マーガリン、マヨネーズなどの油脂類;乳飲料、ヨーグルト類、乳酸菌飲料、アイスクリーム類、クリーム類などの乳製品;農産缶詰、ジャム・マーマレード類、シリアルなどの農産加工品;冷凍食品などが挙げられる。好ましくは、食品は、乳製品であり、より好ましくは乳飲料、乳酸菌飲料である。 The food composition is other than the pharmaceutical composition, and is not particularly limited as long as it is a form that can be taken orally, such as a solution, suspension, emulsion, powder, or solid molded product. Specifically, for example, instant noodles, retort food, canned food, microwave food, instant soup / miso soup, freeze-dried food, etc .; soft drink, fruit juice drink, vegetable drink, soy milk drink, coffee drink, tea Beverages such as beverages, powdered beverages, concentrated beverages, alcoholic beverages; flour products such as bread, pasta, noodles, cake mixes, bread crumbs; rice cakes, caramel, chewing gum, chocolate, cookies, biscuits, cakes, pies, snacks, crackers, Confectionery such as Japanese confectionery, dessert confectionery; sauces, tomato processing seasonings, flavor seasonings, cooking mixes, sauces, dressings, soups, curry and stew ingredients; processed fats, butter, margarine, Fats and oils such as mayonnaise; milk drinks, yogurts, lactic acid bacteria drinks, ice creams, creams How dairy products; agricultural canning, jam, marmalade such, processed agricultural products such as serial; such as frozen food, and the like. Preferably, the food is a dairy product, more preferably a milk beverage or a lactic acid bacteria beverage.
また食品には、健康食品、機能性食品、栄養補助食品、機能性表示食品、特定保健用食品、病者用食品、乳幼児用調整粉乳、妊産婦もしくは授乳婦用粉乳、または疾病リスク低減表示を付した食品のような分類のものも包含される。 Foods are also labeled with health foods, functional foods, dietary supplements, functional labeling foods, foods for specified health use, foods for the sick, infant formulas, powdered milk for pregnant or lactating women, or a disease risk reduction label. Such foods are also included.
本発明の別の実施態様によれば、0.2~1.2重量%の大豆多糖類、0.1~0.5重量%のHMペクチン、0.01~0.1重量%の繊維状の不溶性セルロース、カゼインタンパク質とホエイタンパク質とを含む乳タンパク質混合物を含む酸性液状組成物を有効成分とする、ホエイタンパク質に対するカゼインタンパク質のタンパク質量比(カゼインタンパク質/ホエイタンパク質)が2~20である、筋肉合成促進用食品が提供される。本発明の筋肉合成促進用食品は、筋肉合成促進効果、またはそれに起因する効果が表示された食品を包含する。本発明の好ましい実施態様によれば、0.2~1.2重量%の大豆多糖類、0.1~0.5重量%のHMペクチン、0.01~0.1重量%の繊維状の不溶性セルロース、カゼインタンパク質とホエイタンパク質とを含む乳タンパク質混合物を含む酸性液状組成物を有効成分とする筋肉合成促進用飲料(好ましくは乳製品、より好ましくは乳飲料または乳酸菌飲料)であって、ホエイタンパク質に対するカゼインタンパク質のタンパク質量比(カゼインタンパク質/ホエイタンパク質)が2~20である筋肉合成促進用乳製品が提供される。 According to another embodiment of the invention, 0.2-1.2% by weight soybean polysaccharide, 0.1-0.5% by weight HM pectin, 0.01-0.1% by weight fibrous. The protein amount ratio of casein protein to whey protein (casein protein / whey protein) is 2 to 20, comprising as an active ingredient an acidic liquid composition containing a milk protein mixture containing insoluble cellulose, casein protein and whey protein, A food for promoting muscle synthesis is provided. The food for promoting muscle synthesis of the present invention includes foods that display the effect of promoting muscle synthesis or the effects resulting therefrom. According to a preferred embodiment of the present invention, 0.2-1.2% by weight soybean polysaccharide, 0.1-0.5% by weight HM pectin, 0.01-0.1% by weight fibrous A muscle synthesis promoting beverage (preferably a dairy product, more preferably a dairy beverage or a lactic acid bacteria beverage) comprising an acidic liquid composition containing a milk protein mixture containing insoluble cellulose, casein protein and whey protein as an active ingredient, Provided is a dairy product for promoting muscle synthesis, wherein the ratio of casein protein to protein (casein protein / whey protein) is 2 to 20.
医薬組成物とは、製剤化のために許容されうる添加剤を併用して、常法に従い、経口製剤または非経口製剤として調製したものである。経口製剤の場合には、錠剤、散剤、細粒剤、顆粒剤、カプセル剤、丸剤、徐放剤などの固形製剤、溶液、懸濁液、乳濁液などの液状製剤の形態をとることができる。また、非経口製剤の場合には、注射剤や座剤の形態をとることができる。簡易性の点からは、経口製剤であることが好ましい。製剤化のために許容されうる添加剤としては、例えば、賦形剤、安定剤、防腐剤、湿潤剤、乳化剤、滑沢剤、甘味料、着色料、香料、緩衝剤、酸化防止剤、pH調整剤などが挙げられる。本発明の医薬組成物には、筋肉合成促進を必要とする疾患、具体的には、筋肉損傷疾患、例えば、サルコペニアの処置用組成物、より具体的には予防用組成物および治療用組成物が含まれる。 The pharmaceutical composition is prepared as an oral preparation or a parenteral preparation according to a conventional method using additives that are acceptable for formulation. For oral preparations, take the form of solid preparations such as tablets, powders, fine granules, granules, capsules, pills, sustained-release preparations, and liquid preparations such as solutions, suspensions, and emulsions. Can do. In the case of a parenteral preparation, it can take the form of an injection or a suppository. From the viewpoint of simplicity, an oral preparation is preferable. Additives that are acceptable for formulation include, for example, excipients, stabilizers, preservatives, wetting agents, emulsifiers, lubricants, sweeteners, colorants, fragrances, buffers, antioxidants, pH Examples thereof include regulators. The pharmaceutical composition of the present invention comprises a composition for the treatment of diseases requiring the promotion of muscle synthesis, specifically a muscular damage disease such as sarcopenia, more specifically a preventive composition and a therapeutic composition. Is included.
本発明のさらに別の実施態様によれば、0.2~1.2重量%の大豆多糖類、0.1~0.5重量%のHMペクチン、0.01~0.1重量%の繊維状の不溶性セルロース、カゼインタンパク質とホエイタンパク質とを含む乳タンパク質混合物を含む酸性液状組成物を、筋肉合成促進を必要とする対象に、同時または逐次摂取させることを含んでなる、筋肉合成促進方法であって、ホエイタンパク質に対するカゼインタンパク質のタンパク質量比(カゼインタンパク質/ホエイタンパク質)が2~20である筋肉合成促進方法が提供される。本発明の筋肉合成促進方法は、ヒトに対する医療行為を除く方法が好ましい。ここで、「ヒトに対する医療行為」とは、医師等の処方を必要として、ヒトに対して医薬品を摂取させる(投与する)行為などを意味する。本発明の筋肉合成促進方法は、本発明の筋肉合成促進剤について、本願明細書に記載された内容に従って実施することができる。 According to yet another embodiment of the present invention, 0.2-1.2% by weight soybean polysaccharide, 0.1-0.5% by weight HM pectin, 0.01-0.1% by weight fiber. A method for promoting muscle synthesis, comprising: ingesting an acidic liquid composition comprising a milk protein mixture comprising insoluble cellulose, casein protein and whey protein simultaneously or sequentially to a subject in need of muscle synthesis promotion A method for promoting muscle synthesis, in which the ratio of the amount of casein protein to whey protein (casein protein / whey protein) is 2 to 20, is provided. The method for accelerating muscle synthesis of the present invention is preferably a method that excludes medical practice for humans. Here, the “medical action for humans” means an action that requires a doctor or the like to ingest (administer) a medicine to a human. The muscle synthesis promoting method of the present invention can be carried out according to the contents described in the present specification for the muscle synthesis promoting agent of the present invention.
本発明の一つの好ましい実施態様によれば、本発明の筋肉合成促進方法において、酸性液状組成物は、0.5~5重量%のトレハロースを含有することができる。また、本発明の一つの好ましい態様によれば、本発明の筋肉合成促進方法において、酸性液状組成物のpHを3~6にすることができる。さらに、本発明の一つの好ましい態様によれば、本発明の筋肉合成促進方法において、酸性液状組成物は、繊維状の不要性セルロースとして、発酵セルロースを含むことができる。 According to one preferred embodiment of the present invention, in the muscle synthesis promotion method of the present invention, the acidic liquid composition may contain 0.5 to 5% by weight of trehalose. According to one preferred embodiment of the present invention, the pH of the acidic liquid composition can be adjusted to 3 to 6 in the muscle synthesis promoting method of the present invention. Furthermore, according to one preferable aspect of the present invention, in the muscle synthesis promoting method of the present invention, the acidic liquid composition may contain fermented cellulose as fibrous unnecessary cellulose.
本発明の一つの好ましい実施態様によれば、本発明の筋肉合成促進方法において、前記乳タンパク質混合物を総タンパク質量で一食あたり0.06g以上/kg体重となるように摂取(投与)させることができ、具体的には、0.06~0.7g/kg体重であり、好ましくは0.06~0.6g/kg体重、より好ましくは0.06~0.5g/kg体重、さらに好ましくは0.08~0.4g/kg体重、特に好ましくは0.1~0.4g/kg体重となるように摂取させることができる。 According to one preferred embodiment of the present invention, in the muscle synthesis promoting method of the present invention, the milk protein mixture is ingested (administered) so that the total protein amount is 0.06 g / kg body weight or more per meal. Specifically, it is 0.06 to 0.7 g / kg body weight, preferably 0.06 to 0.6 g / kg body weight, more preferably 0.06 to 0.5 g / kg body weight, still more preferably It can be ingested so as to give 0.08 to 0.4 g / kg body weight, particularly preferably 0.1 to 0.4 g / kg body weight.
本発明の一つの好ましい実施態様によれば、本発明の筋肉合成促進方法において、前記乳タンパク質混合物を総タンパク質量で一食あたり3g以上となるように摂取させることができ、具体的には、3~40g、好ましくは3~20g、より好ましくは4~20g、さらに好ましくは4~15g、特に好ましくは5~15gとなるように摂取させることができる。 According to one preferred embodiment of the present invention, in the muscle synthesis promotion method of the present invention, the milk protein mixture can be ingested so that the total protein amount is 3 g or more per meal, specifically 3 It can be ingested to a dose of ˜40 g, preferably 3 to 20 g, more preferably 4 to 20 g, even more preferably 4 to 15 g, particularly preferably 5 to 15 g.
本発明の一つの好ましい実施態様によれば、本発明の筋肉合成促進方法において、筋肉合成促進を必要とする対象は、好ましくは即効的な筋肉合成促進を必要とする対象であり、より好ましくは運動する対象、さらに好ましくは、筋肉トレーニングをする対象に摂取させることができる。 According to one preferred embodiment of the present invention, in the muscle synthesis promoting method of the present invention, the subject in need of muscle synthesis promotion is preferably a subject in need of immediate muscle synthesis promotion, more preferably It can be ingested by a subject that exercises, more preferably by a subject performing muscle training.
本発明の一つの実施態様によれば、本発明の筋肉合成促進方法において、前記酸性液状組成物を、筋肉合成促進を必要とする対象に加温した液状形態で摂取させることができる。 According to one embodiment of the present invention, in the muscle synthesis promotion method of the present invention, the acidic liquid composition can be ingested in a heated liquid form to a subject in need of muscle synthesis promotion.
本発明の別の実施形態によれば、0.2~1.2重量%の大豆多糖類、0.1~0.5重量%のHMペクチン、0.01~0.1重量%の繊維状の不溶性セルロース、カゼインタンパク質とホエイタンパク質とを含む乳タンパク質混合物を含む酸性液状組成物を、筋肉合成促進を必要とする疾患対象に摂取させることを含んでなる、筋肉合成促進を必要とする疾患の処置方法であって、ホエイタンパク質に対するカゼインタンパク質のタンパク質量比(カゼインタンパク質/ホエイタンパク質)が2~20である処置方法が提供される。本発明の筋肉合成促進を必要とする疾患の処置方法には、筋肉損傷疾患の処置方法、例えばサルコペニアの処置方法が含まれる。処置方法には、予防方法および治療方法が含まれる。本発明の処置方法は、本発明の筋肉合成促進方法について、本願明細書に記載された内容に従って実施することができる。 According to another embodiment of the present invention, 0.2-1.2% by weight soybean polysaccharide, 0.1-0.5% by weight HM pectin, 0.01-0.1% by weight fibrous. An insoluble cellulose, an acidic liquid composition comprising a milk protein mixture comprising casein protein and whey protein, ingested by a disease subject in need of muscle synthesis promotion, for a disease in need of muscle synthesis promotion A treatment method is provided, wherein the protein amount ratio of casein protein to whey protein (casein protein / whey protein) is 2-20. The method for treating a disease requiring the promotion of muscle synthesis of the present invention includes a method for treating a muscle damage disease, for example, a method for treating sarcopenia. Treatment methods include prophylactic and therapeutic methods. The treatment method of the present invention can be carried out in accordance with the contents described in the present specification for the muscle synthesis promotion method of the present invention.
本発明の一つの実施形態によれば、筋肉合成を促進するための、0.2~1.2重量%の大豆多糖類、0.1~0.5重量%のHMペクチン、0.01~0.1重量%の繊維状の不溶性セルロース、およびカゼインタンパク質とホエイタンパク質とを含む乳タンパク質混合物を含む酸性液状組成物を有効成分として含んでなる筋肉合成促進剤またはそれを含んでなる組成物であって、ホエイタンパク質に対するカゼインタンパク質のタンパク質量比(カゼインタンパク質/ホエイタンパク質)が2~20である、筋肉合成促進剤またはそれを含んでなる組成物の使用が提供される。本発明の一つの好ましい実施態様によれば、本発明の使用は、非治療的使用とされる。本発明の筋肉合成促進剤またはそれを含んでなる組成物の使用は、本発明の筋肉合成促進剤および筋肉合成促進方法ついて本明細書に記載された内容に従って実施することができる。 According to one embodiment of the present invention, 0.2-1.2% by weight soybean polysaccharide, 0.1-0.5% by weight HM pectin, 0.01- A muscle synthesis promoter comprising as an active ingredient an acidic liquid composition comprising 0.1% by weight of fibrous insoluble cellulose and a milk protein mixture comprising casein protein and whey protein, or a composition comprising the same There is provided use of a muscle synthesis promoter or a composition comprising the same, wherein the protein amount ratio of casein protein to whey protein (casein protein / whey protein) is 2 to 20. According to one preferred embodiment of the invention, the use of the invention is a non-therapeutic use. The use of the muscle synthesis promoter of the present invention or the composition comprising the same can be carried out according to the contents described herein for the muscle synthesis promoter of the present invention and the muscle synthesis promotion method.
本発明の一つの実施形態によれば、筋肉合成を促進するための食品または医薬品の製造のための、0.2~1.2重量%の大豆多糖類、0.1~0.5重量%のHMペクチン、0.01~0.1重量%の繊維状の不溶性セルロース、およびカゼインタンパク質とホエイタンパク質とを含む乳タンパク質混合物を含む酸性液状組成物を有効成分として含んでなる筋肉合成促進剤またはそれを含んでなる組成物であって、ホエイタンパク質に対するカゼインタンパク質のタンパク質量比(カゼインタンパク質/ホエイタンパク質)が2~20である筋肉合成促進剤またはそれを含んでなる組成物の使用が提供される。本発明の筋肉合成促進剤または組成物の使用は、本発明の筋肉合成促進剤および筋肉合成促進方法について本明細書に記載された内容に従って実施することができる。 According to one embodiment of the present invention, 0.2-1.2% by weight soy polysaccharide, 0.1-0.5% by weight for the manufacture of a food or pharmaceutical product to promote muscle synthesis. A muscle synthesis promoter comprising as an active ingredient an acidic liquid composition comprising HM pectin, 0.01 to 0.1% by weight of fibrous insoluble cellulose, and a milk protein mixture containing casein protein and whey protein, or There is provided a composition comprising the same, a muscle synthesis promoter having a protein content ratio of casein protein to whey protein (casein protein / whey protein) of 2 to 20, or a composition comprising the same. The The use of the muscle synthesis promoter or composition of the present invention can be carried out in accordance with the contents described herein for the muscle synthesis promoter and the muscle synthesis promotion method of the present invention.
本発明の一つの好ましい実施態様によれば、本発明の使用において、酸性液状組成物は、0.5~5重量%のトレハロースを含有することができる。また、本発明の一つの好ましい態様によれば、本発明の使用において、酸性液状組成物のpHを3~6にすることができる。さらに、本発明の一つの好ましい態様によれば、本発明の使用において、酸性液状組成物は、繊維状の不要性セルロースとして、発酵セルロースを含むことができる。 According to one preferred embodiment of the present invention, in the use of the present invention, the acidic liquid composition can contain 0.5 to 5% by weight of trehalose. According to one preferred embodiment of the present invention, the pH of the acidic liquid composition can be adjusted to 3-6 in the use of the present invention. Furthermore, according to one preferable aspect of the present invention, in the use of the present invention, the acidic liquid composition can contain fermented cellulose as fibrous unnecessary cellulose.
本発明の一つの好ましい実施態様によれば、本発明の使用において、前記乳タンパク質混合物を総タンパク質量で一食あたり0.06g以上/kg体重となるように摂取(投与)させることができ、具体的には、0.06~0.7g/kg体重であり、好ましくは0.06~0.6g/kg体重、より好ましくは0.06~0.5g/kg体重、さらに好ましくは0.08~0.4g/kg体重、特に好ましくは0.1~0.4g/kg体重となるように摂取させることができる。 According to one preferred embodiment of the present invention, in the use of the present invention, the milk protein mixture can be ingested (administered) so that the total protein amount is 0.06 g / kg body weight or more per meal, Specifically, it is 0.06 to 0.7 g / kg body weight, preferably 0.06 to 0.6 g / kg body weight, more preferably 0.06 to 0.5 g / kg body weight, and still more preferably 0.08. It can be ingested at a dose of ˜0.4 g / kg body weight, particularly preferably 0.1-0.4 g / kg body weight.
本発明の一つの好ましい実施態様によれば、本発明の使用において、前記乳タンパク質混合物を総タンパク質量で一食あたり3g以上となるように摂取させることができ、具体的には、3~40g、好ましくは3~20g、より好ましくは4~20g、さらに好ましくは4~15g、特に好ましくは5~15gとなるように摂取させることができる。 According to one preferred embodiment of the present invention, in the use of the present invention, the milk protein mixture can be ingested so that the total protein amount is 3 g or more per meal, specifically, 3 to 40 g, The ingestion amount is preferably 3 to 20 g, more preferably 4 to 20 g, still more preferably 4 to 15 g, and particularly preferably 5 to 15 g.
本発明の一つの好ましい実施態様によれば、本発明の使用において、対象は、運動する対象、好ましくは、筋肉トレーニングをする対象である。 According to one preferred embodiment of the present invention, in the use of the present invention, the subject is an exercise subject, preferably a muscle training subject.
本発明の一つの実施態様によれば、0.2~1.2重量%の大豆多糖類、0.1~0.5重量%のHMペクチン、0.01~0.1重量%の繊維状の不溶性セルロース、およびカゼインタンパク質とホエイタンパク質とを含む乳タンパク質混合物を含む酸性液状組成物であって、ホエイタンパク質に対するカゼインタンパク質のタンパク質量比(カゼインタンパク質/ホエイタンパク質)が2~20である、筋肉合成を促進するための、酸性液状組成物が提供される。本発明の筋肉合成を促進するための、酸性液状組成物は、本発明の筋肉合成促進剤について本明細書に記載された内容に従って設計することができる。 According to one embodiment of the invention, 0.2-1.2% by weight soybean polysaccharide, 0.1-0.5% by weight HM pectin, 0.01-0.1% by weight fibrous. An insoluble cellulose and an acidic liquid composition comprising a milk protein mixture containing casein protein and whey protein, wherein the protein amount ratio of casein protein to whey protein (casein protein / whey protein) is 2 to 20 An acidic liquid composition is provided to facilitate synthesis. The acidic liquid composition for promoting muscle synthesis of the present invention can be designed according to the contents described herein for the muscle synthesis promoter of the present invention.
ところで、本発明の筋肉合成促進剤は、例えば、0.2~1.2重量%の大豆多糖類、0.1~0.5重量%のHMペクチン、0.01~0.1重量%の繊維状の不溶性セルロースが含まれておらず、かつ酸性化されていない、カゼインタンパク質とホエイタンパク質とを含む乳タンパク質混合物を有効成分として含んでなる筋肉合成促進剤であって、ホエイタンパク質に対するカゼインタンパク質のタンパク質量比(カゼインタンパク質/ホエイタンパク質)が4である、非特許文献1の知見に基づく筋肉合成促進剤(以下、「乳タンパク質混合物のみからなる中性液状組成物を有効成分として含む筋肉合成促進剤」)と比較して、筋肉合成促進効果がより高まる。例えば、後述する動物実験による実施例(試験例1)において、同一量の乳タンパク質を摂取(投与)した場合、本発明の筋肉合成促進剤は、乳タンパク質混合物のみからなる中性液状組成物を有効成分として含む筋肉合成促進剤と比較して、高い効果を有することが示された。また、後述する動物実験による実施例(試験例2)において、本発明の筋肉合成促進剤を0.85g乳タンパク質/kg体重と低用量で摂取(投与)した場合と、乳タンパク質混合物のみからなる中性液状組成物を有効成分として含む筋肉合成促進剤を1.8g乳タンパク質/kg体重と高用量で摂取(投与)した場合とでは、その筋肉合成促進剤としての効果は同等の程度であった。 By the way, the muscle synthesis promoter of the present invention is, for example, 0.2 to 1.2% by weight soybean polysaccharide, 0.1 to 0.5% by weight HM pectin, 0.01 to 0.1% by weight. A muscle synthesis promoter comprising a milk protein mixture containing casein protein and whey protein, which is free of fibrous insoluble cellulose and is not acidified, as an active ingredient, and a casein protein for whey protein The protein synthesis ratio (casein protein / whey protein) is 4, a muscle synthesis promoter based on the knowledge of Non-Patent Document 1 (hereinafter referred to as “muscle synthesis containing a neutral liquid composition consisting only of a milk protein mixture as an active ingredient” Compared with the “accelerating agent”), the muscle synthesis promoting effect is further enhanced. For example, when the same amount of milk protein is ingested (administered) in an Example (Test Example 1) based on animal experiments described later, the muscle synthesis promoter of the present invention is a neutral liquid composition consisting only of a milk protein mixture. Compared with the muscle synthesis promoter containing as an active ingredient, it was shown to have a high effect. Further, in Examples (Test Example 2) based on animal experiments described later, the muscle synthesis promoter of the present invention was ingested (administered) at a low dose of 0.85 g milk protein / kg body weight, and consisted only of milk protein mixture When a muscle synthesis promoter containing a neutral liquid composition as an active ingredient is ingested (administered) at a high dose of 1.8 g milk protein / kg body weight, the effect as a muscle synthesis promoter is comparable. It was.
すなわち、本発明の筋肉合成促進剤は、乳タンパク質混合物のみからなる中性液状組成物を有効成分とする筋肉合成促進剤と比較して、一定量の乳タンパク質を摂取(投与)すれば、強い筋肉合成促進効果が期待できる。また、本発明の筋肉合成促進剤は、乳タンパク質混合物のみからなる中性液状組成物を有効成分とする筋肉合成促進剤と同等の効果を得るために、摂取すべき乳タンパク質混合物の量を低減することができ、より摂取(投与)しやすくなる。さらに、本発明の筋肉合成促進剤は、適度な酸味による爽やかさがあり、乳タンパク質混合物のみからなる中性液状組成物を有効成分とする筋肉合成促進剤と比較して、同じ濃度の乳タンパク質混合物を含有している場合においても、より摂取(投与)しやすくなる。 That is, the muscle synthesis promoter of the present invention is stronger when a certain amount of milk protein is ingested (administered) compared to a muscle synthesis promoter comprising a neutral liquid composition consisting only of a milk protein mixture as an active ingredient. Expected to promote muscle synthesis. In addition, the muscle synthesis promoter of the present invention reduces the amount of milk protein mixture to be consumed in order to obtain the same effect as the muscle synthesis promoter comprising a neutral liquid composition consisting only of a milk protein mixture as an active ingredient. Can be more easily taken (administered). Furthermore, the muscle synthesis promoter of the present invention has a refreshing property with a moderate acidity, and has the same concentration of milk protein as compared to a muscle synthesis promoter comprising a neutral liquid composition consisting only of a milk protein mixture as an active ingredient. Even when it contains a mixture, it becomes easier to ingest (administer).
以下では、実施例を挙げて、本発明をさらに詳細に説明するが、本発明は、これにより限定されない。 Hereinafter, the present invention will be described in more detail with reference to examples, but the present invention is not limited thereto.
[実施例1]
乳タンパク質濃縮物(乳タンパク質80重量%、乳糖6.5重量%)4.25kgを40.75kgの水に加熱溶解し、溶液Aとした。大豆多糖類(SM-900、三栄源エフエフアイ社製)0.45kg、HMペクチン(AYD5110SB、ユニテックフーズ社製)0.2kg、発酵セルロース(サンアーティストPG、三栄源エフエフアイ社製)0.05kg、トレハロース1kg、砂糖3.3kgスクラロース0.0063kgを39.99kgの水に加温溶解し、溶液Bとした。クエン酸0.64kgを9.36kgの水に溶解し、溶液Cとした。溶液Aと溶液Bを混合後、この混合液を撹拌しながら溶液Cを10回に分けて5分間かけて添加し、殺菌前のベースミックスとした。このベースミックスをプレート殺菌機で15MPaの均質化処理(70~80℃)をしてから、130℃2秒間の殺菌をした後に、10℃以下に冷却したものを実施例1の筋肉合成促進剤(乳タンパク質3.4重量%、大豆多糖類0.45重量%、HMペクチン0.2重量%、発酵セルロース0.05重量%、トレハロース1重量%)とした。実施例1の筋肉合成促進剤のpH4.1、粘度は10mPa・s(10℃)であった。「飲み口」、「沈殿」、「再分散性」ともに良好であった。以下、試験例1、2において、実施例1を「筋肉合成促進剤」と称する。なお、ここで使用した乳タンパク質濃縮物は、脱脂乳を膜分離処理(UF処理、MF処理など)して、乳糖や灰分を除去し、カゼインタンパク質とホエイタンパク質とを主体として濃縮した、カゼインタンパク質とホエイタンパク質との混合物であり、その形態は、乾燥粉末である。そして、乳タンパク質濃縮物のタンパク質量比は、生乳(牛乳)と同様に、カゼインタンパク質:ホエイタンパク質=約8:2である(山内邦男および横山健吉編、ミルク総合辞典参照)。
[Example 1]
4.25 kg of milk protein concentrate (milk protein 80 wt%, lactose 6.5 wt%) was dissolved by heating in 40.75 kg of water to obtain a solution A. Soy polysaccharides (SM-900, Saneigen FFI) 0.45 kg, HM pectin (AYD5110SB, Unitech Foods) 0.2 kg, fermented cellulose (Sun artist PG, Saneigen FFI) 0.05 kg 1 kg of trehalose and 3.3 kg of sugar 0.0063 kg of sucralose were dissolved by heating in 39.99 kg of water to obtain a solution B. A solution C was prepared by dissolving 0.64 kg of citric acid in 9.36 kg of water. After mixing the solution A and the solution B, the solution C was added in 10 portions over 5 minutes while stirring the mixed solution to obtain a base mix before sterilization. The base mix was homogenized at 15 MPa (70 to 80 ° C.) with a plate sterilizer, sterilized at 130 ° C. for 2 seconds, and then cooled to 10 ° C. or lower to obtain the muscle synthesis promoter of Example 1. (3.4% by weight of milk protein, 0.45% by weight of soybean polysaccharide, 0.2% by weight of HM pectin, 0.05% by weight of fermented cellulose, 1% by weight of trehalose). The muscle synthesis promoter of Example 1 had a pH of 4.1 and a viscosity of 10 mPa · s (10 ° C.). “Drinking mouth”, “precipitation” and “redispersibility” were all good. Hereinafter, in Test Examples 1 and 2, Example 1 is referred to as “muscle synthesis promoter”. The milk protein concentrate used here is casein protein obtained by subjecting skim milk to membrane separation treatment (UF treatment, MF treatment, etc.), removing lactose and ash, and concentrating mainly on casein protein and whey protein. And a whey protein in the form of a dry powder. And the protein amount ratio of milk protein concentrate is casein protein: whey protein = about 8: 2, like raw milk (milk) (see Kunio Yamauchi and Kenkichi Yokoyama, Milk General Dictionary).
[試験例1]
以下の通り、実施例1の筋肉合成促進剤による筋肉合成促進効果を検証した。
[Test Example 1]
The muscle synthesis promoting effect of the muscle synthesis promoter of Example 1 was verified as follows.
(1)ラットの水泳試験
実験動物には、初期体重が130~170gのSD系雄性ラット(日本クレア株式会社より入手した)を用いた。全てのラットは、明期7時~19時、暗期19時~7時として、室温の22±2℃の条件下にて、ステンレス製ケージ内で個体別に飼育された。
(1) Rat swimming test SD male rats (obtained from CLEA Japan, Inc.) having an initial weight of 130 to 170 g were used as experimental animals. All rats were individually housed in stainless steel cages at room temperature of 22 ± 2 ° C. with a light period of 7 to 19 o'clock and a dark period of 19 to 7 o'clock.
固形飼料(オリエンタル酵母工業株式会社製)を用いて、ラットを3~5日間予備飼育した後、水泳運動に馴化させるために、ラットを30分間の水泳運動(水温34℃)に供した。馴化水泳運動実施日の翌日から翌々日にかけて16時間絶食させた後、ラットを試験群ごとで体重差が生じないように9つに分けた(各試験群6~8尾ずつ)。その後、ラットを2時間の水泳運動に供した。水泳運動終了直後に、筋肉合成促進剤または乳タンパク質3.4重量%の脱脂粉乳溶液を24.24mL/kg体重でラットに経口摂取させた。経口摂取から15分後、または45分後、または75分後、または105分後に、重水素ラベルフェニルアラニン溶液(重水素ラベルフェニルアラニン225mgを生理食塩水10mLに溶解して調製した)を2.0mL/kg体重でラットに尾静脈投与した。尾静脈投与から15分後に(すなわち経口摂取から30分後、または60分後、または90分後、または120分後に)、イソフルラン麻酔下でラットを解剖した。腹部大静脈より全採血した後に、上肢三頭筋を摘出し、生理食塩水で洗浄後、直ちに液体窒素で凍結した。尾静脈投与の時刻および上肢三頭筋の凍結保存の時刻は正確に記録した。上肢三頭筋は分析時まで-80℃に保存した。
The rats were preliminarily raised for 3 to 5 days using a solid feed (Oriental Yeast Co., Ltd.), and then subjected to a 30-minute swimming exercise (water temperature 34 ° C.) in order to acclimate to the swimming exercise. After fasting for 16 hours from the next day to the day after the acclimated swimming exercise, the rats were divided into 9 groups (6 to 8 animals in each test group) so that there was no difference in body weight between the test groups. Thereafter, the rats were subjected to a 2-hour swimming exercise. Immediately after the end of swimming exercise, rats were orally ingested with a muscle synthesis promoter or a skim milk solution of 3.4% by weight of milk protein at 24.24 mL / kg body weight. After 15 minutes, 45 minutes, 75 minutes, or 105 minutes after ingestion, a deuterium labeled phenylalanine solution (prepared by dissolving 225 mg of deuterium labeled phenylalanine in 10 mL of physiological saline) was added at 2.0 mL / Rats were administered tail vein with kg body weight. Rats were dissected under isoflurane anesthesia 15 minutes after tail vein administration (
(2)骨格筋合成速度(FSR)の測定
先行文献(A. Kanda et al., Br J Nutr, Sep. 28, 981-987, 2013)の記載に基づいて、摘出、保存した上肢三頭筋についての骨格筋合成速度(FSR)を測定した。具体的には、骨格筋細胞のタンパク質に同化して存在する、あるいは骨格筋細胞中に遊離状態で存在する、フェニルアラニン(Phe)および重水素ラベルフェニルアラニン(Phe(Ring-D5))量を、LC/MS/MS(Waters社製)を用いてそれぞれ定量した。この測定条件は以下の通りである。すなわち、装置:LC/MS/MS(Waters社製)、カラム:ACQUITY UPLC BEH C18(Waters社製)、移動相:0.05%TFA水/0.05%TFA含有アセトニトリル、注入量 3μL、流速 0.3mL/min、UV 215nmである。
(2) Measurement of skeletal muscle synthesis rate (FSR) The triceps muscle of the extremity extracted and stored based on the description in the previous literature (A. Kanda et al., Br J Nutr, Sep. 28, 981-987, 2013) The skeletal muscle synthesis rate (FSR) for was measured. Specifically, the amounts of phenylalanine (Phe) and deuterium labeled phenylalanine (Phe (Ring-D5)) that are assimilated to the protein of skeletal muscle cells or are present in the skeletal muscle cells in a free state are expressed as LC Quantification was performed using / MS / MS (manufactured by Waters). The measurement conditions are as follows. That is, apparatus: LC / MS / MS (manufactured by Waters), column: ACQUITY UPLC BEH C18 (manufactured by Waters), mobile phase: acetonitrile containing 0.05% TFA water / 0.05% TFA,
ここで、以下の式により、骨格筋合成速度(FSR)を算出した。
FSR(%/day)=(Eb×100)/(Ea×t)
Ea:エンリッチメント(骨格筋細胞中に遊離状態で存在)
Eb:エンリッチメント(骨格筋細胞のタンパク質に同化して存在)
t:尾静脈投与から、上肢三頭筋を凍結保存するまでの時間(単位:日)
エンリッチメント=Phe(Ring-D5)/(Phe+Phe(Ring-D5))
Here, the skeletal muscle synthesis rate (FSR) was calculated by the following equation.
FSR (% / day) = (Eb × 100) / (Ea × t)
Ea: enrichment (present in free state in skeletal muscle cells)
Eb: enrichment (present assimilated to skeletal muscle cell protein)
t: Time from administration of tail vein to cryopreservation of triceps surae (unit: days)
Enrichment = Phe (Ring−D5) / (Phe + Phe (Ring−D5))
得られた数値から各試験群の平均値±標準誤差を求めた。統計処理は各タイムポイント(経口摂取後30分または60分または90分または120分)において、筋肉合成促進剤群と脱脂粉乳溶液群との間でStudentのt検定を行った。有意水準は5%未満とした(p<0.05)。この結果を図1に示す。 The average value ± standard error of each test group was determined from the obtained numerical values. In statistical processing, Student's t-test was performed between the muscle synthesis promoter group and the skim milk solution group at each time point (30 minutes, 60 minutes, 90 minutes, or 120 minutes after oral intake). The significance level was less than 5% (p <0.05). The result is shown in FIG.
筋肉合成促進剤の摂取によって、摂取30分後におけるラットの骨格筋合成速度が、脱脂粉乳溶液と比較して、有意に高値を示した(p<0.05、図1)。また、筋肉合成促進剤の摂取によって、摂取60分、90分、120分後においても脱脂粉乳溶液と比較して骨格筋合成速度の値が高まる傾向が見られた(p<0.10、図1)。これらの結果より、筋肉合成促進剤は、脱脂粉乳溶液より高い骨格筋合成促進効果を有することが示された。
As a result of ingestion of the muscle synthesis promoter, the skeletal muscle synthesis rate of the
[試験例2]
以下の通り、実施例1の筋肉合成促進剤による筋肉合成促進効果を検証した。
[Test Example 2]
The muscle synthesis promoting effect of the muscle synthesis promoter of Example 1 was verified as follows.
(1)ラットの水泳試験
実験動物には、初期体重が130~170gのSD系雄性ラット(日本クレア株式会社より入手した)を用いた。全てのラットは、明期7時~19時、暗期19時~7時として、室温の22±2℃の条件下にて、ステンレス製ケージ内で個体別に飼育された。
(1) Rat swimming test SD male rats (obtained from CLEA Japan, Inc.) having an initial weight of 130 to 170 g were used as experimental animals. All rats were individually housed in stainless steel cages at room temperature of 22 ± 2 ° C. with a light period of 7 to 19 o'clock and a dark period of 19 to 7 o'clock.
固形飼料(オリエンタル酵母工業株式会社製)を用いて、ラットを3~5日間予備飼育した後、水泳運動に馴化させるために、ラットを30分間の水泳運動(水温34℃)に供した。馴化水泳運動実施日の翌日から翌々日にかけて16時間絶食させた後、ラットを試験群ごとで体重差が生じないように9つに分けた(各試験群6~8尾ずつ)。その後、ラットを2時間の水泳運動に供した。水泳運動終了直後に、筋肉合成促進剤または乳タンパク質6.8重量%の脱脂粉乳溶液(高用量脱脂粉乳溶液)を24.24mL/kg体重でラットに経口摂取させた。経口摂取から15分後、または45分後、または75分後、または105分後に、重水素ラベルフェニルアラニン溶液(重水素ラベルフェニルアラニン225mgを生理食塩水10mLに溶解して調製した)を2.0mL/kg体重でラットに尾静脈投与した。尾静脈投与から15分後に(すなわち経口摂取から30分後、または60分後、または90分後、または120分後に)、イソフルラン麻酔下でラットを解剖した。腹部大静脈より全採血した後に、上肢三頭筋を摘出し、生理食塩水で洗浄後、直ちに液体窒素で凍結した。尾静脈投与の時刻および上肢三頭筋の凍結保存の時刻は正確に記録した。上肢三頭筋は分析時まで-80℃に保存した。
The rats were preliminarily raised for 3 to 5 days using a solid feed (Oriental Yeast Co., Ltd.), and then subjected to a 30-minute swimming exercise (water temperature 34 ° C.) in order to acclimate to the swimming exercise. After fasting for 16 hours from the next day to the day after the acclimated swimming exercise, the rats were divided into 9 groups (6 to 8 animals in each test group) so that there was no difference in body weight between the test groups. Thereafter, the rats were subjected to a 2-hour swimming exercise. Immediately after the end of swimming exercise, rats were orally ingested with a muscle synthesis promoter or 6.8 wt% skim milk solution (high-dose skim milk solution) of milk protein at 24.24 mL / kg body weight. After 15 minutes, 45 minutes, 75 minutes, or 105 minutes after ingestion, a deuterium labeled phenylalanine solution (prepared by dissolving 225 mg of deuterium labeled phenylalanine in 10 mL of physiological saline) was added at 2.0 mL / Rats were administered tail vein with kg body weight. Rats were dissected under isoflurane anesthesia 15 minutes after tail vein administration (
(2)骨格筋合成速度(FSR)の測定
先行文献(A. Kanda et al., Br J Nutr, Sep. 28, 981-987, 2013)の記載に基づいて、摘出、保存した上肢三頭筋についての骨格筋合成速度(FSR)を測定した。具体的には、骨格筋細胞のタンパク質に同化して存在する、あるいは骨格筋細胞中に遊離状態で存在する、フェニルアラニン(Phe)および重水素ラベルフェニルアラニン(Phe(Ring-D5))量を、LC/MS/MS(Waters社製)を用いてそれぞれ定量した。この測定条件は以下の通りである。すなわち、装置:LC/MS/MS(Waters社製)、カラム:ACQUITY UPLC BEH C18(Waters社製)、移動相:0.05%TFA水/0.05%TFA含有アセトニトリル、注入量 3μL、流速 0.3mL/min、UV 215nmである。
(2) Measurement of skeletal muscle synthesis rate (FSR) The triceps muscle of the extremity extracted and stored based on the description in the previous literature (A. Kanda et al., Br J Nutr, Sep. 28, 981-987, 2013) The skeletal muscle synthesis rate (FSR) for was measured. Specifically, the amounts of phenylalanine (Phe) and deuterium labeled phenylalanine (Phe (Ring-D5)) that are assimilated to the protein of skeletal muscle cells or are present in the skeletal muscle cells in a free state are expressed as LC Quantification was performed using / MS / MS (manufactured by Waters). The measurement conditions are as follows. That is, apparatus: LC / MS / MS (manufactured by Waters), column: ACQUITY UPLC BEH C18 (manufactured by Waters), mobile phase: acetonitrile containing 0.05% TFA water / 0.05% TFA,
ここで、以下の式により、骨格筋合成速度(FSR)を算出した。
FSR(%/day)=(Eb×100)/(Ea×t)
Ea:エンリッチメント(骨格筋細胞中に遊離状態で存在)
Eb:エンリッチメント(骨格筋細胞のタンパク質に同化して存在)
t:尾静脈投与から、上肢三頭筋を凍結保存するまでの時間(単位:日)
エンリッチメント=Phe(Ring-D5)/(Phe+Phe(Ring-D5))
Here, the skeletal muscle synthesis rate (FSR) was calculated by the following equation.
FSR (% / day) = (Eb × 100) / (Ea × t)
Ea: enrichment (present in free state in skeletal muscle cells)
Eb: enrichment (present assimilated to skeletal muscle cell protein)
t: Time from administration of tail vein to cryopreservation of triceps surae (unit: days)
Enrichment = Phe (Ring−D5) / (Phe + Phe (Ring−D5))
得られた数値から各試験群の平均値±標準誤差を求めた。統計処理は各タイムポイント(経口摂取後30分または60分または90分または120分)において、筋肉合成促進剤群と脱脂粉乳溶液群との間でStudentのt検定を行った。有意水準は5%未満とした(p<0.05)。この結果を図2に示す。 The average value ± standard error of each test group was determined from the obtained numerical values. In statistical processing, Student's t-test was performed between the muscle synthesis promoter group and the skim milk solution group at each time point (30 minutes, 60 minutes, 90 minutes, or 120 minutes after oral intake). The significance level was less than 5% (p <0.05). The result is shown in FIG.
筋肉合成促進剤は、高用量脱脂粉乳溶液と同等の骨格筋合成促進効果を示した。活性本体である乳タンパク質の摂取量は、筋肉合成促進剤群が0.85g/kg体重、高用量脱脂粉乳溶液群が1.8g/kg体重であり、筋肉合成促進剤は、脱脂粉乳溶液よりも少ない乳タンパク質摂取量で骨格筋合成を促進することが示された。 The muscle synthesis promoter showed an effect of promoting skeletal muscle synthesis equivalent to that of a high-dose skim milk solution. The intake of milk protein as the active body is 0.85 g / kg body weight in the muscle synthesis promoter group, and 1.8 g / kg body weight in the high-dose skim milk solution group. It was also shown that skeletal muscle synthesis was promoted with low milk protein intake.
[試験例3]
人工胃液(ペプシン0.6%含有、pH1.2)と筋肉合成促進剤とを、重量比で(人工胃液):(筋肉合成促進剤)=1:1.6となるように混合し、37℃10分間保持した。この時に、人工胃液と混合した筋肉合成促進剤では、筋肉合成促進剤に由来する乳タンパク質が凝集しなかった。対照として、同様の試験を、試験例1で使用した乳タンパク質3.4重量%の脱脂粉乳溶液、試験例2で使用した乳タンパク質6.8重量%の脱脂粉乳溶液(高用量脱脂粉乳溶液)を使用した試験も行った。人工胃液(ペプシン0.6%含有、pH1.2)と脱脂粉乳溶液とを、重量比で(人工胃液):(脱脂粉乳溶液)=1:1.6となるように混合し、37℃10分間保持した。この時に、人工胃液と混合した脱脂粉乳溶液では、どちらも脱脂粉乳溶液に由来する乳タンパク質が凝集した。
[Test Example 3]
The artificial gastric juice (containing 0.6% pepsin, pH 1.2) and the muscle synthesis promoter were mixed so that the weight ratio (artificial gastric fluid) :( muscle synthesis promoter) = 1: 1.6, 37 Hold for 10 minutes. At this time, in the muscle synthesis promoter mixed with the artificial gastric juice, milk proteins derived from the muscle synthesis promoter did not aggregate. As a control, the same test was carried out by using the milk protein 3.4% by weight skim milk solution used in Test Example 1 and the milk protein 6.8% by weight skim milk powder solution used in Test Example 2 (high-dose skim milk solution). A test using was also performed. Artificial gastric juice (containing 0.6% pepsin, pH 1.2) and skim milk powder solution are mixed at a weight ratio of (artificial gastric fluid) :( skim milk powder solution) = 1: 1.6 at 37 ° C. Hold for a minute. At this time, in the skim milk powder solution mixed with the artificial gastric juice, milk protein derived from the skim milk powder solution aggregated.
試験例1~3より、本発明の筋肉合成促進剤は、脱脂粉乳溶液と比較して、摂取(投与)された後に、胃内において、乳タンパク質が凝集(カード化)されないため、その後の腸管での乳タンパク質の吸収性が高まり、筋肉合成促進効果が高めるものと推察された。 From Test Examples 1 to 3, the muscle synthesis promoter of the present invention is not aggregated (carded) in the stomach after ingestion (administration) as compared with the skim milk solution, and the subsequent intestinal tract It was inferred that the milk protein absorbability increased in, and the effect of promoting muscle synthesis was enhanced.
Claims (13)
0.1~0.5重量%のHMペクチン、
0.01~0.1重量%の繊維状の不溶性セルロース、および
カゼインタンパク質とホエイタンパク質とを含む乳タンパク質混合物
を含む酸性液状組成物を有効成分として含んでなる筋肉合成促進剤であって、
ホエイタンパク質に対するカゼインタンパク質のタンパク質量比(カゼインタンパク質/ホエイタンパク質)が2~20である、筋肉合成促進剤。 0.2-1.2% by weight of soy polysaccharides,
0.1-0.5% by weight of HM pectin,
A muscle synthesis promoter comprising as an active ingredient an acidic liquid composition comprising 0.01 to 0.1% by weight of fibrous insoluble cellulose and a milk protein mixture containing casein protein and whey protein,
A muscle synthesis promoter having a protein amount ratio of casein protein to whey protein (casein protein / whey protein) of 2 to 20.
0.1~0.5重量%のHMペクチン、
0.01~0.1重量%の繊維状の不溶性セルロース、および
カゼインタンパク質とホエイタンパク質とを含む乳タンパク質混合物
を含む酸性液状組成物を、筋肉合成促進を必要とする対象に摂取させることを含んでなる、筋肉合成促進方法であって、ホエイタンパク質に対するカゼインタンパク質のタンパク質量比(カゼインタンパク質/ホエイタンパク質)が2~20である、筋肉合成促進方法。 0.2-1.2% by weight of soy polysaccharides,
0.1-0.5% by weight of HM pectin,
Ingesting an acidic liquid composition comprising 0.01 to 0.1% by weight of fibrous insoluble cellulose and a milk protein mixture comprising casein protein and whey protein into a subject in need of muscle synthesis promotion. A method for promoting muscle synthesis, wherein the ratio of the amount of casein protein to whey protein (casein protein / whey protein) is 2 to 20.
0.1~0.5重量%のHMペクチン、
0.01~0.1重量%の繊維状の不溶性セルロース、および
カゼインタンパク質とホエイタンパク質とを含む乳タンパク質混合物
を含む酸性液状組成物を、筋肉合成促進を必要とする対象に摂取させることを含んでなる、筋肉合成促進方法(ヒトに対する医療行為を除く)であって、ホエイタンパク質に対するカゼインタンパク質のタンパク質量比(カゼインタンパク質/ホエイタンパク質)が2~20である、筋肉合成促進方法。 0.2-1.2% by weight of soy polysaccharides,
0.1-0.5% by weight of HM pectin,
Ingesting an acidic liquid composition comprising 0.01 to 0.1% by weight of fibrous insoluble cellulose and a milk protein mixture comprising casein protein and whey protein into a subject in need of muscle synthesis promotion. A method for promoting muscle synthesis, which comprises a method for promoting muscle synthesis (excluding medical practice for humans), wherein the ratio of casein protein to whey protein (casein protein / whey protein) is 2 to 20.
0.2~1.2重量%の大豆多糖類、
0.1~0.5重量%のHMペクチン、
0.01~0.1重量%の繊維状の不溶性セルロース、および
カゼインタンパク質とホエイタンパク質とを含む乳タンパク質混合物
を含む酸性液状組成物を有効成分として含んでなる筋肉合成促進剤の使用であって、
ホエイタンパク質に対するカゼインタンパク質のタンパク質量比(カゼインタンパク質/ホエイタンパク質)が2~20である、使用。 To promote muscle synthesis,
0.2-1.2% by weight of soy polysaccharides,
0.1-0.5% by weight of HM pectin,
Use of a muscle synthesis promoter comprising as an active ingredient an acidic liquid composition comprising 0.01 to 0.1% by weight of fibrous insoluble cellulose and a milk protein mixture containing casein protein and whey protein, ,
Use, wherein the protein amount ratio of casein protein to whey protein (casein protein / whey protein) is 2-20.
0.2~1.2重量%の大豆多糖類、
0.1~0.5重量%のHMペクチン、
0.01~0.1重量%の繊維状の不溶性セルロース、および
カゼインタンパク質とホエイタンパク質とを含む乳タンパク質混合物
を含む酸性液状組成物を有効成分として含んでなる筋肉合成促進剤の使用であって、
ホエイタンパク質に対するカゼインタンパク質のタンパク質量比(カゼインタンパク質/ホエイタンパク質)が2~20である、使用。 For the production of food or pharmaceuticals to promote muscle synthesis,
0.2-1.2% by weight of soy polysaccharides,
0.1-0.5% by weight of HM pectin,
Use of a muscle synthesis promoter comprising as an active ingredient an acidic liquid composition comprising 0.01 to 0.1% by weight of fibrous insoluble cellulose and a milk protein mixture containing casein protein and whey protein, ,
Use, wherein the protein amount ratio of casein protein to whey protein (casein protein / whey protein) is 2-20.
0.1~0.5重量%のHMペクチン、
0.01~0.1重量%の繊維状の不溶性セルロース、および
カゼインタンパク質とホエイタンパク質とを含む乳タンパク質混合物
を含む酸性液状組成物であって、
ホエイタンパク質に対するカゼインタンパク質のタンパク質量比(カゼインタンパク質/ホエイタンパク質)が2~20である、
筋肉合成を促進するための、酸性液状組成物。 0.2-1.2% by weight of soy polysaccharides,
0.1-0.5% by weight of HM pectin,
An acidic liquid composition comprising 0.01 to 0.1% by weight of fibrous insoluble cellulose and a milk protein mixture comprising casein protein and whey protein,
The protein amount ratio of casein protein to whey protein (casein protein / whey protein) is 2 to 20,
An acidic liquid composition for promoting muscle synthesis.
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201680007692.XA CN107427058A (en) | 2015-01-29 | 2016-01-29 | Muscle synthesis accelerant |
| HK18104907.4A HK1245588A1 (en) | 2015-01-29 | 2016-01-29 | Muscle synthesis promoter |
| JP2016572178A JP6728071B2 (en) | 2015-01-29 | 2016-01-29 | Muscle synthesis promoter |
| SG11201705735QA SG11201705735QA (en) | 2015-01-29 | 2016-01-29 | Muscle synthesis promoter |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2015-016093 | 2015-01-29 | ||
| JP2015016093 | 2015-01-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2016121923A1 true WO2016121923A1 (en) | 2016-08-04 |
Family
ID=56543527
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/JP2016/052638 Ceased WO2016121923A1 (en) | 2015-01-29 | 2016-01-29 | Muscle synthesis promoter |
Country Status (6)
| Country | Link |
|---|---|
| JP (1) | JP6728071B2 (en) |
| CN (1) | CN107427058A (en) |
| HK (1) | HK1245588A1 (en) |
| SG (1) | SG11201705735QA (en) |
| TW (1) | TWI741975B (en) |
| WO (1) | WO2016121923A1 (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2018064494A (en) * | 2016-10-19 | 2018-04-26 | ハイドロックス株式会社 | Glycosaminoglycan and sialic acid-containing food |
| WO2018164251A1 (en) * | 2017-03-10 | 2018-09-13 | 株式会社明治 | Composition for improving physical strength |
| JP2019092415A (en) * | 2017-11-21 | 2019-06-20 | 株式会社大塚製薬工場 | Stabilizer, beverage and production method of the same |
| JPWO2019124355A1 (en) * | 2017-12-18 | 2020-12-10 | 株式会社明治 | Fermented milk for promoting muscle synthesis |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113100339A (en) * | 2021-04-22 | 2021-07-13 | 中国农业科学院北京畜牧兽医研究所 | A kind of preparation method of novel sheep muscle enhancer |
| CN114431380A (en) * | 2022-02-25 | 2022-05-06 | 广东君悦营养医学有限公司 | A kind of protein water suitable for sarcopenia syndrome and preparation method thereof |
| EP4494476A4 (en) * | 2022-03-15 | 2025-04-09 | FUJIFILM Corporation | Plant-derived protein binder, chunk-meat-like meat alternative, and method for producing chunk-meat-like meat alternative |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005245217A (en) * | 2004-03-01 | 2005-09-15 | Sanei Gen Ffi Inc | Acidic milk beverage and method for producing the same |
| JP2006320308A (en) * | 2005-04-19 | 2006-11-30 | Yuho:Kk | Method for producing animal/plant extract solution, animal/plant extract solution, and health drink, food, cosmetic or drug containing the animal/plant extract solution |
| JP2009507044A (en) * | 2005-09-09 | 2009-02-19 | マレー ゴールバーン コーオペラティブ コー リミテッド | Milk-derived composition and use for enhancing muscle mass or strength |
| WO2013150887A1 (en) * | 2012-04-05 | 2013-10-10 | サッポロホールディングス株式会社 | Soy milk fermentation product and method for producing same |
| JP2014100146A (en) * | 1998-10-28 | 2014-06-05 | Sanei Gen Ffi Inc | Sucralose-containing composition and application of the same |
| JP2014236668A (en) * | 2013-06-06 | 2014-12-18 | 日本新薬株式会社 | Acid liquid food composition |
| WO2015037720A1 (en) * | 2013-09-12 | 2015-03-19 | 株式会社明治 | Muscle repair promoter |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5695326B2 (en) * | 2010-02-12 | 2015-04-01 | 雪印メグミルク株式会社 | Protein synthesis promoter |
| CN101904354B (en) * | 2010-07-01 | 2012-12-12 | 内蒙古伊利实业集团股份有限公司 | Fruit-vinegar-contained acidic flavored milk beverage and preparation method thereof |
-
2016
- 2016-01-29 WO PCT/JP2016/052638 patent/WO2016121923A1/en not_active Ceased
- 2016-01-29 SG SG11201705735QA patent/SG11201705735QA/en unknown
- 2016-01-29 JP JP2016572178A patent/JP6728071B2/en active Active
- 2016-01-29 HK HK18104907.4A patent/HK1245588A1/en unknown
- 2016-01-29 CN CN201680007692.XA patent/CN107427058A/en active Pending
- 2016-01-29 TW TW105102895A patent/TWI741975B/en active
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2014100146A (en) * | 1998-10-28 | 2014-06-05 | Sanei Gen Ffi Inc | Sucralose-containing composition and application of the same |
| JP2005245217A (en) * | 2004-03-01 | 2005-09-15 | Sanei Gen Ffi Inc | Acidic milk beverage and method for producing the same |
| JP2006320308A (en) * | 2005-04-19 | 2006-11-30 | Yuho:Kk | Method for producing animal/plant extract solution, animal/plant extract solution, and health drink, food, cosmetic or drug containing the animal/plant extract solution |
| JP2009507044A (en) * | 2005-09-09 | 2009-02-19 | マレー ゴールバーン コーオペラティブ コー リミテッド | Milk-derived composition and use for enhancing muscle mass or strength |
| WO2013150887A1 (en) * | 2012-04-05 | 2013-10-10 | サッポロホールディングス株式会社 | Soy milk fermentation product and method for producing same |
| JP2014236668A (en) * | 2013-06-06 | 2014-12-18 | 日本新薬株式会社 | Acid liquid food composition |
| WO2015037720A1 (en) * | 2013-09-12 | 2015-03-19 | 株式会社明治 | Muscle repair promoter |
Non-Patent Citations (4)
| Title |
|---|
| DAICHI NAKAJIMA ET AL.: "Effect of total milk proteins ingestion on muscle mass and body fat", FOOD STYLE 21, vol. 16, no. 9, 2012, pages 76 - 78 * |
| KYOSUKE NAKAYAMA ET AL.: "Shinki Sansei Nyuinryo' wa Undogo no Kokkakukin Gosei o Sumiyaka ni Sokushin suru", PROCEEDINGS OF THE 2015 ANNUAL MEETING OF JAPAN SOCIETY FOR BIOSCIENCE, BIOTECHNOLOGY, AND AGROCHEMISTRY, 5 March 2015 (2015-03-05), pages 4F37a03, ISSN: 2186-7976 * |
| SEIICHIRO HIGASHI ET AL.: "Shinki Sansei Nyuinryo' wa Nyu Tanpakushitsu no Kyushu ga Hayai", PROCEEDINGS OF THE 2015 ANNUAL MEETING OF JAPAN SOCIETY FOR BIOSCIENCE, BIOTECHNOLOGY, AND AGROCHEMISTRY, 5 March 2015 (2015-03-05), pages 4F37a02, ISSN: 2186-7976 * |
| TAKAYUKI KITAGISHI ET AL.: "Intake of total milk proteins and prevention of sarcopenia", FOOD STYLE 21, vol. 17, no. 4, 1 April 2013 (2013-04-01), pages 56 - 58 * |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2018064494A (en) * | 2016-10-19 | 2018-04-26 | ハイドロックス株式会社 | Glycosaminoglycan and sialic acid-containing food |
| WO2018164251A1 (en) * | 2017-03-10 | 2018-09-13 | 株式会社明治 | Composition for improving physical strength |
| JP2019092415A (en) * | 2017-11-21 | 2019-06-20 | 株式会社大塚製薬工場 | Stabilizer, beverage and production method of the same |
| JP7052997B2 (en) | 2017-11-21 | 2022-04-12 | 株式会社大塚製薬工場 | Stabilizers, beverages and their manufacturing methods |
| JPWO2019124355A1 (en) * | 2017-12-18 | 2020-12-10 | 株式会社明治 | Fermented milk for promoting muscle synthesis |
Also Published As
| Publication number | Publication date |
|---|---|
| SG11201705735QA (en) | 2017-08-30 |
| TWI741975B (en) | 2021-10-11 |
| CN107427058A (en) | 2017-12-01 |
| JP6728071B2 (en) | 2020-07-22 |
| HK1245588A1 (en) | 2018-08-31 |
| TW201635920A (en) | 2016-10-16 |
| JPWO2016121923A1 (en) | 2017-11-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6728071B2 (en) | Muscle synthesis promoter | |
| RU2489905C2 (en) | Liquid enteral nutritional composition with high protein content | |
| JP5603871B2 (en) | Whey protein compositions, methods and uses | |
| JPWO2015037720A1 (en) | Muscle synthesis promoter | |
| JP6895257B2 (en) | Acidic milk drink and its manufacturing method | |
| TWI773739B (en) | A composition for promoting the increase in the amount of BDNF in the body | |
| Çelik | Whey every aspect | |
| JPWO2017026429A1 (en) | Muscle synthesis promoter | |
| EP3386316B1 (en) | Compositions | |
| JP6037595B2 (en) | Satiety induction composition and method for producing the same | |
| JP6430386B2 (en) | Body moisture retention agent | |
| TW201635909A (en) | Fatigue ameliorating agent | |
| AU2014253468A1 (en) | Whey protein compositions, methods and uses | |
| JPWO2018123873A1 (en) | Composition for promoting sweating | |
| WO2017146141A1 (en) | Rehydration agent | |
| WO2024185888A1 (en) | Nutrition-adjusted food and production method for same | |
| HK1225290A1 (en) | Muscle repair promoter | |
| TW201825011A (en) | Composition for improving protein efficiency ratio | |
| HK1225233A1 (en) | Bodily moisture retaining agent | |
| HK1261308A1 (en) | Rehydration agent | |
| HK1237217A1 (en) | Fatigue ameliorating agent | |
| NZ624548B2 (en) | Dairy product and process |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 16743526 Country of ref document: EP Kind code of ref document: A1 |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 11201705735Q Country of ref document: SG |
|
| ENP | Entry into the national phase |
Ref document number: 2016572178 Country of ref document: JP Kind code of ref document: A |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 16743526 Country of ref document: EP Kind code of ref document: A1 |